Ingersoll Rand (IR) 10-K 25 Feb 22 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Feb. 18, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-38095
Entity Registrant Name	Ingersoll Rand Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-2393770
Entity Address, Address Line One	800-A Beaty Street
Entity Address, City or Town	Davidson
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28036
City Area Code	704
Local Phone Number	655-4000
Title of 12(b) Security	Common Stock, $0.01 Par Value per share
Trading Symbol	IR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 18.9
Entity Common Stock, Shares Outstanding		407,967,909
Documents Incorporated by Reference	Portions of the Proxy Statement for the registrant’s 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.
Entity Central Index Key	0001699150
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	Charlotte, NC
Auditor Firm ID	34

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenues	$ 5,152,400,000	$ 3,973,200,000	$ 2,017,500,000
Cost of sales	3,163,900,000	2,568,300,000	1,239,200,000
Gross Profit	1,988,500,000	1,404,900,000	778,300,000
Selling and administrative expenses	1,028,000,000	789,300,000	409,600,000
Amortization of intangible assets	332,900,000	335,100,000	105,300,000
Impairment of other intangible assets	0	19,900,000	0
Other operating expense, net	61,900,000	201,000,000	69,300,000
Operating Income	565,700,000	59,600,000	194,100,000
Interest expense	87,700,000	111,100,000	88,400,000
Loss on extinguishment of debt	9,000,000	2,000,000	200,000
Other income, net	(44,000,000)	(8,100,000)	(4,700,000)
Income (Loss) Before Income Taxes	513,000,000	(45,400,000)	110,200,000
Provision (benefit) for income taxes	(21,800,000)	11,400,000	12,900,000
Loss on equity method investments	(11,400,000)	0	0
Income (Loss) from Continuing Operations	523,400,000	(56,800,000)	97,300,000
Income from discontinued operations, net of tax	41,600,000	24,400,000	61,800,000
Net Income (Loss)	565,000,000	(32,400,000)	159,100,000
Less: Net income attributable to noncontrolling interests	2,500,000	900,000	0
Net Income (Loss) Attributable to Ingersoll Rand Inc.	562,500,000	(33,300,000)	159,100,000
Amounts attributable to Ingersoll Rand Inc. common stockholders:
Income (loss) from continuing operations, net of tax	520,900,000	(57,700,000)	97,300,000
Income from discontinued operations, net of tax	41,600,000	24,400,000	61,800,000
Net Income (Loss) Attributable to Ingersoll Rand Inc.	$ 562,500,000	$ (33,300,000)	$ 159,100,000
Basic earnings (loss) per share of common stock:
Earnings (loss) from continuing operations (USD per share)	$ 1.26	$ (0.15)	$ 0.48
Earnings (loss) from discontinued operations (USD per share)	0.10	0.06	0.30
Net earnings (loss) (USD per share)	1.36	(0.09)	0.78
Diluted earnings (loss) per share of common stock:
Earnings (loss) from continuing operations (USD per share)	1.24	(0.15)	0.47
Earnings (loss) from discontinued operations (USD per share)	0.10	0.06	0.30
Net earnings (loss) (USD per share)	$ 1.34	$ (0.09)	$ 0.76

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Comprehensive Income Attributable to Ingersoll Rand Inc.
Net income (loss) attributable to Ingersoll Rand Inc.	$ 562.5	$ (33.3)	$ 159.1
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net	(103)	268.2	(1.5)
Unrecognized gains on cash flow hedges, net	0	10.9	7.2
Pension and other postretirement prior service cost and gain (loss), net	48.7	(8.9)	(6.5)
Other comprehensive income (loss), net of tax	(54.3)	270.2	(0.8)
Comprehensive income attributable to Ingersoll Rand Inc.	508.2	236.9	158.3
Comprehensive Income (Loss) Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests	2.5	0.9	0
Other comprehensive loss, net of tax:
Foreign currency translation adjustments, net	(2.3)	(1.4)	0
Total other comprehensive loss, net of tax	(2.3)	(1.4)	0
Comprehensive income (loss) attributable to noncontrolling interests	0.2	(0.5)	0
Total Comprehensive Income	$ 508.4	$ 236.4	$ 158.3

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 2,109.6	$ 1,750.9
Accounts receivable, net of allowance for credit losses of $42.3 and $50.9, respectively	948.6	861.8
Inventories	854.2	716.7
Other current assets	186.9	195.3
Assets of discontinued operations - current	15.6	337.4
Total current assets	4,114.9	3,862.1
Property, plant and equipment, net of accumulated depreciation of $357.7 and $291.1, respectively	648.6	609
Goodwill	5,981.6	5,582.6
Other intangible assets, net	3,912.7	3,797.2
Deferred tax assets	28	15.6
Other assets	468.7	329.3
Assets of discontinued operations - long-term	0	1,862.8
Total assets	15,154.5	16,058.6
Current liabilities
Short-term borrowings and current maturities of long-term debt	38.8	40.4
Accounts payable	670.5	536.4
Accrued liabilities	741.3	708.9
Liabilities of discontinued operations - current	17.1	212.9
Total current liabilities	1,467.7	1,498.6
Long-term debt, less current maturities	3,401.8	3,859.1
Pensions and other postretirement benefits	195.1	272.5
Deferred income taxes	708.6	702.4
Other liabilities	310.1	343.7
Liabilities of discontinued operations - long-term	0	192.8
Total liabilities	6,083.3	6,869.1
Commitments and contingencies
Stockholders’ equity
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 423,785,571 and 420,123,978 shares issued as of December 31, 2021 and 2020, respectively	4.3	4.2
Capital in excess of par value	9,408.6	9,310.3
Retained earnings (accumulated deficit)	378.6	(175.7)
Accumulated other comprehensive income (loss)	(41.6)	14.2
Treasury stock at cost; 16,000,364 and 1,496,169 shares as of December 31, 2021 and 2020, respectively	(748.4)	(33.3)
Total Ingersoll Rand Inc. stockholders’ equity	9,001.5	9,119.7
Noncontrolling interests	69.7	69.8
Total equity	9,071.2	9,189.5
Total liabilities and equity	$ 15,154.5	$ 16,058.6

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 42.3	$ 50.9
Accumulated depreciation on property, plant and equipment	$ 357.7	$ 291.1
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock authorized (shares)	1,000,000,000	1,000,000,000
Common stock issued (shares)	423,785,571	420,123,978
Treasury stock (shares)	16,000,364	1,496,169

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Total Ingersoll Rand Inc. Stockholders’ Equity	Total Ingersoll Rand Inc. Stockholders’ EquityCumulative Effect, Period of Adoption, Adjustment	Common Stock	Capital in Excess of Par Value	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit)Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2018					201.1
Balance at beginning of period at Dec. 31, 2018	$ 1,676	$ 0	$ 1,676		$ 2	$ 2,282.7	$ (308.7)	$ 8.2	$ (247)	$ (8.2)	$ (53)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	159.1		159.1				159.1
Issuance of common stock for stock-based compensation plans (shares)					5.7
Issuance of common stock for stock-based compensation plans	34.6		34.6		$ 0.1	34.5
Purchases of treasury stock	(18.6)		(18.6)								(18.6)
Issuance of treasury stock for stock-based compensation plans	8.4		8.4			(26.4)					34.8
Stock-based compensation	11.2		11.2			11.2
Other comprehensive income (loss), net of tax	$ (0.8)		(0.8)						(0.8)
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Balance at end of period (shares) at Dec. 31, 2019					206.8
Balance at end of period at Dec. 31, 2019	$ 1,869.9	$ (1)	1,869.9	$ (1)	$ 2.1	2,302	(141.4)	$ (1)	(256)		(36.8)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(32.4)		(33.3)				(33.3)					0.9
Issuance of common stock for stock-based compensation plans (shares)					2.3
Issuance of common stock for stock-based compensation plans	20.1		20.1			20.1
Purchases of treasury stock	(2.1)		(2.1)								(2.1)
Issuance of treasury stock for stock-based compensation plans	2.4		2.4			(3.2)					5.6
Acquisition of Ingersoll Rand Industrial (Note 3) (shares)					211
Acquisition of Ingersoll Rand Industrial (Note 4)	7,010.3		6,937		$ 2.1	6,934.9						73.3
Costs of issuing equity securities (Note 4)	(1)		(1)			(1)
Stock-based compensation	57.5		57.5			57.5
Other comprehensive income (loss), net of tax	268.8		270.2						270.2			(1.4)
Adjustments for shares tendered in open offer (Note 13)	(14.9)											(14.9)
Adjustments for shares sold in offer for sale (Note 13)	11.9											11.9
Balance at end of period (shares) at Dec. 31, 2020					420.1
Balance at end of period at Dec. 31, 2020	9,189.5		9,119.7		$ 4.2	9,310.3	(175.7)		14.2		(33.3)	69.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	565		562.5				562.5					2.5
Dividends declared	(8.2)		(8.2)				(8.2)
Issuance of common stock for stock-based compensation plans (shares)					3.7
Issuance of common stock for stock-based compensation plans	20.4		20.4		$ 0.1	20.3
Purchases of treasury stock	(736.8)		(736.8)								(736.8)
Issuance of treasury stock for stock-based compensation plans	1.8		1.8			(19.9)					21.7
Stock-based compensation	97.9		97.9			97.9
Other comprehensive income (loss), net of tax	(56.6)								(54.3)		(54.3)	(2.3)
Divestiture of foreign subsidiaries	(1.5)		(1.5)						(1.5)
Dividends attributable to noncontrolling interests	(0.3)											(0.3)
Balance at end of period (shares) at Dec. 31, 2021					423.8
Balance at end of period at Dec. 31, 2021	$ 9,071.2		$ 9,001.5		$ 4.3	$ 9,408.6	$ 378.6		$ (41.6)		$ (748.4)	$ 69.7

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash Flows From Operating Activities
Net Income (Loss)	$ 565,000,000	$ (32,400,000)	$ 159,100,000
Income from discontinued operations, net of tax	41,600,000	24,400,000	61,800,000
Income (loss) from continuing operations	523,400,000	(56,800,000)	97,300,000
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities from continuing operations:
Amortization of intangible assets	332,900,000	335,100,000	105,300,000
Depreciation	89,200,000	77,400,000	41,200,000
Impairment of other intangible assets	0	19,900,000	0
Non-cash restructuring charges	1,100,000	6,200,000	400,000
Stock-based compensation expense	87,200,000	47,500,000	18,700,000
Loss on equity method investments	11,400,000	0	0
Foreign currency transaction losses (gains), net	(12,000,000)	18,600,000	7,300,000
Loss on extinguishment of debt	9,000,000	2,000,000	200,000
Non-cash adjustments to carrying value of LIFO inventories	33,200,000	39,800,000	200,000
Deferred income taxes	103,600,000	83,100,000	21,300,000
Other non-cash adjustments	(200,000)	0	800,000
Changes in assets and liabilities
Receivables	(62,500,000)	52,400,000	(14,500,000)
Inventories	(134,400,000)	159,000,000	27,400,000
Accounts payable	118,200,000	(43,400,000)	44,200,000
Accrued liabilities	(220,000,000)	115,700,000	(25,000,000)
Other assets and liabilities, net	(45,100,000)	(36,800,000)	(58,700,000)
Net cash provided by operating activities from continuing operations	627,800,000	653,500,000	223,500,000
Cash Flows From Investing Activities
Capital expenditures	(64,100,000)	(42,000,000)	(37,900,000)
Net cash (paid) acquired in business combinations		9,000,000
Net cash (paid) acquired in business combinations	(974,800,000)		(12,000,000)
Disposals of property, plant and equipment	9,500,000	1,700,000	400,000
Net cash used in investing activities from continuing operations	(1,029,400,000)	(31,300,000)	(49,500,000)
Cash Flows From Financing Activities
Principal payments on long-term debt	(435,700,000)	(1,619,100,000)	(32,600,000)
Proceeds from long-term debt	0	1,980,100,000	0
Cash dividends on common stock	(8,200,000)	0	0
Purchases of treasury stock	(736,800,000)	(2,100,000)	(18,600,000)
Proceeds from stock option exercises	23,700,000	22,700,000	42,700,000
Payments of debt issuance costs	0	(47,800,000)	(500,000)
Purchase of shares from noncontrolling interests	0	(14,900,000)	0
Proceeds from sale of noncontrolling interests	0	11,900,000	0
Other financing	0	(2,100,000)	(1,300,000)
Net cash (used in) provided by financing activities from continuing operations	(1,157,000,000)	328,700,000	(10,300,000)
Cash Flows From Discontinued Operations:
Net cash provided by (used in) operating activities	(12,300,000)	260,800,000	119,800,000
Net cash provided by (used in) investing activities	1,943,700,000	(6,600,000)	(4,800,000)
Net cash used in financing activities	0	0	(1,200,000)
Net cash provided by discontinued operations	1,931,400,000	254,200,000	113,800,000
Effect of exchange rate changes on cash and cash equivalents	(14,100,000)	40,300,000	6,800,000
Net increase in cash and cash equivalents	358,700,000	1,245,400,000	284,300,000
Cash and cash equivalents, beginning of year	1,750,900,000	505,500,000	221,200,000
Cash and cash equivalents, end of year	2,109,600,000	1,750,900,000	505,500,000
Supplemental Cash Flow Information
Cash paid for income taxes	427,900,000	106,300,000	61,600,000
Cash paid for interest	79,800,000	98,700,000	85,600,000
Capital expenditures in accounts payable	$ 3,500,000	$ 4,000,000	$ 4,800,000

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Overview and Basis of Presentation Ingersoll Rand Inc. is a global market leader with a broad range of innovative and mission-critical air, fluid, energy, specialty vehicle and medical technologies, providing services and solutions to increase industrial productivity and efficiency. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”). On February 29, 2020, Ingersoll Rand Inc. (formerly known as Gardner Denver Holdings, Inc.) completed the acquisition of the Ingersoll Rand Industrial business (“Ingersoll Rand Industrial”) by way of merger and changed its name from Gardner Denver Holdings, Inc. to Ingersoll Rand Inc. The consolidated financial statements as of and for the year ended December 31, 2020 include the financial results of Ingersoll Rand Industrial from the date of acquisition. Principles of Consolidation The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows. Foreign Currency Translation Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income (loss), and are reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.” Revenue Recognition The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations. See Note 15 “Revenue from Contracts with Customers” for additional information regarding revenue recognition. Cost of Sales Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers. Selling and Administrative Expenses Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses. Cash and Cash Equivalents Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2021 and 2020, cash of $2.5 million and $3.1 million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company. Accounts Receivable Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment. Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions. Inventories Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred. Property, Plant and Equipment Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years. Goodwill and Indefinite-Lived Intangible Assets Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value. The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value. The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates. See Note 9 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets. Long-Lived Assets Including Intangible Assets With Finite Useful Lives Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection. The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose. Warranty Reserves Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure. Stock-Based Compensation Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units are valued at the share price on the date of grant. See Note 18 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans. Pension and Other Postretirement Benefits The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2021 and 2020 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost. See Note 12 “Benefit Plans” for disclosures related to the Company’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations. Income Taxes The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income taxes are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed. The Tax Cuts and Jobs Act, enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above) going forward. The tax provision for the year ended December 31, 2021 reflects this decision. All of the additional calculations and rule changes found in the Tax Act have been considered in the tax provision for the year ended December 31, 2021. The Company recorded a tax expense of $11.7 million in 2021 for the GILTI provisions of the Tax Act. Research and Development For the years ended December 31, 2021, 2020 and 2019, the Company spent approxima tely $74 million, $58 million, and $22 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations. Derivative Financial Instruments All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, or (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge or an eligible net investment in a foreign operation, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations. Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations. Comprehensive Income The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 14 “Accumulated Other Comprehensive Income (Loss).” Restructuring Charges The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs. A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred. Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations. Business Combinations The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred. Earnings per Share The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.

New Accounting Standards

New Accounting Standards	12 Months Ended
	Dec. 31, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting Standards Adopted Accounting Standard Updates (“ASU”) In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for a limited time to ease the potential burden of accounting for reference rate reform on financial reporting. This guidance applies to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates. The guidance is effective beginning on March 12, 2020 through December 31, 2022. The Company has not utilized any of the optional expedients or exceptions available under this ASU. The Company will continue to assess whether this ASU is applicable throughout the effective period. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The amendments in this update simplify the accounting for income taxes by removing certain exceptions and amending and clarifying existing guidance. The guidance is effective for public companies beginning with the first quarter of 2021. Early adoption is permitted. The Company adopted this guidance on January 1, 2021. The adoption did not have a material impact on our consolidated financial statements. Recently Issued Accounting Pronouncements In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848) : Scope, which explicitly clarifies which contracts, hedging relationships, and other transactions are within the scope of the optional expedients and exceptions allowed under Topic 848. The Company has not utilized any of the optional expedients or exceptions available under Topic 848. The Company will continue to assess whether this ASU is applicable through December 31, 2022, in conjunction with our assessment of ASU 2020-4. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805)

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations Discontinued operations comprise two formerly-owned businesses, Specialty Vehicle Technologies (“SVT” or “Club Car”) and High Pressure Solutions (“HPS”). The results of operations, financial positions and cash flows of these businesses are reported as discontinued operations for all periods presented in these consolidated financial statements. Specialty Vehicle Technologies On April 9, 2021, the Company entered into an agreement to sell Club Car to private equity firm Platinum Equity Advisors, LLC (“Platinum Equity”) for $1.68 billion in cash. The sale was substantially completed on June 1, 2021. SVT is presented as a discontinued operation and its net assets are classified as held for sale for all periods presented. The Company recognized a pre-tax gain on sale of $298.3 million for the year ended December 31, 2021. High Pressure Solutions On February 14, 2021, the Company entered into an agreement to sell its majority interest in High Pressure Solutions to private equity firm American Industrial Partners. In exchange for its majority interest of 55%, the Company received net cash proceeds of $278.3 million and retained a 45% common equity interest in the newly-formed entity comprising the HPS business. The Company expects to maintain this minority investment indefinitely and is unable to estimate when this interest may be disposed. This sale was substantially completed on April 1, 2021. HPS is presented as a discontinued operation and its net assets are classified as held for sale for all periods presented. The Company recognized a pre-tax loss on sale of $207.7 million for the year ended December 31, 2021. Financial information of discontinued operations The results of operations of SVT and HPS are presented as discontinued operations for the years ended December 31, 2021, 2020 and 2019 as summarized below: Specialty Vehicle Technologies High Pressure Solutions Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Revenues $ 430.9 $ 741.4 $ — $ 71.9 $ 195.6 $ 434.4 $ 502.8 $ 937.0 $ 434.4 Cost of sales 321.3 564.6 — 60.2 163.9 301.0 381.5 728.5 301.0 Gross Profit 109.6 176.8 — 11.7 31.7 133.4 121.3 208.5 133.4 Selling and administrative expenses 35.7 63.0 — 5.3 42.5 26.8 41.0 105.5 26.8 Amortization of intangible assets 10.4 37.1 — 2.4 23.6 19.0 12.8 60.7 19.0 Loss (gain) on sale (298.3) — — 207.7 — — (90.6) — — Other operating expense, net 18.1 1.7 — 19.0 14.5 6.4 37.1 16.2 6.4 Operating Income (Loss) 343.7 75.0 — (222.7) (48.9) 81.2 121.0 26.1 81.2 Interest expense — — — — — 0.5 — — 0.5 Other expense, net — — — — 0.1 — — 0.1 — Income (Loss) from Discontinued Operations Before Income Taxes 343.7 75.0 — (222.7) (49.0) 80.7 121.0 26.0 80.7 Provision (benefit) for income taxes 87.1 12.9 — (7.7) (11.3) 18.9 79.4 1.6 18.9 Income (Loss) from Discontinued Operations, Net of Tax $ 256.6 $ 62.1 $ — $ (215.0) $ (37.7) $ 61.8 $ 41.6 $ 24.4 $ 61.8 The carrying value of major classes of assets and liabilities related to SVT and HPS that were included in discontinued operations at December 31, 2021 and December 31, 2020 are shown in the table below. Long-term assets and liabilities as of December 31, 2021 have been reclassified as current in the Consolidated Balance Sheets. December 31, 2021 (1) December 31, 2020 (2) Assets Current assets: Cash and cash equivalents $ 6.2 $ — Accounts receivable, net 2.5 104.8 Inventories 5.6 226.9 Other current assets 0.1 5.7 Total current assets 14.4 337.4 Property, plant and equipment, net 1.2 188.3 Goodwill — 721.0 Other intangible assets, net — 935.4 Deferred tax assets — 0.5 Other assets — 17.6 Total non-current assets 1.2 1,862.8 Total assets $ 15.6 $ 2,200.2 Liabilities Current liabilities: Accounts payable $ 2.2 $ 134.7 Accrued liabilities 14.9 78.2 Total current liabilities 17.1 212.9 Pensions and other postretirement benefits — 2.5 Deferred income taxes — 173.3 Other liabilities — 17.0 Total non-current liabilities — 192.8 Total liabilities $ 17.1 $ 405.7 (1) Relates to certain non-U.S. subsidiaries for which legal ownership of assets has not yet transferred. (2) Total assets and total liabilities related to SVT were $1,512.7 million and $354.1 million, respectively, at December 31, 2020. The significant non-cash operating items and capital expenditures reflected in cash flows of discontinued operations for the years ended December 31, 2021, 2020 and 2019 include the following: Specialty Vehicle Technologies High Pressure Solutions Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Loss (gain) on sale $ (298.3) $ — $ — $ 207.7 $ — $ — $ (90.6) $ — $ — Depreciation and amortization 14.8 51.5 — 4.0 36.9 31.6 18.8 88.4 31.6 Stock-based compensation expense 8.2 3.0 — 2.7 0.8 0.5 10.9 3.8 0.5 Capital expenditures 1.6 3.1 — 0.3 3.6 5.3 1.9 6.7 5.3

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting A description of the Company’s two reportable segments, including the specific products manufactured and sold follows below. In the Industrial Technologies and Services segment, the Company designs, manufactures, markets and services a broad range of compression and vacuum equipment as well as fluid transfer equipment and loading systems. The Company’s compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, energy, environmental and other applications. In addition to equipment sales, the Company offers a broad portfolio of service options tailored to customer needs and complete range of aftermarket parts, air treatment equipment, controls and other accessories. The Company’s engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials. In the Precision and Science Technologies segment, the Company designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment and aftermarket parts for medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, energy, food and beverage, agriculture and other markets. The Company’s products are used for a diverse set of applications including precision dosing of chemicals and supplements, blood dialysis, oxygen therapy, food processing, fluid transfer and dispensing, spray finishing and coating, mixing, high-pressure air and gas management and others. The Company sells primarily through a broad global network of specialized and national distributors and original equipment manufacturers who integrate the Company’s products into their devices and systems. The Chief Operating Decision Maker (“CODM”) evaluates the performance of the Company’s reportable segments based on, among other measures, Segment Adjusted EBITDA. Management closely monitors the Segment Adjusted EBITDA of each reportable segment to evaluate past performance and actions required to improve profitability. Inter-segment sales and transfers are not significant. Administrative expenses related to the Company’s corporate offices and shared service centers in the United States and Europe, which includes transaction processing, accounting and other business support functions, are allocated to the business segments. Certain administrative expenses, including senior management compensation, treasury, internal audit, tax compliance, certain information technology, and other corporate functions, are not allocated to the business segments. The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income (Loss) Before Income Taxes for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Revenue Industrial Technologies and Services $ 4,161.0 $ 3,248.2 $ 1,700.9 Precision and Science Technologies 991.4 725.0 316.6 Total Revenue $ 5,152.4 $ 3,973.2 $ 2,017.5 Segment Adjusted EBITDA Industrial Technologies and Services $ 1,033.7 $ 759.8 $ 391.4 Precision and Science Technologies 291.4 220.2 95.8 Total Segment Adjusted EBITDA 1,325.1 980.0 487.2 Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes: Corporate expenses not allocated to segments 133.2 101.9 45.6 Interest expense 87.7 111.1 88.4 Depreciation and amortization expense (1) 418.0 410.4 146.5 Impairment of other intangible assets — 19.9 — Restructuring and related business transformation costs (2) 18.8 88.0 19.6 Acquisition related expenses and non-cash charges (3) 65.2 181.5 54.6 Gain on settlement of post-acquisition contingencies (30.1) — — Stock-based compensation (4) 95.9 47.0 20.2 Loss on extinguishment of debt 9.0 2.0 0.2 Foreign currency transaction losses (gains), net (12.0) 18.6 7.3 Adjustments to LIFO inventories (5) 33.2 39.8 0.2 Shareholder litigation settlement recoveries (6) — — (6.0) Other adjustments (7) (6.8) 5.2 0.4 Income (Loss) Before Income Taxes $ 513.0 $ (45.4) $ 110.2 (1) Depreciation and amortization expense excludes $4.1 million and $2.1 million of depreciation of rental equipment for the years ended December 31, 2021 and 2020, respectively. (2) Restructuring and related business transformation costs consist of the following. 2021 2020 2019 Restructuring charges $ 13.4 $ 83.0 $ 11.1 Facility reorganization, relocation and other costs 3.1 2.1 2.4 Other, net 2.3 2.9 6.1 Total restructuring and related business transformation costs $ 18.8 $ 88.0 $ 19.6 (3) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs (including certain incentive and non-incentive cash compensation costs) and non-cash charges and credits arising from fair value purchase accounting adjustments. (4) Represents sto ck-based compensation expense recognized for the year ended December 31, 2021 of $87.2 million and associated employer taxes of $8.7 million. Represents stock-based compensation expense recognized for the year ended December 31, 2020 of $47.5 million decreased by $0.5 million due to costs associated with employer taxes. Represents stock-based compensation expense recognized for the year ended December 31, 2019 of $18.7 million and associated employer taxes of $1.5 million. (5) For the year ended December 31, 2021, represents $33.2 million of LIFO reserve changes. For the year ended December 31, 2020, includes $4.2 million of LIFO reserve changes and $35.6 million to reduce the carrying value of inventories acquired in the merger with Ingersoll Rand Industrial accounted for under the LIFO method. We have reclassified the amounts in 2020 from “Other adjustments” and “Acquisition related expenses and non-cash charges,” respectively, to conform to the current year presentation. (6) Represents insurance recoveries in 2019 of the Company’s shareholder litigation settlement in 2014. (7) Includes (i) effects of amortization of prior service costs and amortization of losses in pension and other postretirement benefits (“OPEB”) expense, (ii) certain legal and compliance costs and (iii) other miscellaneous adjustments. The following tables provide summarized information about the Company’s reportable segments. Depreciation and Amortization Expense 2021 2020 2019 Industrial Technologies and Services $ 296.6 $ 306.0 $ 120.0 Precision and Science Technologies 108.3 102.4 23.6 Corporate and other 17.2 4.1 2.9 Total depreciation and amortization expense $ 422.1 $ 412.5 $ 146.5 Capital Expenditures 2021 2020 2019 Industrial Technologies and Services $ 53.1 $ 32.2 $ 31.5 Precision and Science Technologies 10.7 9.8 5.5 Corporate and other 0.3 — 0.9 Total capital expenditures $ 64.1 $ 42.0 $ 37.9 Identifiable Assets 2021 2020 Industrial Technologies and Services $ 9,101.7 $ 9,113.4 Precision and Science Technologies 3,572.2 2,852.8 Corporate and other 2,465.0 1,892.2 Assets of discontinued operations 15.6 2,200.2 Total identifiable assets $ 15,154.5 $ 16,058.6 The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2021, and 2020. 2021 2020 United States $ 225.8 $ 203.7 Other Americas 16.5 14.6 Total Americas 242.3 218.3 EMEA (1) 221.3 216.0 Asia Pacific 185.0 174.7 Total $ 648.6 $ 609.0 (1) Europe, Middle East and Africa (“EMEA”)

Business Combinations

Business Combinations	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations 2021 Acquisitions The Company acquired multiple businesses during the year ended December 31, 2021. Pro forma information has not been provided as the acquisitions did not have a material impact on the Company’s Consolidated Statements of Operations individually or in the aggregate. The revenues and operating income of each of the acquisitions below are included in the Company’s consolidated financial statements from the acquisition date. On January 31, 2021, the Company acquired the Vacuum and Blower Systems division of Tuthill Corporation for cash consideration of $184.0 million. The business operates under the tradenames M-D Pneumatics and Kinney Vacuum Pumps and is a leader in the design and manufacture of positive displacement blowers, mechanical vacuum pumps, vacuum boosters and engineered blower and vacuum systems. The acquisition is intended to expand the product portfolio of the Industrial Technologies and Services segment with complementary technologies and applications. The goodwill arising from the acquisition is attributable to the expected cost synergies, anticipated growth of new and existing customers, and the assembled workforce. The goodwill resulting from this acquisition is expected to be deductible for tax purposes. On July 30, 2021, the Company acquired Maximus Solutions for cash consideration of $111.0 million, net of cash acquired. The business is a provider of digital controls and Industrial Internet of Things (IIoT) production management systems for the agritech software and controls market. The acquisition is intended to expand product and service offerings of the Precision and Science Technologies segment into attractive end markets and contribute to growth in digital and connected solutions. The goodwill arising from the acquisition is attributable to synergies expected from building on Maximus’s expertise in digital controls and IIoT systems and from anticipated growth from existing and new customers. None of this goodwill is expected to be deductible for tax purposes. On August 31, 2021, the Company acquired Seepex GmbH (“Seepex”) for cash consideration of $482.1 million, net of cash acquired. Seepex is a global leader in progressive cavity pump solutions. The acquisition expands the product portfolio of the Precision and Science Technologies segment with offerings that primarily serve the water, wastewater, food and beverage, and chemical end markets. The goodwill arising from the acquisition is attributable to the expected cost synergies, anticipated growth of new and existing customers, and the assembled workforce. None of this goodwill is expected to be deductible for tax purposes. On October 29, 2021, the Company acquired Air Dimensions Inc. for cash consideration of $70.6 million. The business designs, manufactures and sells vacuum diaphragm pumps primarily for environmental applications. The acquisition is intended to expand the product portfolio of the Precision and Science Technologies segment and further penetrate end markets such as emission monitoring, biogas, utility and chemical processing. The goodwill arising from the acquisition is attributable to growth expected from product and channel synergies and to the assembled workforce. The goodwill resulting from this acquisition is expected to be deductible for tax purposes. On December 1, 2021, the Company acquired the assets of Tuthill Corporation’s Pump Group for cash consideration of $85.5 million. The business is a market leader in gear and piston pump solutions. The acquisition is intended to complement existing brands and technologies in the Precision and Science Technologies segment and further penetrate high growth end markets, including life and sciences, food and beverage, medical and water and wastewater treatment. The goodwill arising from the acquisition is attributable to revenue growth and cost savings opportunities and to the assembled workforce. The majority of the goodwill resulting from this acquisition is expected to be deductible for tax purposes. Other acquisitions completed during the year ended December 31, 2021 include multiple sales and service businesses and a manufacturer of air purity analysis equipment in the Industrial Technologies and Services segment and a pump technology business in the Precision and Science Technologies segment. The aggregate consideration for these acquisitions was $44.6 million. The following table summarizes the allocation of consideration to the fair values of identifiable assets acquired and liabilities assumed at the acquisition date. The initial accounting for these acquisitions is substantially complete. Any further adjustments during the measurement period are not expected to be material. Seepex M-D Pneumatics and Kinney Vacuum Pumps Maximus Solutions All Others Accounts receivable $ 24.9 $ 4.8 $ 4.3 9.3 Inventories 40.5 3.8 2.9 10.5 Other current assets 1.9 0.2 0.2 0.6 Property, plant and equipment 40.7 16.2 2.1 15.2 Goodwill 245.3 80.0 75.7 78.3 Intangible assets 243.6 82.5 39.5 95.9 Other noncurrent assets 1.1 — — — Total current liabilities (34.4) (3.5) (2.4) (4.0) Deferred tax liabilities (75.4) — (11.3) (4.1) Other noncurrent liabilities (6.1) — — (1.0) Total consideration $ 482.1 $ 184.0 $ 111.0 200.7 Acquisition Revenues and Operating Income The revenue and operating income (loss) included in the financial statements for these acquisitions subsequent to their acquisition date was $145.9 million and $(4.5) million, respectively, for the year ended December 31, 2021. Ingersoll Rand Industrial Acquisition On February 29, 2020, Ingersoll Rand (formerly Gardner Denver Holdings, Inc.) completed the acquisition of and merger with Ingersoll Rand Industrial in exchange for non-cash consideration comprising the following: Fair value of Ingersoll Rand common stock issued for Ingersoll Rand Industrial outstanding common stock $ 6,919.5 Fair value attributable to pre-merger service for replacement equity awards 8.6 Fair value attributable to pre-merger service for deferred compensation plan 8.9 Total purchase consideration $ 6,937.0 Ingersoll Rand Industrial was separated from Ingersoll Rand plc (subsequently renamed Trane Technologies Plc) through a distribution to shareholders of Trane Technologies and subsequently merged with Gardner Denver Holdings, Inc. This transaction was accounted for as a business combination. The Company incurred acquisition costs of $87.3 million, including $42.3 million and $45.0 million in the years ended December 31, 2020 and 2019, respectively. These costs are presented within “Other operating expenses, net” in the Consolidated Statements of Operations. The assets and liabilities of Ingersoll Rand Industrial were measured at their fair values as of the date of the merger. The determination of fair values required the Company to make estimates about expected future cash flows, discount rates, royalty rates and other subjective assumptions and future events that are highly uncertain. These measurements were finalized within one year of the closing date of the transaction. The following table summarizes the allocation of consideration to the fair values of assets acquired and liabilities assumed of Ingersoll Rand Industrial as of February 29, 2020. These amounts include assets and liabilities of the Specialty Vehicle Technologies segment, which was divested during the year ended December 31, 2021 and is reported as a discontinued operation. Refer to Note 2 for further information on the sale of SVT. Fair value Cash $ 38.8 Accounts receivable 585.8 Inventories 625.4 Other current assets 87.2 Property, plant and equipment 516.5 Goodwill 4,899.2 Other intangible assets 3,766.6 Other noncurrent assets 270.9 Total current liabilities, including current maturities of long-term debt of $19.0 million (753.0) Deferred tax liability (842.4) Long-term debt, net of debt issuance costs and an original issue discount (1,851.7) Other noncurrent liabilities (333.0) Noncontrolling interest (73.3) Total consideration $ 6,937.0 Summary of significant fair value methods The methods used to determine the fair value of significant identifiable assets and liabilities included in the allocation of purchase price are discussed below. Inventories Acquired inventory comprised finished goods, work in process and raw materials. The fair value of finished goods was calculated as the estimated selling price, adjusted for costs of the selling effort and a reasonable profit allowance relating to the selling effort. The fair value of work in process inventory was primarily calculated as the estimated selling price, adjusted for estimated costs to complete the manufacturing, estimated costs of the selling effort, as well as a reasonable profit margin on the remaining manufacturing and selling effort. The fair value of raw materials and supplies was determined based on replacement cost which approximates historical carrying value. Property, Plant and Equipment The fair value of property, plant and equipment was primarily calculated using replacement costs adjusted for the age and condition of the asset, with the exception of real property which was calculated using the market approach, and is summarized below. Land and buildings $ 215.1 Machinery and equipment 256.9 Office furniture and equipment 13.4 Other 1.0 Construction in progress 30.1 Total property, plant and equipment $ 516.5 Identifiable Intangible Assets The fair value and weighted average useful life of the Ingersoll Rand Industrial identifiable intangible assets are as follows. Fair Value Weighted Average Useful Life (Years) Tradenames (1) $ 1,312.0 Indefinite Developed technology (2) 236.0 7 Customer relationships (3) 2,101.0 13 Backlog (4) 81.2 <1 Internal-use software and other 36.4 2 Total identifiable intangible assets $ 3,766.6 (1) The fair value of tradenames were determined using a relief from royalty methodology, which estimates the cost savings generated by a company related to the ownership of an asset for which it would otherwise have had to pay royalties or license fees on revenues earned through the use of the asset. Tradenames are expected to have an indefinite useful life. (2) The fair values of developed technology were determined using a relief from royalty methodology, with similar methodology and assumptions as described in the tradename description above. The economic useful lives were determined based on the technology cycle related to each developed technology, as well as the cash flows over the forecast period. (3) The fair values of customer relationships were determined using the Multi-Period Excess Earning Method, which involves isolating the net earnings attributable to the asset being measured based on present value of the incremental after-tax cash flows attributable solely to the intangible asset over its remaining useful life. The economic useful lives were determined based on historical customer attrition rates. (4) The fair values of acquired backlog were determined using the Multi-Period Excess Earning Method. The economic useful lives were based on the time to fulfill the outstanding order backlog obligation. Leases, including lease liabilities and right-of-use assets Lease liabilities, included in “Accrued liabilities” and “Other non-current liabilities” in the Consolidated Balance Sheets, at the acquisition date, were measured at the present value of the future minimum lease payments over the remaining lease term and the incremental borrowing rate of Ingersoll Rand as if the acquired leases were new leases as of the acquisition date. Pension and Other Postretirement Liabilities Ingersoll Rand recognized a pretax net liability representing the net funded status of Ingersoll Rand Industrial’s defined-benefit pension and other postretirement benefit (“OPEB”) plans. Long-Term Debt The fair value for long term debt was determined based on the total indebtedness less debt issuance costs as the debt consummated at the time of closing of the acquisition. Deferred Income Tax Assets and Liabilities The acquisition was structured as a merger and therefore, the Company generally assumed the historical tax basis of assets and liabilities. The deferred income tax assets and liabilities include the expected future federal, state and foreign tax consequences associated with temporary differences between the fair values of the assets acquired and liabilities assumed and the respective tax bases. Tax rates utilized in calculating deferred income taxes generally represent the enacted statutory tax rates at the effective date of the acquisition in the jurisdictions in which legal title of the underlying asset or liability resides. Noncontrolling Interests Ingersoll Rand Industrial had a controlling interest of approximately 74% in Ingersoll-Rand India Limited as of the acquisition date. The remaining shares were owned by unaffiliated shareholders and traded on India stock exchanges, representing a noncontrolling interest. The fair value of this noncontrolling interest was based on market quote of shares as the date of acquisition. Other Assets Acquired and Liabilities Assumed (excluding Goodwill) The Company utilized the carrying values, net of allowances, to value accounts receivable and accounts payable as well as other current assets and liabilities as it was determined that carrying values represented the fair value of those items at the acquisition date. Goodwill The excess of the consideration for the acquisition over the fair value of net assets acquired was recorded as goodwill. The goodwill is attributable to expected synergies and expanded market opportunities from combining the Company’s operations with those of Ingersoll Rand Industrial. The goodwill created in the acquisition is not expected to be deductible for tax purposes. See Note 9 “Goodwill and Other Intangible Assets” for the allocation of goodwill among the Company’s segments. Results of Ingersoll Rand Industrial subsequent to the acquisition The operating results of Ingersoll Rand Industrial have been included in the Company’s consolidated financial statements from the date of acquisition through December 31, 2020. The Company’s consolidated statements of operations for the year ended December 31, 2020 included revenues of $2,930.3 million and net loss of $10.8 million, which includes the effects of purchase accounting adjustments, primarily the amortization of intangible assets and the impacts on operating expenses of fair value adjustments to acquired inventory and property, plant and equipment. Unaudited pro forma information The following unaudited pro forma financial information is provided for information purposes only and presents the results of operations of the Company as if the Ingersoll Rand Industrial acquisition was completed on January 1, 2019. The pro forma results do not necessarily represent the revenue or results of operations would have been realized had the acquisition been completed on January 1, 2019. In addition, these results are not intended to be a projection of future operating results and do not reflect synergies that might be achieved. 2020 2019 Revenues $ 5,398.0 $ 6,146.5 Net Income (Loss) 164.8 101.1 The unaudited pro forma information includes adjustments for the purchase price allocation (including, but not limited to, amortization and depreciation for intangible assets and property, plant and equipment acquired, adjustments to stock-based compensation expense, fair value adjustments to acquired inventories, the purchase accounting effect on deferred revenue, interest expense and amortization of debt issuance costs, transaction costs and related tax impacts) and the alignment of accounting policies. The table below reflects the impact of material and nonrecurring adjustments to the unaudited pro forma results for the years ended December 31, 2020 and 2019 that are directly attributable to the acquisition. 2020 2019 Increase (decrease) to revenue as a result of deferred revenue fair value adjustment, net of tax $ 13.8 $ (13.8) Increase (decrease) to expense as a result of inventory fair value adjustment, net of tax (89.6) 89.6 Increase (decrease) to expense as a result of transaction costs, net of tax (34.8) 34.8 Settlement of post-acquisition contingencies The Company and Trane Technologies concluded several post-closing steps of the Ingersoll Rand Industrial transaction in the second quarter of 2021. These steps included determining the final measurements of transferred working capital, indebtedness and retirement plan funding. Upon finalizing these measurements, Trane Technologies agreed to make a net payment of $49.5 million to Ingersoll Rand. This payment was received in the third quarter of 2021 and is reflected within changes in “Other assets and liabilities, net” on the Consolidated Statement of Cash Flows. The Company realized a gain of $30.1 million in the second quarter of 2021 to adjust its receivables for these items. This gain is reported within “Other income, net” on the Consolidated Statement of Operations. Other 2020 Acquisitions On September 1, 2020, the Company acquired Albin Pump SAS, a manufacturer of electric peristaltic pumps for cash consideration, net of cash acquired, of $15.5 million and deferred consideration of $0.9 million. The results of this business are reported within the Precision and Science Technologies segment from the date of acquisition. Also during the year ended December 31, 2020, the Company acquired two sales and service businesses, one in the United States and one in Europe, in the Industrial Technologies and Services segment, for cash consideration of $15.0 million and deferred consideration of $5.1 million. Acquisition Revenues and Operating Income The revenues included in the financial statements for these acquisitions subsequent to their acquisition date was $23.5 million and $8.9 million, respectively, for the years ended December 31, 2021 and 2020. The operating income included in the financial statements for these acquisitions subsequent to their acquisition date was $2.1 million and $0.9 million, respectively, for the years ended December 31, 2021, and 2020.

Restructuring

Restructuring	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring Restructuring Program 2020 to 2022 Subsequent to the acquisition of Ingersoll Rand Industrial, the Company announced a restructuring program (“2020 Plan”) to create efficiencies and synergies, reduce the number of facilities and optimize operating margin within the merged Company. Through December 31, 2021, we recognized expense related to the 2020 Plan of $96.4 million, comprising $78.7 million, $6.9 million and $10.8 million for Industrial Technologies and Services, Precision and Science Technologies and Corporate, respectively. The Company expects total expense for workforce restructuring, facility consolidation and other exit and disposal activities under the 2020 Plan to be approximately $100 million to $115 million. For the years ended December 31, 2021 and 2020, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following. 2021 2020 Industrial Technologies and Services $ 8.4 $ 70.3 Precision and Science Technologies — 6.9 Corporate 5.0 5.8 Restructuring charges, net $ 13.4 $ 83.0 The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2021 and 2020, respectively. 2021 2020 Balance at beginning of the period $ 17.5 $ 4.8 Charged to expense - termination benefits 9.6 73.5 Charged to expense - other (1) 2.7 3.3 Acquired restructuring — 5.1 Payments (15.9) (70.1) Foreign currency translation and other (1.6) 0.9 Balance at end of the period $ 12.3 $ 17.5 (1) Excludes $1.1 million and $6.2 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2021 and 2020, respectively. Restructuring Program 2018 to 2019 In the third quarter of 2018, the Company announced a restructuring program that primarily involved workforce reductions and facility consolidation. This restructuring program was completed as of December 31, 2020.

Allowance for Credit Losses

Allowance for Credit Losses	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Allowance for Credit Losses	Allowance for Credit Losses The allowance for credit losses for the years ended December 31, 2021, 2020 and 2019 consisted of the following. 2021 2020 2019 Balance at beginning of the period $ 50.9 $ 16.6 $ 16.0 Acquisition - Ingersoll Rand Industrial — 25.1 — Provision (benefit) charged to expense (1) (4.3) 10.3 2.4 Write-offs, net of recoveries (3.8) (3.5) (1.6) Foreign currency translation and other (0.5) 2.4 (0.2) Balance at end of the period $ 42.3 $ 50.9 $ 16.6 (1) In the fourth quarter of 2021, the Company adjusted its allowance for credit losses in certain major portions of the business due to improved collection experience and reduction of past due receivables. The impact of these updates was a $6.6 million reduction in the allowance, with a corresponding benefit within “Selling and administrative expenses.”

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Raw materials, including parts and subassemblies $ 506.6 $ 451.0 Work-in-process 88.6 62.2 Finished goods 283.4 194.7 878.6 707.9 LIFO excess (reserve) (24.4) 8.8 Inventories $ 854.2 $ 716.7 At December 31, 2021 and 2020, approximately 41% and 39%, respectively, of total inventory is accounted for on a last-in, first-out (“LIFO”) basis. In the year ended December 31, 2020, the Company recorded non-cash adjustments of $35.6 million to reduce the carrying value of inventories acquired in the merger with Ingersoll Rand Industrial accounted for under the LIFO method, all of which was recognized in Cost of sales in the three month period ended June 30, 2020.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment, net as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Land and land improvements $ 60.1 $ 54.3 Buildings 300.3 278.3 Machinery and equipment 548.1 485.0 Office furniture and equipment 58.3 53.4 Construction in progress 39.5 29.1 1,006.3 900.1 Accumulated depreciation (357.7) (291.1) Property, plant and equipment, net $ 648.6 $ 609.0

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2021 and 2020 are as follows. Industrial Technologies and Services Precision and Science Technologies Total Balance as of December 31, 2019 $ 865.4 $ 227.5 $ 1,092.9 Acquisitions 3,213.5 1,165.5 4,379.0 Foreign currency translation and other (1) 72.3 38.4 110.7 Balance as of December 31, 2020 4,151.2 1,431.4 5,582.6 Acquisitions 87.9 391.4 479.3 Foreign currency translation and other (1) (61.8) (18.5) (80.3) Balance as of December 31, 2021 $ 4,177.3 $ 1,804.3 $ 5,981.6 (1) Includes measurement period adjustments. The Company acquired multiple businesses during the year ended December 31, 2021. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 2021 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Seepex $ — $ 245.3 $ 245.3 M-D Pneumatics and Kinney Vacuum Pumps 80.0 — 80.0 Maximus Solutions — 75.7 75.7 Other acquisitions 7.9 70.4 78.3 $ 87.9 $ 391.4 $ 479.3 The Company acquired several businesses during the year ended December 31, 2020. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 2020 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Ingersoll Rand Industrial $ 3,198.0 $ 1,162.3 $ 4,360.3 Albin Pump SAS — 3.2 3.2 Other acquisitions 15.5 — 15.5 $ 3,213.5 $ 1,165.5 $ 4,379.0 As of December 31, 2021 and 2020, goodwill included a total of $220.6 million of accumulated impairment losses within the Industrial Technologies and Services segment related to impairments recognized in and prior to 2015. Goodwill Impairment Tests Consistent with our accounting policy in Note 1, we performed our annual goodwill impairment testing as of the first day of our fiscal fourth quarters of 2021, 2020 and 2019. For the years ended December 31, 2021, 2020 and 2019, each reporting unit’s fair value was in excess of its net carrying value, and therefore, no goodwill impairment was recorded. Other Intangible Assets Other intangible assets as of December 31, 2021 and 2020 consisted of the following. December 31, 2021 December 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer lists and relationships $ 3,055.0 $ (1,048.3) $ 2,006.7 $ 2,835.0 $ (841.3) $ 1,993.7 Technology 356.4 (77.8) 278.6 279.9 (38.1) 241.8 Tradenames 47.8 (19.0) 28.8 41.8 (15.6) 26.2 Backlog 8.1 (5.1) 3.0 — — — Other 107.1 (76.9) 30.2 102.8 (58.6) 44.2 Unamortized intangible assets: Tradenames 1,565.4 — 1,565.4 1,491.3 — 1,491.3 Total other intangible assets $ 5,139.8 $ (1,227.1) $ 3,912.7 $ 4,750.8 $ (953.6) $ 3,797.2 Amortization of intangible assets was $332.9 million, $335.1 million and $105.3 million for the years ended December 31, 2021, 2020 and 2019, respectively. Amortization of intangible assets is anticipated to be approximately $300 million in each of 2022, 2023 and 2024, $200 million in 2025 and $160 million in 2026 based upon currency exchange rates as of December 31, 2021. Other Intangible Asset Impairment Tests The Company recognized an impairment in the third quarter of 2020 of $19.9 million to reduce the carrying value of two tradenames in the Industrial Technologies and Services segment. Consistent with our accounting policy in Note 1, we performed our annual intangible asset impairment testing as of the first day of our fiscal fourth quarters of 2021, 2020 and 2019. For the years ended December 31, 2021, 2020 and 2019, other than as discussed above, each tradename’s fair value was in excess of its net carrying value, and therefore, no impairment was recorded.

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities Accrued liabilities as of December 31, 2021 and 2020 consisted of the following: 2021 2020 Salaries, wages, and related fringe benefits $ 232.1 $ 197.0 Contract liabilities 242.1 164.6 Product warranty 42.5 41.1 Operating lease liabilities 34.9 47.1 Restructuring 12.3 17.5 Taxes 41.6 116.1 Other 135.8 125.5 Total accrued liabilities $ 741.3 $ 708.9 A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2021 and 2020 is as follows. 2021 2020 Balance at the beginning of period $ 41.1 $ 19.1 Product warranty accruals 16.1 17.2 Acquired warranty 2.1 19.8 Settlements (15.7) (16.7) Foreign currency translation and other (1.1) 1.7 Balance at the end of period $ 42.5 $ 41.1

Debt

Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Debt	Debt Debt as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Short-term borrowings $ — $ — Long-term debt Dollar Term Loan B, due 2027 (1) $ 1,865.0 $ 1,883.7 Dollar Term Loan, due 2027 (2) 910.5 919.6 Euro Term Loan, due 2027 (3) 670.7 728.0 Dollar Term Loan Series A, due 2027 (4) — 392.4 Finance leases and other long-term debt 23.9 17.2 Unamortized debt issuance costs (29.5) (41.4) Total long-term debt, net, including current maturities 3,440.6 3,899.5 Current maturities of long-term debt 38.8 40.4 Total long-term debt, net $ 3,401.8 $ 3,859.1 (1) As of December 31, 2021, this amount is presented net of unamortized discounts of $1.7 million. As of December 31, 2021, the applicable interest rate was 1.84% and the weighted-average rate was 1.86% for the year ended December 31, 2021. (2) As of December 31, 2021, this amount is presented net of unamortized discounts of $0.9 million. As of December 31, 2021, the applicable interest rate was 1.84% and the weighted-average rate was 1.86% for the year ended December 31, 2021. (3) As of December 31, 2021, this amount is presented net of unamortized discounts of $0.6 million. As of December 31, 2021, the applicable interest rate was 2.00% and the weighted-average rate was 2.00% for the year ended December 31, 2021. (4) The weighted-average rate was 2.86% for the year ended December 31, 2021. Senior Secured Credit Facilities The Company entered into a senior secured credit agreement with UBS AG, Stamford Branch, as administrative agent, and other agents and lenders party thereto (the “Senior Secured Credit Facilities”) on July 30, 2013. The Senior Secured Credit Facilities entered into on July 30, 2013 provided senior secured financing in the equivalent of approximately $2,825.0 million, consisting of: (i) a senior secured term loan facility denominated in U.S. Dollars (the “Original Dollar Term Loan Facility”) in an aggregate principal amount of $1,900.0 million; (ii) a senior secured term loan facility denominated in Euros (the “Original Euro Term Loan Facility”) in an aggregate principal amount of €400.0 million; and (iii) a senior secured revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of $400.0 million available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably acceptable foreign currencies, subject to certain sublimits for the foreign currencies. The Revolving Credit Facility included borrowing capacity available for letters of credit up to $200.0 million and for borrowings on same-day notice, referred to as swingline loans. The borrower of the Dollar Term Loan Facility and the Euro Term Loan Facility is Gardner Denver, Inc. Prior to the Company entering into Amendment No. 1, GD German Holdings II GmbH became an additional borrower and successor in interest to Gardner Denver Holdings GmbH & Co. KG. GD German Holdings II GmbH, GD First (UK) Limited and Gardner Denver, Inc. were the listed borrowers under the Revolving Credit Facility. The Company entered into Amendment No. 1 to the Senior Secured Credit Facilities with UBS AG, Stamford Branch, as administrative agent, and the lenders and other parties thereto on March 4, 2016 (“Amendment No.1”), Amendment No. 2 on August 17, 2017 (“Amendment No.2”) and Amendment No. 3 on December 13, 2018 (“Amendment No.3”). Amendment No. 1 reduced the aggregate principal borrowing capacity of the Revolving Credit Facility by $40.0 million to $360.0 million, extended the term of the Revolving Credit Facility to April 30, 2020 with respect to consenting lenders and provided for customary bail-in provisions to address certain European regulatory requirements. On July 30, 2018, the Revolving Credit Facility principal borrowing capacity decreased to $269.9 million resulting from the maturity of the tranches of the Revolving Credit Facility which were owned by lenders that elected not to modify the original Revolving Credit Facility maturity date. Amendment No. 1 reduced the minimum aggregate principal amount for extension amendments to the facilities from $50.0 million to $35.0 million. Amendment No. 2 refinanced the Original Dollar Term Loan Facility with a replacement $1,285.5 million senior secured U.S. dollar term loan facility (the “New Dollar Term Loan Facility”) and the Original Euro Term Loan Facility with a replacement €615.0 million senior secured euro term loan facility (the “New Euro Term Loan Facility”). Further the maturity for both term loan facilities was extended to July 30, 2024 and LIBOR Floor was reduced from 1.0% to 0.0%. Amendment No. 3 amended the definition of “Change of Control” to (i) remove the requirement that certain specified equity holders maintain a minimum ownership level of the outstanding voting stock of the Company, (ii) increase the threshold at which the acquisition of ownership by a person, entity or group of other equity holders constitutes a “Change of Control” from 35% of the outstanding voting stock of the Company to 50% of the outstanding voting stock of the Company and (iii) make certain other corresponding technical changes and updates. The Company entered into Amendment No. 4 to the Senior Secured Credit Facilities with UBS AG, Stamford Branch, as Resigning Agent and Citibank, N.A. as Successor Agent on June 28, 2019 (“Amendment No. 4”). Amendment No. 4 (i) refinanced the existing senior secured revolving credit facility with a replacement $450.0 million senior secured revolving credit facility (the “New Revolving Credit Facility”); (ii) extended the maturity of the revolving credit facility to June 28, 2024, (iii) terminated the revolving credit facility commitments of certain lenders under the existing senior secured revolving credit facility under the Senior Secured Credit Facilities, (iv) provided for up to $200.0 million of the New Revolving Credit Facility to be available for the purpose of issuing letters of credit; (v) provided for the replacement of GD First (UK) Limited by Gardner Denver Holdings, Ltd. as the UK Borrower under the Senior Secured Credit Facilities; (vi) transferred the Administrative Agent, Collateral Agent and Swingline Lender roles under the Senior Secured Credit Facilities to Citibank, N.A; and (vii) made certain other corresponding technical changes and updates. At the consummation of the merger between Gardner Denver Holdings, Inc., and Ingersoll-Rand plc, Amendment No. 4 increased the aggregate amount of the New Revolving Credit Facility to $1,000.0 million and increased the capacity under the New Revolving Credit Facility to issue letters of credit to $400.0 million. As a result of Amendment No. 4, the Company wrote off $0.2 million of debt issuance costs to the “Loss on extinguishment of debt” in the Consolidated Statements of Operations for the year ended December 31, 2019. On February 28, 2020, the Company entered into Amendment No. 5 to the Credit Agreement (“Amendment No. 5”). Amendment No. 5 refinanced the existing New Dollar Term Loan Facility and New Euro Term Loan Facility. The proceeds from the replacement $927.6 million Dollar Term Loan (“Dollar Term Loan”) and replacement €601.2 million Euro Term Loan (“Euro Term Loan”) were used to refinance the outstanding New Dollar Term Loan Facility and New Euro Term Loan Facility. The proceeds from the Dollar Term Loan and the Euro Term Loan were reduced by an original issue discount of $1.2 million and €0.8 million, respectively. The Euro Term Loan and Dollar Term Loan will mature on February 28, 2027. The refinancing of the New Dollar Term Loan and the New Euro Term Loan resulted in the write off of unamortized debt issuance costs of $2.0 million which was presented within “Loss on extinguishment of debt” in the Consolidated Statements of Operations. At the time of the acquisition of Ingersoll Rand Industrial, the Credit Agreement was amended to include an additional $1,900.0 million senior secured term loan (“Dollar Term Loan B”) by and among Ingersoll-Rand Services Company, as the borrower, the lenders party thereto and Citi, as the administrative agent. Further, Ingersoll-Rand Services Company, the borrower with respect to the Dollar Term Loan B, was designated as an additional borrower under the Credit Agreement. The Dollar Term Loan B and the Dollar Term Loan and the Euro Term Loan have guarantees from the same credit parties and are secured by the same collateral. The Dollar Term Loan B will mature on February 28, 2027. The proceeds from the $1,900.0 million Dollar Term Loan B were reduced by a $2.4 million original issue discount. On February 29, 2020, the aggregate amount of the Revolving Credit Facility increased to $1,000.0 million and the capacity under the Revolving Credit Facility to issue letters of credit increased to $400.0 million. On June 29, 2020, the Company entered into Amendment No. 6 to the Credit Agreement (“Amendment No. 6”). Amendment No. 6 (i) provided for $400.0 million of incremental term loans (“Dollar Term Loan Series A”), reduced by an original issue discount of $6.0 million, and (ii) established an increase of $100.0 million to the Revolving Credit Facility, bringing the total sum of the Revolving Credit Facility to $1,100.0 million. The proceeds were expected to be used for general business purposes, including providing incremental liquidity in the event of a prolonged adverse impact of the COVID-19 pandemic. On September 30, 2021, the Company elected to prepay the Dollar Term Loan Series A outstanding principal balance of $396.0 million using cash on hand. The prepayment resulted in the write-off of unamortized debt issuance costs and unamortized issuance discount of $9.0 million which was recognized in “Loss on extinguishment of debt” in the Consolidated Statements of Operations. On December 28, 2021, Gardner Denver, Inc. entered into Amendment No. 7 to the Credit Agreement (“Amendment No. 7”). Amendment No. 7 was entered into pursuant to the terms of the Senior Secured Credit Facilities to provide for (i) the change of the underlying rate for borrowings denominated in GBP from a LIBOR-based rate to a SONIA-based rate (Sterling Overnight Index Average), subject to certain adjustments and terms specified in Amendment No. 7, (ii) the change of the underlying rate for borrowings denominated in EUR from a LIBOR-based rate to a EURIBOR-based rate, subject to certain adjustments and terms specified in Amendment No. 7, and (iii) certain other updates and corresponding changes regarding successor interest rates to LIBOR. The Senior Secured Credit Facilities provide that the Company will have the right at any time to request incremental term loans and/or revolving commitments in an aggregate principal amount of up to (i) the greater of (a) $1,600 million and (b) 100% of Consolidated EBITDA (as defined in the Senior Secured Credit Facilities) for the most recently ended four consecutive fiscal quarter period plus (ii) voluntary prepayments and voluntary commitment reductions of the Senior Secured Credit Facilities and certain other permitted indebtedness prior to the date of any such incurrence plus (iii) an additional amount equal to (a) in the case of incremental loans and/or commitments that are secured on an equal priority basis with the Senior Secured Credit Facilities, an amount such that after giving effect to the incurrence of such additional amount, the Company does not exceed a Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) of 4.50 to 1.00 or the Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio immediately prior to any such incurrence and all transactions consummated in connection therewith or (b) in the case of incremental loans and/or commitments that are secured on a junior priority basis to the Senior Secured Credit Facilities, an amount such that after giving effect to the incurrence of such additional amount, the Company does not exceed a Consolidated Total Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) of 5.00 to 1.00 or the Consolidated Total Debt to Consolidated EBITDA Ratio immediately prior to any such incurrence and all transactions consummated in connection therewith. The lenders under the Senior Secured Credit Facilities are not under any obligation to provide any such incremental commitments or loans, and any such addition of, or increase in commitments or loans, will be subject to certain customary conditions. As of December 31, 2021, the aggregate amount of commitments under the Revolving Credit Facility was $1,100.0 million and the capacity under the Revolving Credit Facility to issue letters of credit was $400.0 million. As of December 31, 2021, the Company had no outstanding borrowings, $6.6 million of outstanding letters of credit under the New Revolving Credit Facility and unused availability of $1,093.4 million. Interest Rate and Fees Borrowings under the Dollar Term Loan, Dollar Term Loan B, and Revolving Credit Facility (other than Revolving Credit Facility borrowings in GBP or EUR) bear interest at a rate equal to, at the Company’s option, either (a) the greater of LIBOR for the relevant interest period or 0.00% per annum, in each case adjusted for statutory reserve requirements, plus an applicable margin or (b) a base rate (the “Base Rate”) equal to the highest of (1) the rate of interest publicly announced by the administrative agent as its prime rate in effect at its principal office, (2) the federal funds effective rate plus 0.50%, (3) LIBOR for an interest period of one month, adjusted for statutory reserve requirements, plus 1.00% and (4) 1.00%, in each case, plus an applicable margin. Borrowings under the Euro Term Loan and Revolving Credit Facility borrowings in EUR (if any) bear interest at a rate equal to the greater of EURIBOR for the relevant interest period, or 0.00% per annum, in each case adjusted for statutory reserve requirements, plus an applicable margin. Borrowings under the Revolving Credit Facility in GBP (if any) bear interest at a rate equal to the greater of (a) daily simple SONIA plus an applicable spread adjustment or (b) 0.00% per annum, in each case adjusted for statutory reserve requirements, plus an applicable margin. The applicable margin for (i) the Dollar Term Loan is 1.75% for LIBOR loans and 0.75% for base rate loans, (ii) the Dollar Term Loan B is 1.75% for LIBOR loans and 0.75% for base rate loans, (iii) the Euro Term Loan is 2.00%, (iv) the Revolving Credit Facility is 2.00% for LIBOR loans, EURIBOR loans and SONIA loans and 1.00% for Base Rate loans. In addition to interest payments on outstanding principal under the Senior Secured Credit Facilities, the Company is required to pay a commitment fee of 0.375% per annum to the lenders under the Revolving Credit Facility in respect of the unutilized commitments thereunder. The commitment fee reduces to 0.25% or 0.125% upon the achievement of a Level I or Level II status, respectively. Level I status means that the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) is less than or equal to 1.75 to 1.00. Level II status means that the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio is less than or equal to 1.50 to 1.00. The Company must also pay customary letter of credit fees. Prepayments The Senior Secured Credit Facilities require the Company to prepay outstanding term loans, subject to certain exceptions, with (i) 50% of annual excess cash flow (as defined in the Senior Credit Facilities) commencing with the fiscal year ending December 31, 2021 (which percentage will be reduced to 25% if the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio is less than or equal to 2.25 to 1.00 but greater than 2.00 to 1.00, and which prepayment will not be required if the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio is less than or equal to 2.00 to 1.00), (ii) 100% of the net cash proceeds of non-ordinary asset sales or other dispositions of property, subject to reinvestment rights (which percentage will be reduced to 50% if the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio is less than or equal to 2.25 to 1.00 but greater than 2.00 to 1.00 and which prepayment will not be required if the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio is less than or equal to 2.00 to 1.00), and (iii) 100% of the net cash proceeds of any incurrence of debt, other than proceeds from debt permitted under the Credit Agreement. The mandatory prepayments will be applied to the scheduled installments of principal of the term loans in direct order of maturity. The Company may voluntarily repay outstanding loans under the Senior Secured Credit Facilities at any time without premium or penalty, subject to certain customary conditions, including reimbursements of the lenders’ redeployment costs actually incurred in the case of a prepayment of certain borrowings other than on the last day of the relevant interest period, provided that (i) any voluntary prepayment of the Dollar Term Loan, the Dollar Term Loan B or the Euro Term Loan prior to August 28, 2020, in connection with a repricing transaction would have been subject to a prepayment premium of 1.00% of the principal amount so prepaid and (ii) any voluntary prepayment of Dollar Term Loan Series A prior to December 29, 2020, in connection with a repricing transaction would have been subject to a prepayment premium of 1.00% of the principal amount so prepaid. Amortization and Final Maturity The Dollar Term Loan, Dollar Term Loan B and Euro Term Loan amortize in equal to quarterly installments in aggregate annual amounts equal to 1.00% of the original principal amount of such term loan, with the balances payable on February 28, 2027. Guarantee and Security All obligations of the borrowers under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and all of its material, wholly-owned U.S. restricted subsidiaries, with customary exceptions including where providing such guarantees are not permitted by law, regulation or contract or would result in adverse tax consequences. All obligations of the borrowers under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured, subject to permitted liens and other exceptions, by substantially all of the assets of the borrowers and each guarantor, including but not limited to: (i) a perfected pledge of the capital stock issued by the borrowers and each subsidiary guarantor and (ii) perfected security interests in substantially all other tangible and intangible assets of the borrowers and the guarantors (subject to certain exceptions and exclusions). The obligations of the non-U.S. borrowers are secured by certain assets in jurisdictions outside of the United States. Certain Covenants and Events of Default The Senior Secured Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the Company’s ability to: incur additional indebtedness and guarantee indebtedness; create or incur liens; engage in mergers or consolidations; sell, transfer or otherwise dispose of assets; create limitations on subsidiary distributions; pay dividends and distributions or repurchase its own capital stock; and make investments, loans or advances, prepayments of junior financings, or other restricted payments. The Revolving Credit Facility requires that, if the sum of the aggregate principle amount of all borrowings under the Revolving Credit Facility and non-cash collateralized letters of credit outstanding under the Revolving Credit Facility (less the amount of letters of credit outstanding as of June 28, 2019) exceeds 40% of the commitments under the Revolving Credit Facility, the Company’s Consolidated First Lien Secured Debt to Consolidated EBITDA Ratio shall not exceed 6.25 to 1.00 as of the last day of the fiscal quarter. The Senior Secured Credit Facilities also contain certain customary affirmative covenants and events of default. Total Debt Maturities Total debt maturities for the five years subsequent to December 31, 2021 and thereafter are approximately $38.8 million, $37.8 million, $37.3 million, $37.1 million, $37.2 million and $3,285.1 million, respectively.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans Pension and Postretirement Benefit Plans The Company sponsors a number of pension and postretirement plans worldwide. Pension plan benefits are provided to employees under defined benefit pay-related and service-related plans, which are non-contributory in nature. The Company’s funding policy for the U.S. defined benefit pension plans is to contribute at least the minimum required contribution required by Employee Retirement Income Security Act (“ERISA”), as amended by the Pension Protection Act of 2016 (as amended by MAP-21, HAFTA, and BBA 15). The Company intends to make contributions, as necessary, to prevent benefit restrictions in the plans. The Company’s annual contributions to the non-U.S. pension plans are consistent with the requirements of applicable local laws. The Company also provides postretirement healthcare and life insurance benefits in the United States and South Africa to a limited group of current and retired employees. All of the Company’s postretirement benefit plans are unfunded. The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 2021 2020 Reconciliation of Benefit Obligations: Beginning balance $ 484.3 $ 59.8 $ 445.7 $ 346.5 $ 31.3 $ 3.4 Service cost 5.3 5.8 4.3 3.8 — — Interest cost 10.8 9.5 4.6 6.1 0.6 0.5 Plan amendments — — — — 1.8 (1.6) Actuarial losses (gains) (1) (20.0) 18.1 (30.0) 24.4 (1.6) 2.0 Benefit payments (25.7) (29.0) (13.7) (12.8) (3.3) (2.7) Acquisitions — 421.0 — 56.7 — 29.3 Plan settlements (12.9) (0.9) — — — 0.3 Effect of foreign currency exchange rate changes — — (14.7) 21.0 (0.1) 0.1 Benefit obligations ending balance $ 441.8 $ 484.3 $ 396.2 $ 445.7 $ 28.7 $ 31.3 Reconciliation of Fair Value of Plan Assets: Beginning balance $ 395.0 $ 61.1 $ 284.8 $ 249.1 Actual return on plan assets 4.8 36.5 25.4 19.0 Employer contributions 11.5 0.1 7.6 7.6 Acquisitions 12.0 327.2 — 12.0 Plan settlements (12.9) (0.9) — — Benefit payments (25.7) (29.0) (13.7) (12.8) Effect of foreign currency exchange rate changes — — (6.4) 9.9 Fair value of plan assets ending balance $ 384.7 $ 395.0 $ 297.7 $ 284.8 Funded Status as of Period End $ (57.1) $ (89.3) $ (98.5) $ (160.9) $ (28.7) $ (31.3) (1) Actuarial losses (gains) primarily resulted from changes in discount rates. Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2021 and 2020 that have not been recognized as a component of net periodic benefit cost are presented in the following table. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 2021 2020 Net actuarial losses (gains) $ (12.7) $ (0.8) $ 26.0 $ 75.7 $ 0.5 $ 2.4 Prior service cost — — 3.1 3.2 0.2 (1.6) Amounts included in accumulated other comprehensive income (loss) $ (12.7) $ (0.8) $ 29.1 $ 78.9 $ 0.7 $ 0.8 Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2021 and 2020. 2021 2020 Other assets $ 10.4 $ 2.3 Accrued liabilities (10.9) (17.9) Pension and other postretirement benefits (183.8) (265.9) The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2021 and 2020. U.S. Pension Plans Non-U.S. Pension Plans 2021 2020 2021 2020 Projected benefit obligations $ 385.0 $ 425.2 $ 154.7 $ 441.4 Accumulated benefit obligation 382.8 415.9 126.4 406.3 Fair value of plan assets 326.7 331.0 26.9 260.5 The accumulated benefit obligation for all U.S. defined benefit pension plans was $439.6 million and $478.0 million as of December 31, 2021 and 2020, respectively. The accumulated benefit obligation for all non-U.S. defined benefit pension plans was $386.4 million and $426.7 million as of December 31, 2021 and 2020, respectively. The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2021, 2020 and 2019. U.S. Pension Plans 2021 2020 2019 Net Periodic Benefit Cost (Income): Service cost $ 5.3 $ 5.8 $ — Interest cost 10.8 9.5 2.2 Expected return on plan assets (12.2) (12.0) (2.2) Amortization of net actuarial loss — — 0.1 Net periodic benefit cost 3.9 3.3 0.1 Gain due to settlement (0.6) — — Total net periodic benefit cost recognized $ 3.3 $ 3.3 $ 0.1 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial gain $ (12.5) $ (6.4) $ (0.9) Amortization of net actuarial gain (loss) 0.6 — (0.1) Total recognized in other comprehensive income (loss) $ (11.9) $ (6.4) $ (1.0) Total recognized in net periodic benefit (income) cost and other comprehensive income (loss) $ (8.6) $ (3.1) $ (0.9) Non-U.S. Pension Plans 2021 2020 2019 Net Periodic Benefit Cost (Income): Service cost $ 4.3 $ 3.8 $ 1.5 Interest cost 4.6 6.1 7.7 Expected return on plan assets (12.2) (11.0) (10.3) Amortization of prior-service cost 0.2 0.1 0.1 Amortization of net actuarial loss 4.9 2.9 2.0 Total net periodic benefit cost recognized $ 1.8 $ 1.9 $ 1.0 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ (43.3) $ 16.3 $ 10.9 Amortization of net actuarial loss (4.9) (2.9) (2.0) Amortization of prior service cost (0.2) (0.1) (0.1) Effect of foreign currency exchange rate changes (1.4) 4.2 1.1 Total recognized in other comprehensive income (loss) $ (49.8) $ 17.5 $ 9.9 Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ (48.0) $ 19.4 $ 10.9 Other Postretirement Benefits 2021 2020 2019 Net Periodic Benefit Cost: Interest cost $ 0.6 $ 0.5 $ 0.1 Amortization of prior-service cost 0.1 — — Amortization of net actuarial loss 0.1 — — Net periodic benefit cost 0.8 0.5 0.1 Loss due to curtailments or settlements — 0.3 — Total net periodic benefit cost recognized $ 0.8 $ 0.8 $ 0.1 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ (1.6) $ 2.0 $ 0.4 Amortization of net actuarial loss (0.1) — — Prior service cost 1.9 (1.6) — Amortization of prior service cost (0.1) — — Effect of foreign currency exchange rate changes — — — Total recognized in other comprehensive income (loss) $ 0.1 $ 0.4 $ 0.4 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ 0.9 $ 1.2 $ 0.5 The discount rate selected to measure the present value of the Company’s benefit obligations was derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under a plan. The Company selects the expected long-term rate of return on plan assets in consultation with the plans’ actuaries. This rate is intended to reflect the expected average rate of earnings on the funds invested or to be invested to provide plan benefits and the Company’s most recent plan assets target allocations. In estimating the expected long-term rate of return on plan assets, appropriate consideration is given to historical performance of the major asset classes held or anticipated to be held by the plans and to current forecasts of future rates of return for those asset classes. Because assets are held in qualified trusts, expected returns are not adjusted for taxes. The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2021, 2020 and 2019. U.S. Pension Plans Non-U.S. Pension Plans 2021 2020 2019 2021 2020 2019 Weighted-average actuarial assumptions used to determine net periodic benefit cost (income): Discount rate 2.4 % 2.7 % 4.0 % 1.1 % 1.6 % 2.6 % Expected long-term rate of return on plan assets 3.2 % 2.6 % 4.0 % 4.3 % 4.4 % 4.9 % Rate of compensation increases 3.0 % 4.0 % NA 3.1 % 2.7 % 2.8 % Weighted-average actuarial assumptions used to determine benefit obligations: Discount rate 2.7 % 2.4 % 3.0 % 1.6 % 1.1 % 1.7 % Rate of compensation increases 3.0 % 3.0 % NA 4.3 % 3.1 % 2.7 % The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2021, 2020 and 2019. Other Postretirement Benefits 2021 2020 2019 Discount rate used to determine net periodic benefit cost (income) 1.8% - 2.4% 2.3% - 3.0% 4.7 % Discount rate used to determine benefit obligations 2.4% - 3.0% 1.9% - 2.3% 3.8 % Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations: Healthcare cost trend rate assumed for next year 6.8 % 6.3 % 7.1 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 4.5 % 4.7 % 7.1 % Year that the date reaches the ultimate trend rate 2034 2029 2021 The following table reflects the estimated benefit payments for the next five years and for the years 2027 through 2031. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2021. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2022 $ 38.1 $ 13.7 $ 3.3 2023 31.0 13.5 3.1 2024 28.6 14.3 2.8 2025 28.5 16.2 2.6 2026 26.8 16.4 2.3 Aggregate 2027-2031 127.0 85.8 8.8 In 2022, the Company expects to contribute approximately $4.2 million to the U.S. pension plans, approximately $6.8 million to the non-U.S. pension plans, and approximately $3.3 million to the other postretirement benefit plans. Plan Asset Investment Strategy The Company’s overall investment strategy and objectives for its pension plan assets is to (i) meet current and future benefit payment needs through diversification across asset classes, investing strategies and investment managers to achieve an optimal balance between risk and return and between income and growth of assets through capital appreciation, (ii) secure participant retirement benefits, (iii) minimize reliance on contributions as a source of benefit security, and (iv) maintain sufficient liquidity to pay benefit obligations and proper expenses. The composition of the actual investments in various securities changes over time based on short and long-term investment opportunities. None of the plan assets of Ingersoll Rand’s defined benefit plans are invested in the Company’s common stock. The Company uses both active and passive investment strategies. Plan Asset Risk Management The target financial objectives for the pension plans are established in conjunction with periodic comprehensive reviews of each plan’s liability structure. The Company’s asset allocation policy is based on detailed asset and liability model (“ALM”) analyses. A formal ALM study of each major plan is undertaken every 2-5 years or whenever there has been a material change in plan demographics, benefit structure, or funded status. In order to determine the recommended asset allocation, the advisors model varying return and risk levels for different theoretical portfolios, using a relative measure of excess return over treasury bills, divided by the standard deviation of the return (the “Sharpe Ratio”). The Sharpe Ratio for different portfolio options was used to compare each portfolio’s potential return, on a risk-adjusted basis. The Company selected a recommended portfolio that achieved the targeted composite return with the least amount of risk. The Company’s primary pension plans are in the U.S. and UK which together comprise approximately 81% of the total benefit obligations and 93% of total plan assets as of December 31, 2021. The following table presents the long-term target allocations for these plans as of December 31, 2021. U.S. Plans UK Plan Asset category: Equity 13 % 32 % Fixed income 84 % 30 % Real estate and other 3 % 38 % Total 100 % 100 % Fair Value Measurements The following tables present the fair values of the Company’s pension plan assets as of December 31, 2021 and 2020 by asset category within the ASC 820 hierarchy (as defined in Note 20 “Fair Value Measurements”). December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 12.7 $ — $ — $ — $ 12.7 Equity funds: U.S. small-cap — — — 6.3 6.3 U.S. large-cap — 8.0 — 29.0 37.0 International equity (2) 24.3 45.9 — 68.3 138.5 Total equity funds 24.3 53.9 — 103.6 181.8 Fixed income funds: Corporate bonds - international — 25.3 — 9.6 34.9 UK index-linked gilts — 35.9 — — 35.9 U.S. fixed income - government securities — — — 38.0 38.0 U.S. fixed income - short duration — — — 5.2 5.2 U.S. fixed income - intermediate duration — — — 41.1 41.1 U.S. fixed income - long corporate — — — 234.8 234.8 Global fixed income — — — 13.5 13.5 Total fixed income funds — 61.2 — 342.2 403.4 Other types of investments: International real estate (3) — 49.5 — — 49.5 Other (4) — 34.0 1.0 35.0 Total $ 37.0 $ 164.6 $ 34.0 $ 446.8 $ 682.4 December 31, 2020 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 8.5 $ — $ — $ — $ 8.5 Equity funds: U.S. large-cap — 6.4 — 49.0 55.4 International equity (2) 24.2 39.8 — 81.7 145.7 Total equity funds 24.2 46.2 — 130.7 201.1 Fixed income funds: Corporate bonds - international — 25.2 — — 25.2 UK index-linked gilts — 41.5 — — 41.5 U.S. fixed income - government securities — 98.9 — 4.7 103.6 U.S. fixed income - short duration — 15.2 — 4.5 19.7 U.S. fixed income - intermediate duration — 26.3 — 45.2 71.5 U.S. fixed income - long corporate — 120.6 — 9.6 130.2 Total fixed income funds — 327.7 — 64.0 391.7 Other types of investments: International real estate (3) — 42.3 — — 42.3 Other (4) — — 36.2 — 36.2 Total $ 32.7 $ 416.2 $ 36.2 $ 194.7 $ 679.8 (1) Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets. (2) The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors. (3) International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties. (4) Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services. (5) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. Defined Contribution Plans The Company also sponsors defined contribution plans at various locations throughout the world. Benefits are determined and funded regularly based on terms of the plans or as stipulated in a collective bargaining agreement. The Company’s full-time salaried and hourly employees in the U.S. are eligible to participate in Company-sponsored defined contribution savings plans, which are qualified plans under the requirements of Section 401(k) of the Internal Revenue Code. The Company’s contributions to the savings plans are in the form of cash. The Company’s total contributions to all worldwide defined contribution plans for the years ended December 31, 2021, 2020, and 2019 were $40.6 million, $35.9 million and $19.5 million, respectively. Other Benefit Plans The Company offers a long-term service award program for qualified employees at certain of its non-U.S. locations. Under this program, qualified employees receive a service gratuity (“Jubilee”) payment once they have achieved a certain number of years of service. The Company’s actuarially calculated obligation equaled $4.9 million and $4.4 million as of December 31, 2021 and 2020, respectively. There are various other employment contracts, deferred compensation arrangements, covenants not to compete, and change in control agreements with certain employees and former employees. The liabilities associated with such arrangements are not material to the Company’s consolidated financial statements.

Stockholders' Equity and Noncon

Stockholders' Equity and Noncontrolling Interests	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Stockholders' Equity and Noncontrolling Interests	Stockholders’ Equity and Noncontrolling Interests Stockholders’ Equity As of December 31, 2021 and 2020, 1,000,000,000 shares of voting common stock were authorized. Shares of common stock outstanding wer e 407,785,207 and 418,627,809 as of December 31, 2021 and 2020, respectively. The Company is governed by the General Corporation Law of the State of Delaware. All authorized shares of voting common stock have a par value of $0.01. Shares of common stock reacquired are considered issued and reported as Treasury shares. Noncontrolling Interests The Company has a controlling interest of approximately 75% of the common shares of Ingersoll-Rand India Limited (“IR India Limited”). The remaining shares are owned by unaffiliated shareholders and traded on India stock exchanges regulated by Securities and Exchange Board of India (“SEBI”). The Company’s acquisition of Ingersoll Rand Industrial in 2020 resulted in an indirect change in control of IR India Limited as defined by SEBI Substantial Acquisition of Shares and Takeovers (“SAST”) regulations. As a result, the Company was required to pursue either a tender offer for a certain number of noncontrolling shares or a voluntary delisting of the entity from India stock exchanges. In June 2020, the Company initiated a tender offer to purchase up to 26% of outstanding shares of Ingersoll-Rand India Limited from eligible noncontrolling shareholders. The offer price was determined in accordance with SEBI (SAST) regulations as the average market price of shares of IR India Limited on India stock exchanges for a period of sixty days preceding the announcement of the Ingersoll Rand Industrial merger transaction, adjusted for imputed interest for the period of time between announcement of the merger and announcement of the tender offer. The Company determined this offer was a freestanding financial instrument and not a contractual redemption right embedded in the related equity securities. The noncontrolling interest remained classified and measured in accordance with ASC 810 Consolidation with the carrying value presented in permanent equity. The tender offer concluded and was settled in July 2020. Approximately 6% of outstanding shares were tendered for an aggregate purchase price of $14.9 million. As a result, the Company’s ownership interest in IR India Limited increased from approximately 74% as of June 30, 2020 to approximately 80%. The Company was required by SEBI regulations to take necessary steps to decrease the non-public shareholding of IR India Limited to at or below 75% within twelve months of the date the non-public shareholding exceeded 75%. In November 2020, the Company initiated an offer to sell up to 5% of the total shares of IR India Limited on India stock exchanges. The offer for sale concluded and was settled in November 2020. Approximately 5% of outstanding shares were sold for an aggregate purchase price of $11.9 million. As a result, the Company’s ownership interest in IR India Limited decreased from approximately 80% as of September 30, 2020 to approximately 75% after the sale. Share Repurchase Programs On August 1, 2018, the Board of Directors of Ingersoll Rand authorized a share repurchase program pursuant to which the Company may repurchase up to $250.0 million of its common stock effective through July 31, 2020, the date on which the repurchase program expired. Under the repurchase program, Ingersoll Rand was authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Act of 1934. There were no shares repurchased under the August 1, 2018 program for the year ended December 31, 2020. On August 24, 2021, the Board of Directors of Ingersoll Rand authorized a share repurchase program pursuant to which the Company may repurchase up to $750.0 million of its common stock (the “2021 Repurchase Program”). Under the repurchase program, Ingersoll Rand is authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Act of 1934. There were no shares repurchased under the 2021 Repurchase Program for the year ended December 31, 2021. Other Share Repurchases On August 6, 2021, KKR completed a secondary offering to sell its remaining 29,788,635 shares of common stock, of which Ingersoll Rand purchased 14,894,317 shares for $49.05 per share.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges (consisting of interest rate swaps), net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 12 “Benefit Plans” and Note 19 “Hedging Activities, Derivative Instruments and Credit Risk.” On January 1, 2019, the Company adopted ASU 2018-02 which reclassified stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income (loss) to retained earnings (accumulated deficit). The Company recorded a cumulative-effect adjustment which increased “Accumulated other comprehensive loss” in the Consolidated Balance Sheet by $8.2 million. The before tax income (loss) and related income tax effect are as follows. Foreign Currency Translation Adjustments, Net Unrealized Gains (Losses) on Cash Flow Hedges Pension and Postretirement Benefit Plans Total Balance as of December 31, 2018 $ (190.6) $ (11.4) $ (45.0) $ (247.0) Before tax income (loss) 4.1 8.2 (9.3) 3.0 Income tax effect (5.6) (1.0) 2.8 (3.8) Other comprehensive income (loss) (1.5) 7.2 (6.5) (0.8) Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02) (1.5) (6.7) — (8.2) Balance as of December 31, 2019 $ (193.6) $ (10.9) $ (51.5) $ (256.0) Before tax income (loss) 253.1 14.2 (11.5) 255.8 Income tax effect 15.1 (3.3) 2.6 14.4 Other comprehensive income (loss) 268.2 10.9 (8.9) 270.2 Balance as of December 31, 2020 $ 74.6 $ — $ (60.4) $ 14.2 Before tax income (loss) (119.9) — 61.6 (58.3) Income tax effect 16.9 — (12.9) 4.0 Other comprehensive income (loss) (103.0) — 48.7 (54.3) Divestiture of foreign subsidiaries (1.5) — — (1.5) Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) The tables above include only the other comprehensive income (loss), net of tax, attributable to Ingersoll Rand Inc. Other comprehensive loss, net, attributable to noncontrolling interest holders was $2.3 million and $1.4 million for the years ended December 31, 2021 and 2020, respectively, and related entirely to foreign currency translation adjustments. Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table (1) . Foreign Currency Translation Adjustments, Net Unrealized Gains (Losses) on Cash Flow Hedges Pension and Postretirement Benefit Plans Total Balance as of December 31, 2018 $ (190.6) $ (11.4) $ (45.0) $ (247.0) Other comprehensive loss before reclassifications (1.5) (4.7) (8.2) (14.4) Amounts reclassified from accumulated other comprehensive income (loss) — 11.9 1.7 13.6 Other comprehensive income (loss) (1.5) 7.2 (6.5) (0.8) Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02) (1.5) (6.7) — (8.2) Balance as of December 31, 2019 $ (193.6) $ (10.9) $ (51.5) $ (256.0) Other comprehensive income (loss) before reclassifications 268.2 (3.0) (11.2) 254.0 Amounts reclassified from accumulated other comprehensive income (loss) — 13.9 2.3 16.2 Other comprehensive income (loss) 268.2 10.9 (8.9) 270.2 Balance as of December 31, 2020 $ 74.6 $ — $ (60.4) $ 14.2 Other comprehensive income (loss) before reclassifications (103.0) — 45.2 (57.8) Amounts reclassified from accumulated other comprehensive income (loss) — — 3.5 3.5 Other comprehensive income (loss) (103.0) — 48.7 (54.3) Divestiture of foreign subsidiaries (1.5) — — (1.5) Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) (1) All amounts are net of tax. Amounts in parentheses indicate debits. Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2021, 2020 and 2019 are presented in the following table. Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Details about Accumulated Other Comprehensive Income (Loss) Components 2021 2020 2019 Affected Line(s) in the Statement Where Net Income is Presented Loss on cash flow hedges (interest rate swaps) $ — $ 18.5 $ 15.6 Interest expense Benefit for income taxes — (4.6) (3.7) Benefit for income taxes Loss on cash flow hedges (interest rate swaps), net of tax $ — $ 13.9 $ 11.9 Amortization of defined benefit pension and other postretirement benefit items (1) $ 4.7 $ 3.0 $ 2.2 Cost of sales and Selling and administrative expenses Benefit for income taxes (1.2) (0.7) (0.5) Benefit for income taxes Amortization of defined benefit pension and other postretirement benefit items, net of tax $ 3.5 $ 2.3 $ 1.7 Total reclassifications for the period $ 3.5 $ 16.2 $ 13.6 (1) These components are included in the computation of net periodic benefit cost. See Note 12 “Benefit Plans” for additional details.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Overview The Company recognizes revenue when it has satisfied its obligation and control is transferred to the customer. The amount of revenue recognized includes adjustments for any variable consideration, such as rebates, sales discounts and liquidated damages, which are included in the transaction price, and allocated to each performance obligation. The variable consideration is estimated throughout the course of the contract using the Company’s best estimates. Judgements impacting variable consideration related to material rebate and sales discount programs, and significant contracts containing liquidated damage clauses are governed by management review processes. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company has certain long duration engineered to order (“ETO”) contracts that require highly-engineered solutions designed to customer specific applications. For contracts where the contractual deliverables have no alternative use and the contract termination clauses provide for the recovery of cost plus a reasonable margin, revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations, generally measured as the ratio of actual costs incurred to date to the estimated total costs to complete the contract. For contracts with termination provisions that do not provide for recovery of cost and a reasonable margin, revenue is recognized at a point in time, generally at shipment or delivery to the customer. Identification of performance obligations, determination of alternative use, assessment of contractual language regarding termination provisions, and estimation of total project costs are all significant judgments required in the application of ASC 606. Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. In the event a contract modification is for goods or services that are not distinct in the contract, and therefore, form part of a single performance obligation that is partially satisfied as of the modification date, the effect of the contract modification on the transaction price and the Company’s measure of progress for the performance obligation to which it relates, is recognized on a cumulative catch-up basis. Taxes assessed by a government authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Sales commissions are due at either collection of payment from customers or recognition of revenue. Applying the practical expedient from ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations. Disaggregation of Revenue The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2021 and 2020. Industrial Technologies and Services Precision and Science Technologies Total 2021 2020 2021 2020 2021 2020 Primary Geographic Markets United States $ 1,554.6 $ 1,142.8 $ 432.2 $ 297.1 $ 1,986.8 $ 1,439.9 Other Americas 264.9 280.7 20.5 38.7 285.4 319.4 Total Americas 1,819.5 1,423.5 452.7 335.8 2,272.2 1,759.3 EMEIA 1,363.4 1,054.4 368.1 256.5 1,731.5 1,310.9 Asia Pacific 978.1 770.3 170.6 132.7 1,148.7 903.0 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 Product Categories Original equipment (1) $ 2,467.1 $ 1,942.8 $ 822.3 $ 618.8 $ 3,289.4 $ 2,561.6 Aftermarket (2) 1,693.9 1,305.4 169.1 106.2 1,863.0 1,411.6 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 Pattern of Revenue Recognition Revenue recognized at point in time (3) $ 3,811.3 $ 2,937.1 $ 988.3 $ 725.0 $ 4,799.6 $ 3,662.1 Revenue recognized over time (4) 349.7 311.1 3.1 — 352.8 311.1 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 (1) Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment. (2) Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment. Service revenue represents less than 10% of consolidated revenue. (3) Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered. (4) Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed. Performance Obligations The majority of the Company’s contracts have a single performance obligation as the promise to transfer goods and/or services. For contracts with multiple performance obligations, the Company utilizes observable prices to determine standalone selling price or cost plus margin if a standalone price is not available. The Company has elected to account for shipping and handling activities as fulfillment costs and not a separate performance obligation. If control transfers and related revenue is recognized for the related good before the shipping and handling activities occur, the related costs of those shipping and handling activities are accrued. The Company’s primary performance obligations include delivering standard or configured to order (“CTO”) goods to customers, designing and manufacturing a broad range of equipment customized to a customer’s specifications in ETO arrangements, rendering of services (maintenance and repair contracts), and certain extended or service type warranties. For incidental items that are immaterial in the context of the contract, costs are expensed as incurred or accrued at delivery. As of December 31, 2021, for contracts with an original duration greater than one year, the Company expects to recognize revenue in the future related to unsatisfied (or partially satisfied) performance obligations of $472.3 million in the next twelve months and $396.7 million in periods thereafter. The performance obligations that are unsatisfied (or partially satisfied) are primarily related to orders for goods or services that were placed prior to the end of the reporting period and have not been delivered to the customer, on-going work on ETO contracts where revenue is recognized over time and service contracts with an original duration greater than one year. Contract Balances The following table provides the contract balances as of December 31, 2021 and December 31, 2020 presented in the Consolidated Balance Sheets. December 31, 2021 December 31, 2020 Accounts receivable, net $ 948.6 $ 861.8 Contract assets 60.8 60.4 Contract liabilities 243.5 166.2 Accounts receivable, net – Amounts due where the Company’s right to receive cash is unconditional. Customer receivables are recorded at face amount less an allowance for credit losses. The Company maintains an allowance for credit losses as a result of customers’ inability to make required payments. Management evaluates the aging of customer receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of customer receivables that may not be collected in the future and records the appropriate provision. Contract assets – The Company’s rights to consideration for the satisfaction of performance obligations subject to constraints apart from timing. Contract assets are transferred to receivables when the right to collect consideration becomes unconditional. Contract assets are presented net of progress billings and related advances from customers. Contract liabilities – Advance payments received from customers for contracts for which revenue is not yet recognized. Contract liability balances are generally recognized in revenue within twelve months. Of the $166.2 million in contract liabilities as of December 31, 2020, we recognized substantially all as revenue in the year ended December 31, 2021. Contract assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. Contract assets and liabilities are presented net on a contract level, where required. Payments from customers are generally due 30 to 60 days after invoicing. Invoicing for sales of standard products generally coincides with shipment or delivery of goods. Invoicing for CTO and ETO contracts typically follows a schedule for billing at contractual milestones. Payment milestones normally include down payments upon the contract signing, completion of product design, completion of customer’s preliminary inspection, shipment or delivery, completion of installation, and customer’s on-site inspection. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income (loss) before income taxes for the years ended December 31, 2021, 2020 and 2019 consisted of the following. 2021 2020 2019 U.S. $ 121.3 $ (158.4) $ (100.5) Non-U.S. 391.7 113.0 210.7 Income (loss) before income taxes $ 513.0 $ (45.4) $ 110.2 The following table details the components of the Provision (benefit) for income taxes for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Current: U.S. federal $ (33.1) $ 6.6 $ (14.6) U.S. state and local 5.8 6.7 2.9 Non-U.S. 109.1 79.6 45.2 Deferred: U.S. federal (19.5) (33.4) (13.2) U.S. state and local (0.9) (2.9) 0.5 Non-U.S. (83.2) (45.2) (7.9) Provision (benefit) for income taxes $ (21.8) $ 11.4 $ 12.9 Certain prior period amounts within this Note have been reclassified to conform to the current period presentation. The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2021, 2020 and 2019 as follows. 2021 2020 2019 U.S. federal corporate statutory rate 21.0 % 21.0 % 21.0 % State and local taxes, less federal tax benefit 1.1 (8.0) 4.1 Net effects of foreign tax rate differential 1.0 (14.6) 2.3 Withholding tax 3.0 (12.9) — Repatriation cost 1.4 17.7 — Global Intangible Low-Tax Income (“GILTI”) 2.3 (11.7) (4.3) ASC 740-30 (formerly APB 23) 2.9 (18.6) 2.0 Valuation allowance changes (5.4) 4.8 (4.3) Uncertain tax positions (1.3) (4.7) 0.7 Equity compensation (2.5) 6.1 (13.9) Capital gain — — 5.1 Nondeductible acquisition costs 0.4 (7.7) 6.1 Foreign Derived Intangible Income (“FDII”) deduction (3.2) 10.1 — Tax credits (0.8) 4.7 — Income not subject to tax (3.3) — — Utilization of capital loss (9.1) — — Non-U.S. deferred change related to asset sales (8.0) — — Return to provision adjustment (1.3) 0.5 — Other, net (2.4) (11.8) (7.1) Effective income tax rate (4.2) % (25.1) % 11.7 % The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2021 and 2020 are as follows. 2021 2020 Deferred Tax Assets: Reserves and accruals $ 69.3 $ 72.9 Allowance for credit losses 10.0 11.0 Inventory reserve 12.0 10.4 Pension and postretirement benefit plans 41.7 62.6 Tax loss carryforwards 95.9 101.7 Deferred taxes recorded in other comprehensive income 10.2 18.0 Foreign tax credit carryforwards 43.8 74.6 Other 30.9 10.7 Total deferred tax assets 313.8 361.9 Valuation allowance (106.4) (140.6) Deferred Tax Liabilities: LIFO inventory (16.2) (16.2) Investment in partnership (37.4) — Property, plant and equipment (40.9) (49.4) Intangible assets (742.1) (809.9) Unremitted foreign earnings (49.6) (32.5) Deferred taxes recorded in other comprehensive income — — Other (1.6) — Total deferred tax liabilities (887.8) (908.0) Net deferred income tax liability $ (680.4) $ (686.7) The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2021 were as follows. Tax Benefit Valuation Allowance Carryforward Period Ends Tax Attributes to be Carried Forward U.S. federal net operating loss $ 0.3 $ (0.3) Unlimited U.S. federal net operating loss 6.3 (0.1) 2031-2040 U.S. federal capital loss — — 2022 U.S. federal capital loss — — 2031-2040 U.S. federal tax credit 43.8 (43.8) 2022-2031 Alternative minimum tax credit 0.8 (0.1) Unlimited U.S. state and local net operating losses 6.5 (3.1) 2022-2041 U.S. state and local tax credit 0.2 — 2022-2040 Non U.S. net operating losses 70.7 (49.7) Unlimited Non U.S. capital losses 0.8 (0.7) Unlimited Excess interest 11.3 (3.7) Unlimited Other deferred tax assets 3.7 (4.9) Unlimited Total tax carryforwards $ 144.4 $ (106.4) A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2021, 2020 and 2019 are as follows. 2021 2020 2019 Beginning balance $ 140.6 $ 67.9 $ 72.5 Revaluation or additions due to acquisitions or mergers (1) — 63.3 — Charged to tax expense (27.6) 8.3 (5.4) Charged to other accounts (6.6) 1.1 0.1 Deductions (2) — — 0.7 Ending balance $ 106.4 $ 140.6 $ 67.9 (1) Revaluation for the tax year ended December 31, 2020 relates to the inclusion of Ingersoll Rand’s opening balance sheet (“OBS”) beginning valuation allowance. (2) Deductions relate to the realization of net operating losses or the removal of deferred tax assets. Total unrecognized tax benefits were $21.1 million, $27.8 million and $12.5 million for the years ended December 31, 2021, 2020 and 2019, respectively. The net decrease in this balance primarily relates to the lapse in statute of limitations of $(11.8) million. Included in total unrecognized benefits at December 31, 2021 is $21.1 million of unrecognized tax benefits that would affect the Company ’ s effective tax rate if recognized, of which $0.1 million would be offset by a reduction of a corresponding deferred tax asset. The balance of total unrecognized tax benefits is not expected to significantly increase or decrease within the next twelve months. Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Beginning balance $ 27.8 $ 12.5 $ 11.5 Gross increases for tax positions of prior years 0.8 — 0.6 Gross increases for tax positions of current year 5.3 16.8 — Lapse of statute of limitations (11.8) (3.5) — Changes due to currency fluctuations (1.0) 2.0 0.4 Ending balance $ 21.1 $ 27.8 $ 12.5 The Company includes interest expense and penalties related to unrecognized tax benefits as part of the provision for income taxes. The Company ’ s income tax liabilities at December 31, 2021 and 2020 include accrued interest and penalties of $1.2 million and $2.3 million, respectively. The statutes of limitations for U.S. Federal tax returns are open beginning with the 2018 tax year, and state returns are open beginning with the 2016 tax year. The Company is subject to income tax in approximately 47 jurisdictions outside the U.S. The statute of limitations varies by jurisdiction with 2016 being the oldest year still open. The Company ’ s significant operations outside the U.S. are located in the United Kingdom, Germany, China, Ireland, Hong Kong, and Singapore. In Germany, a tax audit covering tax years 2015-2019 was still open. The Company is under audit in Italy for tax years 2016 – 2018. However, as this audit covers pre-merger tax years for legacy Ingersoll Rand Industrial entities, the Company has been indemnified by Trane Technologies for any future liability arising from the audit. Note that any other liabilities arising from pre-merger tax years for legacy Ingersoll Rand Industrial entities would be similarly indemnified. The Company does not assert the ASC 740-30 (formerly APB 23) indefinite reinvestment of the Company’s historical non-U.S. earnings or future non-U.S. earnings. This assertion has not changed following the merger. The Company records a deferred foreign tax liability to cover all estimated withholding, state income tax and foreign income tax associated with repatriating all non-U.S. earnings back to the United States. The Company’s deferred income tax liability as of December 31, 2021 was $49.6 million which is a significant increase over prior year due mainly to increased foreign operations as a result of the Ingersoll Rand Industrial acquisition.

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	LeasesThe Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROUs in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets. At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. Subsequent to the commencement date, operating lease liabilities are recorded at the present value of unpaid lease payments discounted at a discount rate established at the commencement date. Due to the absence of an implicit rate in the Company’s lease contracts, an incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread. Operating ROU assets are recorded as the beginning balance less accumulated amortization with accumulated amortization equaling the straight-lined lease expense less the periodic accretion of the lease liability using the effective interest rate method. Subsequent to the commencement date, financing lease liabilities are increased to reflect interest on the lease liability and decreased for principal lease payments made. The financing ROU asset is measured at cost less amortization expense and any accumulated impairment loss. Amortization expense is calculated on a straight-line basis over the lease term or remaining useful life. The Company’s lease terms allow for the extension or termination of its leases and accounts for the extension and termination when it is reasonably certain that the Company will exercise the option or terminate the lease. Reassessment of the lease term occurs when there is a significant event or a significant change in circumstances that is within the control of the Company that directly affects whether the Company is reasonably certain to exercise or not to exercise an option to extend or terminate the lease or to purchase the underlying asset. Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification includes a change to the contractual terms, scope of the lease or the consideration given. In the event that the right to use an additional asset is granted and the lease payments associated with the additional asset are commensurate with the ROU asset’s standalone price, the modification is accounted for as a separate contract and the original contract remains unchanged. In the event that a single lease is modified, the Company reassessed the classification of the modified lease as of the effective date of the modification based on the modified terms and accounts for initial direct costs, lease incentives and any other payments made to or by the Company in connection with the modification in the same manner that items would be accounted for in connection with a new lease. If there is an additional ROU asset included, the lease term is extended or reduced, or the consideration is the only change in the contract, the Company reallocates the remaining consideration in the contract and remeasures the lease liability using a discount rate determined at the effective date of the modification. The remeasured lease liability for the modified lease is an adjustment to the corresponding ROU asset and does not impact the Consolidated Statements of Operations. In the event of a full or partial termination, the carrying value of the ROU asset decreases on a basis proportionate to the full or partial termination and any difference between the reduction in the lease liability and the proportionate reduction of the ROU asset is recognized as a gain or loss at the effective date of the modification. The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material. The components of lease expense for the years ended December 31, 2021 and 2020 are as follows. 2021 2020 Operating lease cost $ 50.6 $ 46.1 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.2 Interest on lease liabilities 1.1 1.1 Total finance lease cost $ 2.6 $ 2.3 Short-term lease cost $ 2.0 $ 2.0 Supplemental cash flow information related to leases for the years ended December 31, 2021 and 2020 is as follows. 2021 2020 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 52.0 $ 56.6 Operating cash flows from finance leases 1.1 1.1 Financing cash flows from finance leases 1.1 0.7 Leased Assets Obtained in Exchange for New Operating Lease Liabilities (1) 15.8 161.3 (1) For the year ended December 31, 2020, this included leases related to the acquisition of Ingersoll Rand Industrial. Supplemental balance sheet information related to leases is as follows. December 31, 2021 December 31, 2020 Operating leases Other assets $ 101.8 $ 142.9 Accrued liabilities 34.9 47.1 Other liabilities 61.0 90.5 Total operating lease liabilities $ 95.9 $ 137.6 Finance Leases Property, plant and equipment $ 15.1 $ 15.7 Short-term borrowings and current maturities of long-term debt 1.1 0.7 Long-term debt, less current maturities 16.0 16.5 Total finance lease liabilities $ 17.1 $ 17.2 Weighted Average Remaining Lease Term (in years) Operating leases 4.0 3.5 Finance leases 11.9 13.2 Weighted Average Discount Rate Operating leases 1.8 % 1.8 % Finance leases 6.3 % 6.4 % Maturities of lease liabilities as of December 31, 2021 are as follows. Operating Leases Finance Leases 2022 $ 36.1 $ 2.2 2023 26.9 2.2 2024 14.5 2.2 2025 7.6 2.0 2026 5.1 2.0 Thereafter 9.2 14.6 Total lease payments $ 99.4 $ 25.2 Less imputed interest (3.5) (8.1) Total $ 95.9 $ 17.1
Leases	LeasesThe Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROUs in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets. At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. Subsequent to the commencement date, operating lease liabilities are recorded at the present value of unpaid lease payments discounted at a discount rate established at the commencement date. Due to the absence of an implicit rate in the Company’s lease contracts, an incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread. Operating ROU assets are recorded as the beginning balance less accumulated amortization with accumulated amortization equaling the straight-lined lease expense less the periodic accretion of the lease liability using the effective interest rate method. Subsequent to the commencement date, financing lease liabilities are increased to reflect interest on the lease liability and decreased for principal lease payments made. The financing ROU asset is measured at cost less amortization expense and any accumulated impairment loss. Amortization expense is calculated on a straight-line basis over the lease term or remaining useful life. The Company’s lease terms allow for the extension or termination of its leases and accounts for the extension and termination when it is reasonably certain that the Company will exercise the option or terminate the lease. Reassessment of the lease term occurs when there is a significant event or a significant change in circumstances that is within the control of the Company that directly affects whether the Company is reasonably certain to exercise or not to exercise an option to extend or terminate the lease or to purchase the underlying asset. Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification includes a change to the contractual terms, scope of the lease or the consideration given. In the event that the right to use an additional asset is granted and the lease payments associated with the additional asset are commensurate with the ROU asset’s standalone price, the modification is accounted for as a separate contract and the original contract remains unchanged. In the event that a single lease is modified, the Company reassessed the classification of the modified lease as of the effective date of the modification based on the modified terms and accounts for initial direct costs, lease incentives and any other payments made to or by the Company in connection with the modification in the same manner that items would be accounted for in connection with a new lease. If there is an additional ROU asset included, the lease term is extended or reduced, or the consideration is the only change in the contract, the Company reallocates the remaining consideration in the contract and remeasures the lease liability using a discount rate determined at the effective date of the modification. The remeasured lease liability for the modified lease is an adjustment to the corresponding ROU asset and does not impact the Consolidated Statements of Operations. In the event of a full or partial termination, the carrying value of the ROU asset decreases on a basis proportionate to the full or partial termination and any difference between the reduction in the lease liability and the proportionate reduction of the ROU asset is recognized as a gain or loss at the effective date of the modification. The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material. The components of lease expense for the years ended December 31, 2021 and 2020 are as follows. 2021 2020 Operating lease cost $ 50.6 $ 46.1 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.2 Interest on lease liabilities 1.1 1.1 Total finance lease cost $ 2.6 $ 2.3 Short-term lease cost $ 2.0 $ 2.0 Supplemental cash flow information related to leases for the years ended December 31, 2021 and 2020 is as follows. 2021 2020 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 52.0 $ 56.6 Operating cash flows from finance leases 1.1 1.1 Financing cash flows from finance leases 1.1 0.7 Leased Assets Obtained in Exchange for New Operating Lease Liabilities (1) 15.8 161.3 (1) For the year ended December 31, 2020, this included leases related to the acquisition of Ingersoll Rand Industrial. Supplemental balance sheet information related to leases is as follows. December 31, 2021 December 31, 2020 Operating leases Other assets $ 101.8 $ 142.9 Accrued liabilities 34.9 47.1 Other liabilities 61.0 90.5 Total operating lease liabilities $ 95.9 $ 137.6 Finance Leases Property, plant and equipment $ 15.1 $ 15.7 Short-term borrowings and current maturities of long-term debt 1.1 0.7 Long-term debt, less current maturities 16.0 16.5 Total finance lease liabilities $ 17.1 $ 17.2 Weighted Average Remaining Lease Term (in years) Operating leases 4.0 3.5 Finance leases 11.9 13.2 Weighted Average Discount Rate Operating leases 1.8 % 1.8 % Finance leases 6.3 % 6.4 % Maturities of lease liabilities as of December 31, 2021 are as follows. Operating Leases Finance Leases 2022 $ 36.1 $ 2.2 2023 26.9 2.2 2024 14.5 2.2 2025 7.6 2.0 2026 5.1 2.0 Thereafter 9.2 14.6 Total lease payments $ 99.4 $ 25.2 Less imputed interest (3.5) (8.1) Total $ 95.9 $ 17.1

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation PlansThe Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan, as amended (“2017 Plan”). Following the Company’s initial public offering, the Company grants stock-based compensation awards pursuant to the 2017 Plan and ceased granting new awards pursuant to the 2013 Plan. 2017 Omnibus Incentive Plan In May 2017, the Company’s Board approved the 2017 Plan. Additionally, in February 2020, the Company’s stockholders approved the amendment and restatement of the 2017 Plan. Under the terms of the Plan, the Company’s Board may grant up to 19.6 million stock based and other incentive awards. Any shares of common stock subject to outstanding awards granted under the Company’s 2013 plan that, after the effective date of the 2017 Plan, expire or are otherwise forfeited or terminated in accordance with their terms are also available for grant under the 2017 Plan. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards typically vest over four 2013 Stock Incentive Plan The Company adopted the 2013 Plan on October 14, 2013 as amended on April 27, 2015 under which the Company had the ability to grant stock-based compensation awards to employees, directors and advisors. The total number of shares available for grant under the 2013 Plan and reserved for issuance was 20.9 million shares. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards vested over either five, four, or three years with 50% of each award vesting based on time and 50% of each award vesting based on the achievement of certain financial targets. Acquisition of Ingersoll Rand Industrial As of the acquisition date of February 29, 2020, Ingersoll Rand Industrial employees’ unvested equity awards and a limited number of vested awards were converted into equity awards denominated in shares of the Company’s common stock based on a defined exchange ratio. Ingersoll Rand Industrial employees’ equity awards were converted into Ingersoll Rand stock options and restricted stock units. For converted restricted stock units, the fair value of the equity award is based on the market price of the common stock on the grant date. The replacement restricted stock units will generally be governed by the same terms and conditions as those applicable prior to the acquisition. The portion of fair value of the replacement awards related to services provided prior to the acquisition was accounted for as consideration transferred. The remaining portion of the fair value is associated with future service and is recognized as compensation expense over the vesting period. For converted stock options, the exercise price per share of the converted award was equal to the exercise price per share of the stock option award immediately prior to the completion of the acquisition divided by the exchange ratio. The replacement options will generally be governed by the same terms and conditions as those applicable prior to the acquisition. The portion of fair value of the replacement awards related to services provided prior to the acquisition was accounted for as consideration transferred. The remaining portion of fair value is associated with future service and is recognized as compensation expense over the vesting period. The fair value of stock options that the Company assumed in connection with the acquisition of Ingersoll Rand Industrial was estimated using the Black-Scholes model with the following assumptions. Converted Stock Option Awards Assumptions: Expected life of options (in years) 2.0 - 3.6 Risk-free interest rate 0.9 % Assumed volatility 34.2 % Expected dividend rate 0.0 % Stock-Based Compensation Expense Stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019 are included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and are as follows. 2021 2020 2019 Stock-based compensation expense recognized in: Continuing operations $ 87.2 $ 47.5 $ 18.7 Discontinued operations 10.9 3.8 0.5 Total stock-based compensation expense $ 98.1 $ 51.3 $ 19.2 Stock-Based Compensation Expense - Continuing Operations For the year ended December 31, 2021, the $87.2 million of stock-based compensation expense included expense for equity awards granted under the 2013 Plan and 2017 Plan of $85.8 million and an increase in the liability for stock appreciation rights (“SAR”) of $1.4 million. Of the $85.8 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $57.4 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020. For the year ended December 31, 2020, the $47.5 million of stock-based compensation expense included expense for modifications of equity awards for certain former employees of $2.9 million, expense for equity awards granted under the 2013 Plan and 2017 Plan of $43.3 million and an increase in the liability for SARs of $1.3 million. The $2.9 million of stock-based compensation expense for modifications provided continued vesting through scheduled vesting dates of certain equity awards for certain former employees. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations. Of the $43.3 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $23.4 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020. For the year ended December 31, 2019, the $18.7 million of stock-based compensation expense included expense for modifications of equity awards for certain former employees of $1.0 million, expense for equity awards granted under the 2013 Plan and 2017 Plan of $9.7 million and an increase in the liability for SARs of $8.0 million. The $1.0 million of stock-based compensation expense for modifications provided continued vesting through scheduled vesting dates and extended expiration dates for certain former employees. These costs are included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statement of Operations. As of December 31, 2021, there was $85.5 million of total unrecognized compensation expense related to outstanding stock option, restricted stock unit and performance share unit awards. SARs, granted under the 2013 Plan, are expected to be settled in cash and are accounted for as liability awards. As of December 31, 2021 and 2020 a liability of approximately $4.5 million and $3.5 million, respectively, for SARs was included in “Accrued liabilities” in the Consolidated Balance Sheets. Stock-Based Compensation Expense - Discontinued Operations For the year ended December 31, 2021, the $10.9 million of stock-based compensation expense included expense for modifications of equity awards of $3.8 million and expense for equity awards granted under the 2013 and 2017 Plan of $7.1 million. The modifications allowed for the vesting of the first tranche of the All-Employee Equity Grant awarded to HPS and SVT employees despite their termination due to the divestitures. Of the $7.1 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $5.4 million related to the All-Employee Equity Grant. Stock Option Awards A summary of the Company’s stock option (including SARs) activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Exercise Price Wtd. Avg. Remaining Contractual Term (years) Aggregate Intrinsic Value of In-The-Money Options Outstanding at December 31, 2020 7,742 $ 18.47 Granted 795 45.78 Exercised or Settled (1,530) 16.11 Forfeited (255) 30.77 Expired (6) 13.01 Outstanding at December 31, 2021 6,746 21.76 5.7 $ 268.7 Vested at December 31, 2021 4,351 15.89 4.4 $ 198.2 The per-share weighted average grant date fair value of stock options granted during the years ended December 31, 2021, 2020 and 2019 was $18.06, $9.29 and $10.16, respectively. The intrinsic value of stock options exercised was $53.5 million, $66.0 million and $109.8 million during the years ended December 31, 2021, 2020 and 2019, respectively. The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Expected life of options (in years) 6.3 6.3 6.3 Risk-free interest rate 0.9% - 1.3% 0.4% - 1.5% 1.7% - 2.6% Assumed volatility 38.6% - 39.4% 24.6% - 41.1% 24.8% - 31.8% Expected dividend rate 0.0% - 0.1% 0.0 % 0.0 % Restricted Stock Unit Awards Restricted stock units are typically granted in the first quarter of the year to employees and non-employee directors based on the market price of the Company’s common stock on the grant date and recognized in compensation expense over the vesting period. Eligible employees were also granted restricted stock units, during the third quarter of 2020, that vest ratably over two years, subject to the passage of time and the employee ’ s continued employment during such period. In some instances, such as death, awards may vest concurrently with or following an employee ’ s termination. A summary of the Company’s restricted stock unit activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2020 5,546 $ 33.09 Granted 340 45.76 Vested (2,542) 33.44 Forfeited (667) 34.27 Non-vested as of December 31, 2021 2,677 34.08 Performance Share Unit Awards Performance share units are granted to certain key employees and are subject to a three year performance period. The number of shares issued at the end of the performance period is determined by the Company’s total shareholder return percentile rank versus the S&P 500 index for the three year performance period. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a three year period. A summary of the Company’s performance stock unit activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2020 255 $ 29.72 Granted 158 55.84 Vested — — Forfeited (20) 36.36 Non-vested as of December 31, 2021 393 39.89 The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2021 and 2020 using the Monte Carlo simulation pricing model. 2021 2020 Expected term (in years) 2.9 2.8 Risk-free interest rate 0.2 % 0.5 % Assumed volatility 36.9 % 35.2 % Expected dividend rate 0.0 % 0.0 %

Hedging Activities, Derivative

Hedging Activities, Derivative Instruments and Credit Risk	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Hedging Activities, Derivative Instruments and Credit Risk	Hedging Activities, Derivative Instruments and Credit Risk Hedging Activities The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including foreign currency forward contracts and interest rate swaps, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes. Fluctuations in interest rates and foreign currency exchange rates can be volatile, and the Company’s risk management activities do not totally eliminate these risks. Consequently, these fluctuations could have a significant effect on the Company’s financial results. The Company’s exposure to interest rate risk results primarily from its variable-rate borrowings. The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using pay-fixed interest rate swaps from time to time as cash flow hedges of variable rate debt in order to adjust the relative fixed and variable proportions. A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. Other than the USD, the EUR, GBP, and Chinese Renminbi are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company has certain U.S. subsidiaries borrow in currencies other than the USD. The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances at least quarterly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of non-functional currencies generally mature within one year. Derivative Instruments The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020. December 31, 2021 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair Value $ 22.1 $ — $ — $ — $ — Foreign currency forwards Fair Value $ 19.3 $ — $ — $ 0.2 $ — December 31, 2020 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair Value $ 230.5 $ 2.9 $ — $ — $ — Foreign currency forwards Fair Value $ 51.2 $ — $ — $ 0.7 $ — (1) Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively. Gains and losses on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2021, 2020 and 2019 are presented in the table below. 2021 2020 2019 Interest Rate Swap Contracts Gain (loss) recognized in AOCI on derivatives $ — $ (4.4) $ (7.4) Loss reclassified from AOCI into income (effective portion) (1) — (18.5) (15.6) (1) Losses on derivatives reclassified from accumulated other comprehensive income (“AOCI”) into income were included in “Interest expense” in the Consolidated Statements of Operations. As of December 31, 2021, the Company has no interest rate swap contracts. Our previous interest rate swap contracts expired during the third quarter of 2020 and the remaining amounts in AOCI were reclassified to Interest Expense during the same period. The Company’s variable rate borrowings outstanding as of December 31, 2021 were $2,778.1 million and €590.6 million. The Company had five foreign currency forward contracts outstanding as of December 31, 2021 with notional amounts ranging from $2.3 million to $14.9 million. These contracts are used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Consolidated Balance Sheets. The amount available to be netted is not material. The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2021, 2020 and 2019 were as follows. 2021 2020 2019 Foreign currency forward contracts gains (losses) (3.2) 15.0 (4.9) Total foreign currency transaction gains (losses), net 12.0 (18.6) (7.3) The Company has a significant investment in consolidated subsidiaries with functional currencies other than the USD, particularly the EUR. On August 17, 2017, the Company designated the €615.0 million Euro Term Loan as a hedge of the Company’s net investment in subsidiaries with EUR functional currencies. As of December 31, 2021, the Euro Term Loan of €590.6 million remained designated. The Company’s gains, net of income tax, associated with changes in the value of debt for the years ended December 31, 2021 and 2020, and the net balance of such gains included in accumulated other comprehensive income (loss) as of December 31, 2021 and 2020 were as follows. 2021 2020 Gain (loss), net of income tax, recorded through other comprehensive income $ 35.0 $ (45.1) Balance included in accumulated other comprehensive income (loss) as of December 31, 2021 and 2020, respectively 65.7 30.7 All cash flows associated with derivatives are classified as operating cash flows in the Consolidated Statements of Cash Flows. There were no off-balance sheet derivative instruments as of December 31, 2021 or 2020. Credit Risk Credit risk related to derivatives arises when amounts receivable from a counterparty exceed those payable. Because the notional amount of the derivative instruments only serves as a basis for calculating amounts receivable or payable, the risk of loss with any counterparty is limited to a fraction of the notional amount. The Company minimizes the credit risk related to derivatives by transacting only with multiple, high-quality counterparties that are major financial institutions with investment-grade credit ratings. The Company has not experienced any financial loss as a result of counterparty nonperformance in the past. The majority of the derivative contracts to which the Company is a party, settle monthly or quarterly, or mature within one year. Because of these factors, the Company believes it has minimal credit risk related to derivative contracts as of December 31, 2021. Concentrations of credit risk with respect to trade receivables are limited due to the wide variety of customers and industries to which the Company’s products and services are sold, as well as their dispersion across many different geographic areas . As a result, the Company does not believe it has any significant concentrations of credit risk as of December 31, 2021 or 2020.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows. Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date. Level 2 Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company assessed indefinite-lived intangible assets, tradenames, in conjunction with the 2021 and 2020 annual goodwill impairment tests. The valuation of tradenames was based upon current sales projections and the relief from royalty method was applied. No impairment charges were recorded as a result of the 2021 analysis. As a result of the 2020 analysis, two trademarks were determined to have a carrying amount above their estimated fair value. These represented Level 3 assets measured on a nonrecurring basis subsequent to their original recognition. This resulted in a total non-cash impairment charge of $19.9 million. The fair value was determined using the relief from royalty method. Refer to Note 1 “Summary of Significant Accounting Policies” for a discussion of the valuation assumptions utilized in the valuation of goodwill and indefinite-lived intangible assets. The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis. December 31, 2021 Level 1 Level 2 Level 3 Total Financial Assets Foreign currency forwards (1) $ — $ — $ — $ — Trading securities held in deferred compensation plan (2) 12.0 — — 12.0 Total $ 12.0 $ — $ — $ 12.0 Financial Liabilities Foreign currency forwards (1) $ — $ 0.2 $ — $ 0.2 Deferred compensation plan (2) 22.4 — — 22.4 Total $ 22.4 $ 0.2 $ — $ 22.6 December 31, 2020 Level 1 Level 2 Level 3 Total Financial Assets Foreign currency forwards (1) $ — $ 2.9 $ — $ 2.9 Trading securities held in deferred compensation plan (2) 9.1 — — 9.1 Total $ 9.1 $ 2.9 $ — $ 12.0 Financial Liabilities Foreign currency forwards (1) $ — $ 0.7 $ — $ 0.7 Deferred compensation plan (2) 25.7 — — 25.7 Total $ 25.7 $ 0.7 $ — $ 26.4 (1) Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates. (2) Based on the quoted price of publicly traded mutual funds which are classified as trading securities and accounted for using the mark-to-market method.

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of its size and sector. The Company believes that such proceedings, lawsuits and administrative actions will not materially adversely affect its operations, financial condition, liquidity or competitive position. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth below. Asbestos and Silica Related Litigation The Company has been named as a defendant in a number of asbestos-related and silica-related personal injury lawsuits. The plaintiffs in these suits allege exposure to asbestos or silica from multiple sources and typically the Company is one of approximately 25 or more named defendants. Predecessors to the Company sometimes manufactured, distributed and sold products allegedly at issue in the pending asbestos and silica-related lawsuits (the “Products”). However, neither the Company nor its predecessors ever mined, manufactured, mixed, produced or distributed asbestos fiber or silica sand, the materials that allegedly caused the injury underlying the lawsuits. Moreover, the asbestos-containing components of the Products, if any, were enclosed within the subject Products. Although the Company has never mined, manufactured, mixed, produced or distributed asbestos fiber or silica sand nor sold products that could result in a direct asbestos or silica exposure, many of the companies that did engage in such activities or produced such products are no longer in operation. This has led to law firms seeking potential alternative companies to name in lawsuits where there has been an asbestos or silica related injury. The Company believes that the pending and future asbestos and silica-related lawsuits are not likely to, in the aggregate, have a material adverse effect on its consolidated financial position, results of operations or liquidity, based on: the Company’s anticipated insurance and indemnification rights to address the risks of such matters; the limited potential asbestos exposure from the Products described above; the Company’s experience that the vast majority of plaintiffs are not impaired with a disease attributable to alleged exposure to asbestos or silica from or relating to the Products or for which the Company otherwise bears responsibility; various potential defenses available to the Company with respect to such matters; and the Company’s prior disposition of comparable matters. However, inherent uncertainties of litigation and future developments, including, without limitation, potential insolvencies of insurance companies or other defendants, an adverse determination in the Adams County Case (discussed below), or other inability to collect from the Company’s historical insurers or indemnitors, could cause a different outcome. While the outcome of legal proceedings is inherently uncertain, based on presently known facts, experience, and circumstances, the Company believes that the amounts accrued on its balance sheet are adequate and that the liabilities arising from the asbestos and silica-related personal injury lawsuits will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity. “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets include a reserve of $136.9 million and $131.4 million as of December 31, 2021 and 2020, respectively, for asbestos-related indemnification. Asbestos-related defense costs are excluded from this liability and are recorded separately as services are incurred. In the event of unexpected future developments, it is possible that the ultimate resolution of these matters may be material to the Company’s consolidated financial position, results of operation or liquidity. The Company has entered into a series of agreements with certain of its or its predecessors’ legacy insurers and certain potential indemnitors to secure insurance coverage and reimbursement for the costs associated with the asbestos and silica-related lawsuits filed against the Company. The Company has also pursued litigation against certain insurers or indemnitors, where necessary. The Company has an insurance recovery receivable for probable asbestos related recoveries of approximately $145.1 million and $132.1 million as of December 31, 2021 and 2020, respectively, which was included in “Other assets” in the Consolidated Balance Sheets. There were no material recoveries received in the years ended December 31, 2021, 2020 and 2019. The most recent significant action brought by the Company against an insurer, Gardner Denver, Inc. v. Certain Underwriters at Lloyd’s, London, et al., was filed on July 9, 2010, in the Eighth Judicial Circuit, Adams County, Illinois, as case number 10-L-48 (the “Adams County Case”). In the lawsuit, the Company seeks, among other things, to require certain excess insurer defendants to honor their insurance policy obligations to the Company, including payment in whole or in part of the costs associated with the asbestos-related lawsuits filed against the Company. In October 2011, the Company reached a settlement with one of the insurer defendants, which had issued both primary and excess policies, for approximately the amount of such defendant’s policies that were subject to the lawsuit. Since then, the case has been proceeding through the discovery and motions process with the remaining insurer defendants. On January 29, 2016, the Company prevailed on the first phase of that discovery and motions process (“Phase I”). Specifically, the Court in the Adams County Case ruled that the Company has rights under all of the policies in the case, subject to their terms and conditions, even though the policies were sold to the Company’s former owners rather than to the Company itself. On June 9, 2016, the Court denied a motion by several of the insurers who sought permission to appeal the Phase I ruling immediately rather than waiting until the end of the whole case as is normally required. The case is now proceeding through the discovery process regarding the remaining issues in dispute (“Phase II”). A majority of the Company’s expected future recoveries of the costs associated with the asbestos-related lawsuits are the subject of the Adams County Case. The amounts recorded by the Company for asbestos-related liabilities and insurance recoveries are based on currently available information and assumptions that the Company believes are reasonable based on an evaluation of relevant factors. The actual liabilities or insurance recoveries could be higher or lower than those recorded if actual results vary significantly from the assumptions. There are a number of key variables and assumptions including the number and type of new claims to be filed each year, the resolution or outcome of these claims, the average cost of resolution of each new claim, the amount of insurance available, allocation methodologies, the contractual terms with each insurer with whom the Company has reached settlements, the resolution of coverage issues with other excess insurance carriers with whom the Company has not yet achieved settlements, and the solvency risk with respect to the Company’s insurance carriers. Other factors that may affect the future liability include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, legal rulings that may be made by state and federal courts, and the passage of state or federal legislation. The Company makes the necessary adjustments for the asbestos liability and corresponding insurance recoveries on an annual basis unless facts or circumstances warrant assessment as of an interim date. Environmental Matters The Company has been identified as a potentially responsible party (“PRP”) with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. Persons potentially liable for such costs and damages generally include the site owner or operator and persons that disposed or arranged for the disposal of hazardous substances found at those sites. Although these laws impose joint and several liability on PRPs, in application the PRPs typically allocate the investigation and cleanup costs based upon the volume of waste contributed by each PRP. Based on currently available information, the Company was only a small contributor to these waste sites, and the Company has, or is attempting to negotiate, de minimis settlements for their cleanup. The cleanup of the remaining sites is substantially complete and the Company’s future obligations entail a share of the sites’ ongoing operating and maintenance expense. The Company is also addressing several on-site cleanups for which it is the primary responsible party. The Company has undiscounted liabilities of $12.9 million and $13.7 million as of December 31, 2021 and 2020, respectively, on its Consolidated Balance Sheets to the extent costs are known or can be reasonably estimated for its remaining financial obligations for the environmental matters discussed above and does not anticipate that any of these matters will result in material additional costs beyond amounts accrued. Based upon consideration of currently available information, the Company does not anticipate any material adverse effect on its results of operations, financial condition, liquidity or competitive position as a result of compliance with federal, state, local or foreign environmental laws or regulations, or cleanup costs relating to these matters.

Other Operating Expense, Net

Other Operating Expense, Net	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Other Operating Expense, Net	Other Operating Expense, Net The components of “Other operating expense, net” for the years ended December 31, 2021, 2020 and 2019 were as follows. 2021 2020 2019 Other Operating Expense, Net Foreign currency transaction losses (gains), net $ (12.0) $ 18.6 $ 7.3 Restructuring charges (1) 13.4 83.0 11.1 Shareholder litigation settlement recoveries (2) — — (6.0) Acquisition related expenses (3) 55.3 93.3 53.8 Other, net 5.2 6.1 3.1 Total other operating expense, net $ 61.9 $ 201.0 $ 69.3 (1) See Note 5 “Restructuring.” (2) Represents insurance recoveries of the Company’s shareholder litigation settlement in 2014.

Former Related Party

Former Related Party	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Former Related Party	Former Related Party Affiliates of Kohlberg Kravis Roberts & Co. L.P. (“KKR”) served on the Company ’ s board of directors until November 9, 2021 and KKR maintained an equity interest in the Company until August 6, 2021. On August 6, 2021, KKR completed a secondary offering to sell its remaining 29,788,635 shares of common stock, of which Ingersoll Rand purchased 14,894,317 shares. KKR did not own any shares of common stock as of December 31, 2021. Affiliates of KKR participated as a provider of services for the fiscal years 2020 and 2019 debt refinancing transactions. In June 2019, KKR Capital Markets LLC was the joint lead arranger and bookrunner of Amendment No. 4 to the Credit Agreement and earned $0.4 million in structuring fees for their involvement in the Amendment. During 2020, KKR Capital Markets LLC earned $7.5 million in underwriting fees for their involvement in Amendment No. 5 and Amendment No. 6 to the Credit Agreement.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The number of weighted-average shares outstanding used in the computations of basic and diluted earnings (loss) per share are as follows. Year Ended December 31, 2021 2020 2019 Average shares outstanding: Basic 414.8 382.8 203.5 Diluted 421.2 382.8 208.9

SCHEDULE I - FINANCIAL STATEMEN

SCHEDULE I - FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Condensed Financial Information of Parent Company Only	SCHEDULE 1 – INGERSOLL RAND INC. (PARENT COMPANY ONLY) STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (in millions) For the Years Ended December 31, 2021 2020 2019 Revenues $ — $ — $ — Cost of sales 1.0 14.6 0.6 Gross Profit (1.0) (14.6) (0.6) Operating costs 67.9 30.9 10.4 Other operating expense, net (8.4) (4.9) (47.0) Operating Income (Loss) (60.5) (40.6) 36.0 Interest income (28.8) 42.5 42.3 Income (Loss) Before Income Taxes (89.3) 1.9 78.3 Income tax provision (benefit) (18.1) (3.9) (5.1) Income (Loss) of Parent Company (71.2) 5.8 83.4 Equity in undistributed income of subsidiaries 592.1 (63.5) 13.9 Income (Loss) from Continuing Operations 520.9 (57.7) 97.3 Income from discontinued operations, net of tax 41.6 24.4 61.8 Net Income (Loss) 562.5 (33.3) 159.1 Other comprehensive income (loss) (54.3) 270.2 (0.8) Comprehensive Income $ 508.2 $ 236.9 $ 158.3 SCHEDULE 1 – INGERSOLL RAND INC. (PARENT COMPANY ONLY) BALANCE SHEETS (in millions) As of December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ — $ — Other current assets — 0.4 Total current assets — 0.4 Equity in net assets of subsidiaries 8,513.3 8,006.0 Intercompany receivables 484.1 1,107.3 Deferred tax assets 10.8 10.9 Total assets $ 9,008.2 $ 9,124.6 Liabilities and Equity Other liabilities $ 6.7 $ 4.9 Total liabilities 6.7 4.9 Stockholders ’ equity: Common stock, $0.01 par value; 1,000,000,000 shares authorized; 423,785,571 and 420,123,978 shares issued as of December 31, 2021 and 2020, respectively 4.3 4.2 Capital in excess of par value 9,408.6 9,310.3 Accumulated deficit 378.6 (175.7) Accumulated other comprehensive loss (41.6) 14.2 Treasury stock at cost; 16,000,364 and 1,496,169 shares as of December 31, 2021 and 2020, respectively (748.4) (33.3) Total Ingersoll Rand Inc. stockholders ’ equity 9,001.5 9,119.7 Total liabilities and equity $ 9,008.2 $ 9,124.6 SCHEDULE 1 – INGERSOLL RAND INC. (PARENT COMPANY ONLY) CONDENSED STATEMENTS OF CASH FLOWS (in millions) For the Years Ended December 31, 2021 2020 2019 Cash Flows From Operating Activities: Net cash provided by (used in) operating activities $ (9.7) $ (15.1) $ (15.1) Cash Flows From Investing Activities: Advances to subsidiaries 731.0 (2.5) (10.1) Net cash provided by (used in) investing activities 731.0 (2.5) (10.1) Cash Flows From Financing Activities: Proceeds from stock option exercises 23.7 22.7 42.8 Cash dividends on common stock (8.2) — — Purchases of treasury stock (736.8) (2.1) (18.6) Purchase of shares from noncontrolling interest — (14.9) — Proceeds from sale of noncontrolling interest — 11.9 — Net cash provided by (used in) financing activities (721.3) 17.6 24.2 Increase (decrease) in cash and cash equivalents — — (1.0) Cash and cash equivalents, beginning of year — — 1.0 Cash and cash equivalents, end of year $ — $ — $ — SCHEDULE I - INGERSOLL RAND INC. (PARENT COMPANY ONLY) NOTES TO CONDENSED FINANCIAL STATEMENTS 1. Overview and Basis of Presentation On February 29, 2020, Ingersoll Rand Inc. (formerly known as Gardner Denver Holdings, Inc.) completed the acquisition of and merger with Ingersoll Rand Industrial (“Ingersoll Rand Industrial”) and changed its name from Gardner Denver Holdings, Inc. to Ingersoll Rand Inc. Ingersoll Rand Inc. Parent Company Only financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this report. The accounting policies for the registrant are the same as those described in Note 1 “Summary of Significant Accounting Policies” to our audited consolidated financial statements included elsewhere in this Form 10-K. 2. Subsidiary Transactions Investment in Subsidiaries Ingersoll Rand Inc.’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries. Dividends and Capital Distributions There were no dividends received from subsidiaries during the years ended December 31, 2021, 2020 and 2019. 3. Debt A discussion of long-term debt, including the five-year debt maturity schedule, can be found in Note 11 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K. Ingersoll Rand Inc. had no long-term debt obligations as of December 31, 2021 and 2020. 4. Contingencies For a summary of contingencies, see Note 21 “Contingencies” to our audited consolidated financial statements included elsewhere in this Form 10-K.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Ingersoll Rand Inc. is a global market leader with a broad range of innovative and mission-critical air, fluid, energy, specialty vehicle and medical technologies, providing services and solutions to increase industrial productivity and efficiency. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”). On February 29, 2020, Ingersoll Rand Inc. (formerly known as Gardner Denver Holdings, Inc.) completed the acquisition of the Ingersoll Rand Industrial business (“Ingersoll Rand Industrial”) by way of merger and changed its name from Gardner Denver Holdings, Inc. to Ingersoll Rand Inc. The consolidated financial statements as of and for the year ended December 31, 2020 include the financial results of Ingersoll Rand Industrial from the date of acquisition.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation	Foreign Currency Translation Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income (loss), and are reported in accumulated other comprehensive income (loss), a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition	Revenue Recognition The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations. See Note 15 “Revenue from Contracts with Customers” for additional information regarding revenue recognition.
Cost of Sales	Cost of Sales Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished
Selling and Administrative Expenses	Selling and Administrative Expenses Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2021 and 2020, cash of $2.5 million and $3.1 million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company.
Accounts Receivable	Accounts Receivable Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment. Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories	Inventories Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets	Goodwill and Indefinite-Lived Intangible Assets Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value. The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value. The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates. See Note 9 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives	Long-Lived Assets Including Intangible Assets With Finite Useful Lives Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection. The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves	Warranty Reserves Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units are valued at the share price on the date of grant. See Note 18 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans.
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2021 and 2020 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost. See Note 12 “Benefit Plans” for disclosures related to the Company’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations.
Income Taxes	Income Taxes The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income taxes are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed. The Tax Cuts and Jobs Act, enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above) going forward. The tax provision for the year ended December 31, 2021 reflects this decision. All of the additional calculations and rule changes found in the Tax Act have been considered in the tax provision for the year ended December 31, 2021. The Company recorded a tax expense of $11.7 million in 2021 for the GILTI provisions of the Tax Act.
Research and Development	Research and Development For the years ended December 31, 2021, 2020 and 2019, the Company spent approxima tely $74 million, $58 million, and $22 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments	Derivative Financial Instruments All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, or (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge or an eligible net investment in a foreign operation, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations. Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income	Comprehensive Income The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 14 “Accumulated Other Comprehensive Income (Loss).”
Restructuring Charges	Restructuring Charges The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs. A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred. Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations	Business Combinations The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share	Earnings per Share The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Adopted Accounting Standards Updates ("ASU") & Recently Issued Accounting Pronouncements	Adopted Accounting Standard Updates (“ASU”) In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional expedients and exceptions for a limited time to ease the potential burden of accounting for reference rate reform on financial reporting. This guidance applies to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates. The guidance is effective beginning on March 12, 2020 through December 31, 2022. The Company has not utilized any of the optional expedients or exceptions available under this ASU. The Company will continue to assess whether this ASU is applicable throughout the effective period. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . The amendments in this update simplify the accounting for income taxes by removing certain exceptions and amending and clarifying existing guidance. The guidance is effective for public companies beginning with the first quarter of 2021. Early adoption is permitted. The Company adopted this guidance on January 1, 2021. The adoption did not have a material impact on our consolidated financial statements. Recently Issued Accounting Pronouncements In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848) : Scope, which explicitly clarifies which contracts, hedging relationships, and other transactions are within the scope of the optional expedients and exceptions allowed under Topic 848. The Company has not utilized any of the optional expedients or exceptions available under Topic 848. The Company will continue to assess whether this ASU is applicable through December 31, 2022, in conjunction with our assessment of ASU 2020-4. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805)

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	The results of operations of SVT and HPS are presented as discontinued operations for the years ended December 31, 2021, 2020 and 2019 as summarized below: Specialty Vehicle Technologies High Pressure Solutions Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Revenues $ 430.9 $ 741.4 $ — $ 71.9 $ 195.6 $ 434.4 $ 502.8 $ 937.0 $ 434.4 Cost of sales 321.3 564.6 — 60.2 163.9 301.0 381.5 728.5 301.0 Gross Profit 109.6 176.8 — 11.7 31.7 133.4 121.3 208.5 133.4 Selling and administrative expenses 35.7 63.0 — 5.3 42.5 26.8 41.0 105.5 26.8 Amortization of intangible assets 10.4 37.1 — 2.4 23.6 19.0 12.8 60.7 19.0 Loss (gain) on sale (298.3) — — 207.7 — — (90.6) — — Other operating expense, net 18.1 1.7 — 19.0 14.5 6.4 37.1 16.2 6.4 Operating Income (Loss) 343.7 75.0 — (222.7) (48.9) 81.2 121.0 26.1 81.2 Interest expense — — — — — 0.5 — — 0.5 Other expense, net — — — — 0.1 — — 0.1 — Income (Loss) from Discontinued Operations Before Income Taxes 343.7 75.0 — (222.7) (49.0) 80.7 121.0 26.0 80.7 Provision (benefit) for income taxes 87.1 12.9 — (7.7) (11.3) 18.9 79.4 1.6 18.9 Income (Loss) from Discontinued Operations, Net of Tax $ 256.6 $ 62.1 $ — $ (215.0) $ (37.7) $ 61.8 $ 41.6 $ 24.4 $ 61.8 The carrying value of major classes of assets and liabilities related to SVT and HPS that were included in discontinued operations at December 31, 2021 and December 31, 2020 are shown in the table below. Long-term assets and liabilities as of December 31, 2021 have been reclassified as current in the Consolidated Balance Sheets. December 31, 2021 (1) December 31, 2020 (2) Assets Current assets: Cash and cash equivalents $ 6.2 $ — Accounts receivable, net 2.5 104.8 Inventories 5.6 226.9 Other current assets 0.1 5.7 Total current assets 14.4 337.4 Property, plant and equipment, net 1.2 188.3 Goodwill — 721.0 Other intangible assets, net — 935.4 Deferred tax assets — 0.5 Other assets — 17.6 Total non-current assets 1.2 1,862.8 Total assets $ 15.6 $ 2,200.2 Liabilities Current liabilities: Accounts payable $ 2.2 $ 134.7 Accrued liabilities 14.9 78.2 Total current liabilities 17.1 212.9 Pensions and other postretirement benefits — 2.5 Deferred income taxes — 173.3 Other liabilities — 17.0 Total non-current liabilities — 192.8 Total liabilities $ 17.1 $ 405.7 (1) Relates to certain non-U.S. subsidiaries for which legal ownership of assets has not yet transferred. (2) Total assets and total liabilities related to SVT were $1,512.7 million and $354.1 million, respectively, at December 31, 2020. The significant non-cash operating items and capital expenditures reflected in cash flows of discontinued operations for the years ended December 31, 2021, 2020 and 2019 include the following: Specialty Vehicle Technologies High Pressure Solutions Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Loss (gain) on sale $ (298.3) $ — $ — $ 207.7 $ — $ — $ (90.6) $ — $ — Depreciation and amortization 14.8 51.5 — 4.0 36.9 31.6 18.8 88.4 31.6 Stock-based compensation expense 8.2 3.0 — 2.7 0.8 0.5 10.9 3.8 0.5 Capital expenditures 1.6 3.1 — 0.3 3.6 5.3 1.9 6.7 5.3

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Schedule of Segment Results	The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income (Loss) Before Income Taxes for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Revenue Industrial Technologies and Services $ 4,161.0 $ 3,248.2 $ 1,700.9 Precision and Science Technologies 991.4 725.0 316.6 Total Revenue $ 5,152.4 $ 3,973.2 $ 2,017.5 Segment Adjusted EBITDA Industrial Technologies and Services $ 1,033.7 $ 759.8 $ 391.4 Precision and Science Technologies 291.4 220.2 95.8 Total Segment Adjusted EBITDA 1,325.1 980.0 487.2 Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes: Corporate expenses not allocated to segments 133.2 101.9 45.6 Interest expense 87.7 111.1 88.4 Depreciation and amortization expense (1) 418.0 410.4 146.5 Impairment of other intangible assets — 19.9 — Restructuring and related business transformation costs (2) 18.8 88.0 19.6 Acquisition related expenses and non-cash charges (3) 65.2 181.5 54.6 Gain on settlement of post-acquisition contingencies (30.1) — — Stock-based compensation (4) 95.9 47.0 20.2 Loss on extinguishment of debt 9.0 2.0 0.2 Foreign currency transaction losses (gains), net (12.0) 18.6 7.3 Adjustments to LIFO inventories (5) 33.2 39.8 0.2 Shareholder litigation settlement recoveries (6) — — (6.0) Other adjustments (7) (6.8) 5.2 0.4 Income (Loss) Before Income Taxes $ 513.0 $ (45.4) $ 110.2 (1) Depreciation and amortization expense excludes $4.1 million and $2.1 million of depreciation of rental equipment for the years ended December 31, 2021 and 2020, respectively. (2) Restructuring and related business transformation costs consist of the following. 2021 2020 2019 Restructuring charges $ 13.4 $ 83.0 $ 11.1 Facility reorganization, relocation and other costs 3.1 2.1 2.4 Other, net 2.3 2.9 6.1 Total restructuring and related business transformation costs $ 18.8 $ 88.0 $ 19.6 (3) Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs (including certain incentive and non-incentive cash compensation costs) and non-cash charges and credits arising from fair value purchase accounting adjustments. (4) Represents sto ck-based compensation expense recognized for the year ended December 31, 2021 of $87.2 million and associated employer taxes of $8.7 million. Represents stock-based compensation expense recognized for the year ended December 31, 2020 of $47.5 million decreased by $0.5 million due to costs associated with employer taxes. Represents stock-based compensation expense recognized for the year ended December 31, 2019 of $18.7 million and associated employer taxes of $1.5 million. (5) For the year ended December 31, 2021, represents $33.2 million of LIFO reserve changes. For the year ended December 31, 2020, includes $4.2 million of LIFO reserve changes and $35.6 million to reduce the carrying value of inventories acquired in the merger with Ingersoll Rand Industrial accounted for under the LIFO method. We have reclassified the amounts in 2020 from “Other adjustments” and “Acquisition related expenses and non-cash charges,” respectively, to conform to the current year presentation. (6) Represents insurance recoveries in 2019 of the Company’s shareholder litigation settlement in 2014. (7) Includes (i) effects of amortization of prior service costs and amortization of losses in pension and other postretirement benefits (“OPEB”) expense, (ii) certain legal and compliance costs and (iii) other miscellaneous adjustments. The following tables provide summarized information about the Company’s reportable segments. Depreciation and Amortization Expense 2021 2020 2019 Industrial Technologies and Services $ 296.6 $ 306.0 $ 120.0 Precision and Science Technologies 108.3 102.4 23.6 Corporate and other 17.2 4.1 2.9 Total depreciation and amortization expense $ 422.1 $ 412.5 $ 146.5 Capital Expenditures 2021 2020 2019 Industrial Technologies and Services $ 53.1 $ 32.2 $ 31.5 Precision and Science Technologies 10.7 9.8 5.5 Corporate and other 0.3 — 0.9 Total capital expenditures $ 64.1 $ 42.0 $ 37.9 Identifiable Assets 2021 2020 Industrial Technologies and Services $ 9,101.7 $ 9,113.4 Precision and Science Technologies 3,572.2 2,852.8 Corporate and other 2,465.0 1,892.2 Assets of discontinued operations 15.6 2,200.2 Total identifiable assets $ 15,154.5 $ 16,058.6
Scheduled of Geographic Region	The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2021, and 2020. 2021 2020 United States $ 225.8 $ 203.7 Other Americas 16.5 14.6 Total Americas 242.3 218.3 EMEA (1) 221.3 216.0 Asia Pacific 185.0 174.7 Total $ 648.6 $ 609.0 (1) Europe, Middle East and Africa (“EMEA”)

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the allocation of consideration to the fair values of identifiable assets acquired and liabilities assumed at the acquisition date. The initial accounting for these acquisitions is substantially complete. Any further adjustments during the measurement period are not expected to be material. Seepex M-D Pneumatics and Kinney Vacuum Pumps Maximus Solutions All Others Accounts receivable $ 24.9 $ 4.8 $ 4.3 9.3 Inventories 40.5 3.8 2.9 10.5 Other current assets 1.9 0.2 0.2 0.6 Property, plant and equipment 40.7 16.2 2.1 15.2 Goodwill 245.3 80.0 75.7 78.3 Intangible assets 243.6 82.5 39.5 95.9 Other noncurrent assets 1.1 — — — Total current liabilities (34.4) (3.5) (2.4) (4.0) Deferred tax liabilities (75.4) — (11.3) (4.1) Other noncurrent liabilities (6.1) — — (1.0) Total consideration $ 482.1 $ 184.0 $ 111.0 200.7 The following table summarizes the allocation of consideration to the fair values of assets acquired and liabilities assumed of Ingersoll Rand Industrial as of February 29, 2020. These amounts include assets and liabilities of the Specialty Vehicle Technologies segment, which was divested during the year ended December 31, 2021 and is reported as a discontinued operation. Refer to Note 2 for further information on the sale of SVT. Fair value Cash $ 38.8 Accounts receivable 585.8 Inventories 625.4 Other current assets 87.2 Property, plant and equipment 516.5 Goodwill 4,899.2 Other intangible assets 3,766.6 Other noncurrent assets 270.9 Total current liabilities, including current maturities of long-term debt of $19.0 million (753.0) Deferred tax liability (842.4) Long-term debt, net of debt issuance costs and an original issue discount (1,851.7) Other noncurrent liabilities (333.0) Noncontrolling interest (73.3) Total consideration $ 6,937.0
Schedule of Aggregate Purchase Consideration	On February 29, 2020, Ingersoll Rand (formerly Gardner Denver Holdings, Inc.) completed the acquisition of and merger with Ingersoll Rand Industrial in exchange for non-cash consideration comprising the following: Fair value of Ingersoll Rand common stock issued for Ingersoll Rand Industrial outstanding common stock $ 6,919.5 Fair value attributable to pre-merger service for replacement equity awards 8.6 Fair value attributable to pre-merger service for deferred compensation plan 8.9 Total purchase consideration $ 6,937.0
Schedule of Preliminary Fair Value of Property, Plant and Equipment	The fair value of property, plant and equipment was primarily calculated using replacement costs adjusted for the age and condition of the asset, with the exception of real property which was calculated using the market approach, and is summarized below. Land and buildings $ 215.1 Machinery and equipment 256.9 Office furniture and equipment 13.4 Other 1.0 Construction in progress 30.1 Total property, plant and equipment $ 516.5
Schedule of Estimated Preliminary Fair Value and Weighted Average Useful Life of Identifiable Intangible Assets	The fair value and weighted average useful life of the Ingersoll Rand Industrial identifiable intangible assets are as follows. Fair Value Weighted Average Useful Life (Years) Tradenames (1) $ 1,312.0 Indefinite Developed technology (2) 236.0 7 Customer relationships (3) 2,101.0 13 Backlog (4) 81.2 <1 Internal-use software and other 36.4 2 Total identifiable intangible assets $ 3,766.6 (1) The fair value of tradenames were determined using a relief from royalty methodology, which estimates the cost savings generated by a company related to the ownership of an asset for which it would otherwise have had to pay royalties or license fees on revenues earned through the use of the asset. Tradenames are expected to have an indefinite useful life. (2) The fair values of developed technology were determined using a relief from royalty methodology, with similar methodology and assumptions as described in the tradename description above. The economic useful lives were determined based on the technology cycle related to each developed technology, as well as the cash flows over the forecast period. (3) The fair values of customer relationships were determined using the Multi-Period Excess Earning Method, which involves isolating the net earnings attributable to the asset being measured based on present value of the incremental after-tax cash flows attributable solely to the intangible asset over its remaining useful life. The economic useful lives were determined based on historical customer attrition rates. (4) The fair values of acquired backlog were determined using the Multi-Period Excess Earning Method. The economic useful lives were based on the time to fulfill the outstanding order backlog obligation.
Schedule of Pro Forma Information	The pro forma results do not necessarily represent the revenue or results of operations would have been realized had the acquisition been completed on January 1, 2019. In addition, these results are not intended to be a projection of future operating results and do not reflect synergies that might be achieved. 2020 2019 Revenues $ 5,398.0 $ 6,146.5 Net Income (Loss) 164.8 101.1
Schedule of Material and Nonrecurring Adjustments to Unaudited Pro Forma Results	The table below reflects the impact of material and nonrecurring adjustments to the unaudited pro forma results for the years ended December 31, 2020 and 2019 that are directly attributable to the acquisition. 2020 2019 Increase (decrease) to revenue as a result of deferred revenue fair value adjustment, net of tax $ 13.8 $ (13.8) Increase (decrease) to expense as a result of inventory fair value adjustment, net of tax (89.6) 89.6 Increase (decrease) to expense as a result of transaction costs, net of tax (34.8) 34.8

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Activity	For the years ended December 31, 2021 and 2020, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following. 2021 2020 Industrial Technologies and Services $ 8.4 $ 70.3 Precision and Science Technologies — 6.9 Corporate 5.0 5.8 Restructuring charges, net $ 13.4 $ 83.0 The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2021 and 2020, respectively. 2021 2020 Balance at beginning of the period $ 17.5 $ 4.8 Charged to expense - termination benefits 9.6 73.5 Charged to expense - other (1) 2.7 3.3 Acquired restructuring — 5.1 Payments (15.9) (70.1) Foreign currency translation and other (1.6) 0.9 Balance at end of the period $ 12.3 $ 17.5 (1) Excludes $1.1 million and $6.2 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2021 and 2020, respectively.

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Schedule of Allowance for Credit Losses	The allowance for credit losses for the years ended December 31, 2021, 2020 and 2019 consisted of the following. 2021 2020 2019 Balance at beginning of the period $ 50.9 $ 16.6 $ 16.0 Acquisition - Ingersoll Rand Industrial — 25.1 — Provision (benefit) charged to expense (1) (4.3) 10.3 2.4 Write-offs, net of recoveries (3.8) (3.5) (1.6) Foreign currency translation and other (0.5) 2.4 (0.2) Balance at end of the period $ 42.3 $ 50.9 $ 16.6 (1) In the fourth quarter of 2021, the Company adjusted its allowance for credit losses in certain major portions of the business due to improved collection experience and reduction of past due receivables. The impact of these updates was a $6.6 million reduction in the allowance, with a corresponding benefit within “Selling and administrative expenses.”

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Raw materials, including parts and subassemblies $ 506.6 $ 451.0 Work-in-process 88.6 62.2 Finished goods 283.4 194.7 878.6 707.9 LIFO excess (reserve) (24.4) 8.8 Inventories $ 854.2 $ 716.7

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment, net as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Land and land improvements $ 60.1 $ 54.3 Buildings 300.3 278.3 Machinery and equipment 548.1 485.0 Office furniture and equipment 58.3 53.4 Construction in progress 39.5 29.1 1,006.3 900.1 Accumulated depreciation (357.7) (291.1) Property, plant and equipment, net $ 648.6 $ 609.0

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2021 and 2020 are as follows. Industrial Technologies and Services Precision and Science Technologies Total Balance as of December 31, 2019 $ 865.4 $ 227.5 $ 1,092.9 Acquisitions 3,213.5 1,165.5 4,379.0 Foreign currency translation and other (1) 72.3 38.4 110.7 Balance as of December 31, 2020 4,151.2 1,431.4 5,582.6 Acquisitions 87.9 391.4 479.3 Foreign currency translation and other (1) (61.8) (18.5) (80.3) Balance as of December 31, 2021 $ 4,177.3 $ 1,804.3 $ 5,981.6 (1) Includes measurement period adjustments.
Schedule of Goodwill by Segment	The goodwill attributable to these businesses is as follows. 2021 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Seepex $ — $ 245.3 $ 245.3 M-D Pneumatics and Kinney Vacuum Pumps 80.0 — 80.0 Maximus Solutions — 75.7 75.7 Other acquisitions 7.9 70.4 78.3 $ 87.9 $ 391.4 $ 479.3 The Company acquired several businesses during the year ended December 31, 2020. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 2020 Acquisitions Industrial Technologies and Services Precision and Science Technologies Total Ingersoll Rand Industrial $ 3,198.0 $ 1,162.3 $ 4,360.3 Albin Pump SAS — 3.2 3.2 Other acquisitions 15.5 — 15.5 $ 3,213.5 $ 1,165.5 $ 4,379.0
Schedule of Other Intangible Assets	Other intangible assets as of December 31, 2021 and 2020 consisted of the following. December 31, 2021 December 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortized intangible assets: Customer lists and relationships $ 3,055.0 $ (1,048.3) $ 2,006.7 $ 2,835.0 $ (841.3) $ 1,993.7 Technology 356.4 (77.8) 278.6 279.9 (38.1) 241.8 Tradenames 47.8 (19.0) 28.8 41.8 (15.6) 26.2 Backlog 8.1 (5.1) 3.0 — — — Other 107.1 (76.9) 30.2 102.8 (58.6) 44.2 Unamortized intangible assets: Tradenames 1,565.4 — 1,565.4 1,491.3 — 1,491.3 Total other intangible assets $ 5,139.8 $ (1,227.1) $ 3,912.7 $ 4,750.8 $ (953.6) $ 3,797.2

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued liabilities as of December 31, 2021 and 2020 consisted of the following: 2021 2020 Salaries, wages, and related fringe benefits $ 232.1 $ 197.0 Contract liabilities 242.1 164.6 Product warranty 42.5 41.1 Operating lease liabilities 34.9 47.1 Restructuring 12.3 17.5 Taxes 41.6 116.1 Other 135.8 125.5 Total accrued liabilities $ 741.3 $ 708.9
Schedule of Product Warranty Liability	A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2021 and 2020 is as follows. 2021 2020 Balance at the beginning of period $ 41.1 $ 19.1 Product warranty accruals 16.1 17.2 Acquired warranty 2.1 19.8 Settlements (15.7) (16.7) Foreign currency translation and other (1.1) 1.7 Balance at the end of period $ 42.5 $ 41.1

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Debt	Debt as of December 31, 2021 and 2020 consisted of the following. 2021 2020 Short-term borrowings $ — $ — Long-term debt Dollar Term Loan B, due 2027 (1) $ 1,865.0 $ 1,883.7 Dollar Term Loan, due 2027 (2) 910.5 919.6 Euro Term Loan, due 2027 (3) 670.7 728.0 Dollar Term Loan Series A, due 2027 (4) — 392.4 Finance leases and other long-term debt 23.9 17.2 Unamortized debt issuance costs (29.5) (41.4) Total long-term debt, net, including current maturities 3,440.6 3,899.5 Current maturities of long-term debt 38.8 40.4 Total long-term debt, net $ 3,401.8 $ 3,859.1 (1) As of December 31, 2021, this amount is presented net of unamortized discounts of $1.7 million. As of December 31, 2021, the applicable interest rate was 1.84% and the weighted-average rate was 1.86% for the year ended December 31, 2021. (2) As of December 31, 2021, this amount is presented net of unamortized discounts of $0.9 million. As of December 31, 2021, the applicable interest rate was 1.84% and the weighted-average rate was 1.86% for the year ended December 31, 2021. (3) As of December 31, 2021, this amount is presented net of unamortized discounts of $0.6 million. As of December 31, 2021, the applicable interest rate was 2.00% and the weighted-average rate was 2.00% for the year ended December 31, 2021. (4) The weighted-average rate was 2.86% for the year ended December 31, 2021.

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Schedule of Reconciliation of Benefit Obligations	The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 2021 2020 Reconciliation of Benefit Obligations: Beginning balance $ 484.3 $ 59.8 $ 445.7 $ 346.5 $ 31.3 $ 3.4 Service cost 5.3 5.8 4.3 3.8 — — Interest cost 10.8 9.5 4.6 6.1 0.6 0.5 Plan amendments — — — — 1.8 (1.6) Actuarial losses (gains) (1) (20.0) 18.1 (30.0) 24.4 (1.6) 2.0 Benefit payments (25.7) (29.0) (13.7) (12.8) (3.3) (2.7) Acquisitions — 421.0 — 56.7 — 29.3 Plan settlements (12.9) (0.9) — — — 0.3 Effect of foreign currency exchange rate changes — — (14.7) 21.0 (0.1) 0.1 Benefit obligations ending balance $ 441.8 $ 484.3 $ 396.2 $ 445.7 $ 28.7 $ 31.3 Reconciliation of Fair Value of Plan Assets: Beginning balance $ 395.0 $ 61.1 $ 284.8 $ 249.1 Actual return on plan assets 4.8 36.5 25.4 19.0 Employer contributions 11.5 0.1 7.6 7.6 Acquisitions 12.0 327.2 — 12.0 Plan settlements (12.9) (0.9) — — Benefit payments (25.7) (29.0) (13.7) (12.8) Effect of foreign currency exchange rate changes — — (6.4) 9.9 Fair value of plan assets ending balance $ 384.7 $ 395.0 $ 297.7 $ 284.8 Funded Status as of Period End $ (57.1) $ (89.3) $ (98.5) $ (160.9) $ (28.7) $ (31.3) (1) Actuarial losses (gains) primarily resulted from changes in discount rates.
Schedule of Component of Accumulated Other Comprehensive (Loss) Income	Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2021 and 2020 that have not been recognized as a component of net periodic benefit cost are presented in the following table. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 2021 2020 Net actuarial losses (gains) $ (12.7) $ (0.8) $ 26.0 $ 75.7 $ 0.5 $ 2.4 Prior service cost — — 3.1 3.2 0.2 (1.6) Amounts included in accumulated other comprehensive income (loss) $ (12.7) $ (0.8) $ 29.1 $ 78.9 $ 0.7 $ 0.8
Schedule of Pension and Other Postretirement Benefit Liabilities included in Balance Sheets	Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2021 and 2020. 2021 2020 Other assets $ 10.4 $ 2.3 Accrued liabilities (10.9) (17.9) Pension and other postretirement benefits (183.8) (265.9)
Schedule of Pension plans with an Accumulated Benefit Obligation in Excess of Plan Assets	The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2021 and 2020. U.S. Pension Plans Non-U.S. Pension Plans 2021 2020 2021 2020 Projected benefit obligations $ 385.0 $ 425.2 $ 154.7 $ 441.4 Accumulated benefit obligation 382.8 415.9 126.4 406.3 Fair value of plan assets 326.7 331.0 26.9 260.5
Schedule of Components of Net Periodic Benefit Cost (Income) and Other Amounts Recognized in Other Comprehensive (Loss) Income, Before Income Tax Effects	The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2021, 2020 and 2019. U.S. Pension Plans 2021 2020 2019 Net Periodic Benefit Cost (Income): Service cost $ 5.3 $ 5.8 $ — Interest cost 10.8 9.5 2.2 Expected return on plan assets (12.2) (12.0) (2.2) Amortization of net actuarial loss — — 0.1 Net periodic benefit cost 3.9 3.3 0.1 Gain due to settlement (0.6) — — Total net periodic benefit cost recognized $ 3.3 $ 3.3 $ 0.1 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial gain $ (12.5) $ (6.4) $ (0.9) Amortization of net actuarial gain (loss) 0.6 — (0.1) Total recognized in other comprehensive income (loss) $ (11.9) $ (6.4) $ (1.0) Total recognized in net periodic benefit (income) cost and other comprehensive income (loss) $ (8.6) $ (3.1) $ (0.9) Non-U.S. Pension Plans 2021 2020 2019 Net Periodic Benefit Cost (Income): Service cost $ 4.3 $ 3.8 $ 1.5 Interest cost 4.6 6.1 7.7 Expected return on plan assets (12.2) (11.0) (10.3) Amortization of prior-service cost 0.2 0.1 0.1 Amortization of net actuarial loss 4.9 2.9 2.0 Total net periodic benefit cost recognized $ 1.8 $ 1.9 $ 1.0 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ (43.3) $ 16.3 $ 10.9 Amortization of net actuarial loss (4.9) (2.9) (2.0) Amortization of prior service cost (0.2) (0.1) (0.1) Effect of foreign currency exchange rate changes (1.4) 4.2 1.1 Total recognized in other comprehensive income (loss) $ (49.8) $ 17.5 $ 9.9 Total recognized in net periodic benefit cost (income) and other comprehensive income (loss) $ (48.0) $ 19.4 $ 10.9 Other Postretirement Benefits 2021 2020 2019 Net Periodic Benefit Cost: Interest cost $ 0.6 $ 0.5 $ 0.1 Amortization of prior-service cost 0.1 — — Amortization of net actuarial loss 0.1 — — Net periodic benefit cost 0.8 0.5 0.1 Loss due to curtailments or settlements — 0.3 — Total net periodic benefit cost recognized $ 0.8 $ 0.8 $ 0.1 Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss): Net actuarial loss (gain) $ (1.6) $ 2.0 $ 0.4 Amortization of net actuarial loss (0.1) — — Prior service cost 1.9 (1.6) — Amortization of prior service cost (0.1) — — Effect of foreign currency exchange rate changes — — — Total recognized in other comprehensive income (loss) $ 0.1 $ 0.4 $ 0.4 Total recognized in net periodic benefit cost and other comprehensive income (loss) $ 0.9 $ 1.2 $ 0.5
Schedule of Assumptions Used	The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2021, 2020 and 2019. U.S. Pension Plans Non-U.S. Pension Plans 2021 2020 2019 2021 2020 2019 Weighted-average actuarial assumptions used to determine net periodic benefit cost (income): Discount rate 2.4 % 2.7 % 4.0 % 1.1 % 1.6 % 2.6 % Expected long-term rate of return on plan assets 3.2 % 2.6 % 4.0 % 4.3 % 4.4 % 4.9 % Rate of compensation increases 3.0 % 4.0 % NA 3.1 % 2.7 % 2.8 % Weighted-average actuarial assumptions used to determine benefit obligations: Discount rate 2.7 % 2.4 % 3.0 % 1.6 % 1.1 % 1.7 % Rate of compensation increases 3.0 % 3.0 % NA 4.3 % 3.1 % 2.7 % The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2021, 2020 and 2019. Other Postretirement Benefits 2021 2020 2019 Discount rate used to determine net periodic benefit cost (income) 1.8% - 2.4% 2.3% - 3.0% 4.7 % Discount rate used to determine benefit obligations 2.4% - 3.0% 1.9% - 2.3% 3.8 % Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations: Healthcare cost trend rate assumed for next year 6.8 % 6.3 % 7.1 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 4.5 % 4.7 % 7.1 % Year that the date reaches the ultimate trend rate 2034 2029 2021
Schedule of Expected Benefit Payments	The following table reflects the estimated benefit payments for the next five years and for the years 2027 through 2031. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2021. Pension Benefits Other Postretirement Benefits U.S. Plans Non-U.S. Plans 2022 $ 38.1 $ 13.7 $ 3.3 2023 31.0 13.5 3.1 2024 28.6 14.3 2.8 2025 28.5 16.2 2.6 2026 26.8 16.4 2.3 Aggregate 2027-2031 127.0 85.8 8.8
Schedule of Allocation of Plan Assets	The following table presents the long-term target allocations for these plans as of December 31, 2021. U.S. Plans UK Plan Asset category: Equity 13 % 32 % Fixed income 84 % 30 % Real estate and other 3 % 38 % Total 100 % 100 %
Schedule of Changes in Fair Value of Plan Assets	The following tables present the fair values of the Company’s pension plan assets as of December 31, 2021 and 2020 by asset category within the ASC 820 hierarchy (as defined in Note 20 “Fair Value Measurements”). December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 12.7 $ — $ — $ — $ 12.7 Equity funds: U.S. small-cap — — — 6.3 6.3 U.S. large-cap — 8.0 — 29.0 37.0 International equity (2) 24.3 45.9 — 68.3 138.5 Total equity funds 24.3 53.9 — 103.6 181.8 Fixed income funds: Corporate bonds - international — 25.3 — 9.6 34.9 UK index-linked gilts — 35.9 — — 35.9 U.S. fixed income - government securities — — — 38.0 38.0 U.S. fixed income - short duration — — — 5.2 5.2 U.S. fixed income - intermediate duration — — — 41.1 41.1 U.S. fixed income - long corporate — — — 234.8 234.8 Global fixed income — — — 13.5 13.5 Total fixed income funds — 61.2 — 342.2 403.4 Other types of investments: International real estate (3) — 49.5 — — 49.5 Other (4) — 34.0 1.0 35.0 Total $ 37.0 $ 164.6 $ 34.0 $ 446.8 $ 682.4 December 31, 2020 Quoted Prices in Active Markets for Identical Assets Significant Observable Inputs Significant Unobservable Inputs Investments Measured at NAV (5) Total Asset Category Cash and cash equivalents (1) $ 8.5 $ — $ — $ — $ 8.5 Equity funds: U.S. large-cap — 6.4 — 49.0 55.4 International equity (2) 24.2 39.8 — 81.7 145.7 Total equity funds 24.2 46.2 — 130.7 201.1 Fixed income funds: Corporate bonds - international — 25.2 — — 25.2 UK index-linked gilts — 41.5 — — 41.5 U.S. fixed income - government securities — 98.9 — 4.7 103.6 U.S. fixed income - short duration — 15.2 — 4.5 19.7 U.S. fixed income - intermediate duration — 26.3 — 45.2 71.5 U.S. fixed income - long corporate — 120.6 — 9.6 130.2 Total fixed income funds — 327.7 — 64.0 391.7 Other types of investments: International real estate (3) — 42.3 — — 42.3 Other (4) — — 36.2 — 36.2 Total $ 32.7 $ 416.2 $ 36.2 $ 194.7 $ 679.8 (1) Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets. (2) The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors. (3) International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties. (4) Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services. (5) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of Other Comprehensive (Loss) Income	The before tax income (loss) and related income tax effect are as follows. Foreign Currency Translation Adjustments, Net Unrealized Gains (Losses) on Cash Flow Hedges Pension and Postretirement Benefit Plans Total Balance as of December 31, 2018 $ (190.6) $ (11.4) $ (45.0) $ (247.0) Before tax income (loss) 4.1 8.2 (9.3) 3.0 Income tax effect (5.6) (1.0) 2.8 (3.8) Other comprehensive income (loss) (1.5) 7.2 (6.5) (0.8) Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02) (1.5) (6.7) — (8.2) Balance as of December 31, 2019 $ (193.6) $ (10.9) $ (51.5) $ (256.0) Before tax income (loss) 253.1 14.2 (11.5) 255.8 Income tax effect 15.1 (3.3) 2.6 14.4 Other comprehensive income (loss) 268.2 10.9 (8.9) 270.2 Balance as of December 31, 2020 $ 74.6 $ — $ (60.4) $ 14.2 Before tax income (loss) (119.9) — 61.6 (58.3) Income tax effect 16.9 — (12.9) 4.0 Other comprehensive income (loss) (103.0) — 48.7 (54.3) Divestiture of foreign subsidiaries (1.5) — — (1.5) Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6)
Schedule of Changes in Accumulated Other Comprehensive (Loss) Income	Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table (1) . Foreign Currency Translation Adjustments, Net Unrealized Gains (Losses) on Cash Flow Hedges Pension and Postretirement Benefit Plans Total Balance as of December 31, 2018 $ (190.6) $ (11.4) $ (45.0) $ (247.0) Other comprehensive loss before reclassifications (1.5) (4.7) (8.2) (14.4) Amounts reclassified from accumulated other comprehensive income (loss) — 11.9 1.7 13.6 Other comprehensive income (loss) (1.5) 7.2 (6.5) (0.8) Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02) (1.5) (6.7) — (8.2) Balance as of December 31, 2019 $ (193.6) $ (10.9) $ (51.5) $ (256.0) Other comprehensive income (loss) before reclassifications 268.2 (3.0) (11.2) 254.0 Amounts reclassified from accumulated other comprehensive income (loss) — 13.9 2.3 16.2 Other comprehensive income (loss) 268.2 10.9 (8.9) 270.2 Balance as of December 31, 2020 $ 74.6 $ — $ (60.4) $ 14.2 Other comprehensive income (loss) before reclassifications (103.0) — 45.2 (57.8) Amounts reclassified from accumulated other comprehensive income (loss) — — 3.5 3.5 Other comprehensive income (loss) (103.0) — 48.7 (54.3) Divestiture of foreign subsidiaries (1.5) — — (1.5) Balance as of December 31, 2021 $ (29.9) $ — $ (11.7) $ (41.6) (1) All amounts are net of tax. Amounts in parentheses indicate debits.
Schedule of Reclassification out of Accumulated Other Comprehensive Income	Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2021, 2020 and 2019 are presented in the following table. Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Details about Accumulated Other Comprehensive Income (Loss) Components 2021 2020 2019 Affected Line(s) in the Statement Where Net Income is Presented Loss on cash flow hedges (interest rate swaps) $ — $ 18.5 $ 15.6 Interest expense Benefit for income taxes — (4.6) (3.7) Benefit for income taxes Loss on cash flow hedges (interest rate swaps), net of tax $ — $ 13.9 $ 11.9 Amortization of defined benefit pension and other postretirement benefit items (1) $ 4.7 $ 3.0 $ 2.2 Cost of sales and Selling and administrative expenses Benefit for income taxes (1.2) (0.7) (0.5) Benefit for income taxes Amortization of defined benefit pension and other postretirement benefit items, net of tax $ 3.5 $ 2.3 $ 1.7 Total reclassifications for the period $ 3.5 $ 16.2 $ 13.6 (1) These components are included in the computation of net periodic benefit cost. See Note 12 “Benefit Plans” for additional details.

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2021 and 2020. Industrial Technologies and Services Precision and Science Technologies Total 2021 2020 2021 2020 2021 2020 Primary Geographic Markets United States $ 1,554.6 $ 1,142.8 $ 432.2 $ 297.1 $ 1,986.8 $ 1,439.9 Other Americas 264.9 280.7 20.5 38.7 285.4 319.4 Total Americas 1,819.5 1,423.5 452.7 335.8 2,272.2 1,759.3 EMEIA 1,363.4 1,054.4 368.1 256.5 1,731.5 1,310.9 Asia Pacific 978.1 770.3 170.6 132.7 1,148.7 903.0 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 Product Categories Original equipment (1) $ 2,467.1 $ 1,942.8 $ 822.3 $ 618.8 $ 3,289.4 $ 2,561.6 Aftermarket (2) 1,693.9 1,305.4 169.1 106.2 1,863.0 1,411.6 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 Pattern of Revenue Recognition Revenue recognized at point in time (3) $ 3,811.3 $ 2,937.1 $ 988.3 $ 725.0 $ 4,799.6 $ 3,662.1 Revenue recognized over time (4) 349.7 311.1 3.1 — 352.8 311.1 Total $ 4,161.0 $ 3,248.2 $ 991.4 $ 725.0 $ 5,152.4 $ 3,973.2 (1) Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment. (2) Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment. Service revenue represents less than 10% of consolidated revenue. (3) Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered. (4) Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Schedule of Contract Balances	The following table provides the contract balances as of December 31, 2021 and December 31, 2020 presented in the Consolidated Balance Sheets. December 31, 2021 December 31, 2020 Accounts receivable, net $ 948.6 $ 861.8 Contract assets 60.8 60.4 Contract liabilities 243.5 166.2

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Income (Loss) Before Income Taxes	Income (loss) before income taxes for the years ended December 31, 2021, 2020 and 2019 consisted of the following. 2021 2020 2019 U.S. $ 121.3 $ (158.4) $ (100.5) Non-U.S. 391.7 113.0 210.7 Income (loss) before income taxes $ 513.0 $ (45.4) $ 110.2
Schedule of Components of Provision (Benefit) for Income Taxes	The following table details the components of the Provision (benefit) for income taxes for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Current: U.S. federal $ (33.1) $ 6.6 $ (14.6) U.S. state and local 5.8 6.7 2.9 Non-U.S. 109.1 79.6 45.2 Deferred: U.S. federal (19.5) (33.4) (13.2) U.S. state and local (0.9) (2.9) 0.5 Non-U.S. (83.2) (45.2) (7.9) Provision (benefit) for income taxes $ (21.8) $ 11.4 $ 12.9
Schedule of Effective Income Tax Rate Reconciliation	The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2021, 2020 and 2019 as follows. 2021 2020 2019 U.S. federal corporate statutory rate 21.0 % 21.0 % 21.0 % State and local taxes, less federal tax benefit 1.1 (8.0) 4.1 Net effects of foreign tax rate differential 1.0 (14.6) 2.3 Withholding tax 3.0 (12.9) — Repatriation cost 1.4 17.7 — Global Intangible Low-Tax Income (“GILTI”) 2.3 (11.7) (4.3) ASC 740-30 (formerly APB 23) 2.9 (18.6) 2.0 Valuation allowance changes (5.4) 4.8 (4.3) Uncertain tax positions (1.3) (4.7) 0.7 Equity compensation (2.5) 6.1 (13.9) Capital gain — — 5.1 Nondeductible acquisition costs 0.4 (7.7) 6.1 Foreign Derived Intangible Income (“FDII”) deduction (3.2) 10.1 — Tax credits (0.8) 4.7 — Income not subject to tax (3.3) — — Utilization of capital loss (9.1) — — Non-U.S. deferred change related to asset sales (8.0) — — Return to provision adjustment (1.3) 0.5 — Other, net (2.4) (11.8) (7.1) Effective income tax rate (4.2) % (25.1) % 11.7 %
Schedule of Deferred Tax Assets and Liabilities	The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2021 and 2020 are as follows. 2021 2020 Deferred Tax Assets: Reserves and accruals $ 69.3 $ 72.9 Allowance for credit losses 10.0 11.0 Inventory reserve 12.0 10.4 Pension and postretirement benefit plans 41.7 62.6 Tax loss carryforwards 95.9 101.7 Deferred taxes recorded in other comprehensive income 10.2 18.0 Foreign tax credit carryforwards 43.8 74.6 Other 30.9 10.7 Total deferred tax assets 313.8 361.9 Valuation allowance (106.4) (140.6) Deferred Tax Liabilities: LIFO inventory (16.2) (16.2) Investment in partnership (37.4) — Property, plant and equipment (40.9) (49.4) Intangible assets (742.1) (809.9) Unremitted foreign earnings (49.6) (32.5) Deferred taxes recorded in other comprehensive income — — Other (1.6) — Total deferred tax liabilities (887.8) (908.0) Net deferred income tax liability $ (680.4) $ (686.7)
Schedule of Tax Attributes and Related Valuation Allowance	The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2021 were as follows. Tax Benefit Valuation Allowance Carryforward Period Ends Tax Attributes to be Carried Forward U.S. federal net operating loss $ 0.3 $ (0.3) Unlimited U.S. federal net operating loss 6.3 (0.1) 2031-2040 U.S. federal capital loss — — 2022 U.S. federal capital loss — — 2031-2040 U.S. federal tax credit 43.8 (43.8) 2022-2031 Alternative minimum tax credit 0.8 (0.1) Unlimited U.S. state and local net operating losses 6.5 (3.1) 2022-2041 U.S. state and local tax credit 0.2 — 2022-2040 Non U.S. net operating losses 70.7 (49.7) Unlimited Non U.S. capital losses 0.8 (0.7) Unlimited Excess interest 11.3 (3.7) Unlimited Other deferred tax assets 3.7 (4.9) Unlimited Total tax carryforwards $ 144.4 $ (106.4)
Schedule of Valuation Allowance	A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2021, 2020 and 2019 are as follows. 2021 2020 2019 Beginning balance $ 140.6 $ 67.9 $ 72.5 Revaluation or additions due to acquisitions or mergers (1) — 63.3 — Charged to tax expense (27.6) 8.3 (5.4) Charged to other accounts (6.6) 1.1 0.1 Deductions (2) — — 0.7 Ending balance $ 106.4 $ 140.6 $ 67.9 (1) Revaluation for the tax year ended December 31, 2020 relates to the inclusion of Ingersoll Rand’s opening balance sheet (“OBS”) beginning valuation allowance. (2) Deductions relate to the realization of net operating losses or the removal of deferred tax assets.
Schedule of Unrecognized Tax Benefits Roll Forward	Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Beginning balance $ 27.8 $ 12.5 $ 11.5 Gross increases for tax positions of prior years 0.8 — 0.6 Gross increases for tax positions of current year 5.3 16.8 — Lapse of statute of limitations (11.8) (3.5) — Changes due to currency fluctuations (1.0) 2.0 0.4 Ending balance $ 21.1 $ 27.8 $ 12.5

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Schedule of Components of Lease Expense	The components of lease expense for the years ended December 31, 2021 and 2020 are as follows. 2021 2020 Operating lease cost $ 50.6 $ 46.1 Finance lease cost Amortization of right-of-use assets $ 1.5 $ 1.2 Interest on lease liabilities 1.1 1.1 Total finance lease cost $ 2.6 $ 2.3 Short-term lease cost $ 2.0 $ 2.0
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases for the years ended December 31, 2021 and 2020 is as follows. 2021 2020 Supplemental Cash Flows Information Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating cash flows from operating leases $ 52.0 $ 56.6 Operating cash flows from finance leases 1.1 1.1 Financing cash flows from finance leases 1.1 0.7 Leased Assets Obtained in Exchange for New Operating Lease Liabilities (1) 15.8 161.3 (1) For the year ended December 31, 2020, this included leases related to the acquisition of Ingersoll Rand Industrial.
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases is as follows. December 31, 2021 December 31, 2020 Operating leases Other assets $ 101.8 $ 142.9 Accrued liabilities 34.9 47.1 Other liabilities 61.0 90.5 Total operating lease liabilities $ 95.9 $ 137.6 Finance Leases Property, plant and equipment $ 15.1 $ 15.7 Short-term borrowings and current maturities of long-term debt 1.1 0.7 Long-term debt, less current maturities 16.0 16.5 Total finance lease liabilities $ 17.1 $ 17.2 Weighted Average Remaining Lease Term (in years) Operating leases 4.0 3.5 Finance leases 11.9 13.2 Weighted Average Discount Rate Operating leases 1.8 % 1.8 % Finance leases 6.3 % 6.4 %
Schedule of Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of December 31, 2021 are as follows. Operating Leases Finance Leases 2022 $ 36.1 $ 2.2 2023 26.9 2.2 2024 14.5 2.2 2025 7.6 2.0 2026 5.1 2.0 Thereafter 9.2 14.6 Total lease payments $ 99.4 $ 25.2 Less imputed interest (3.5) (8.1) Total $ 95.9 $ 17.1
Schedule of Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of December 31, 2021 are as follows. Operating Leases Finance Leases 2022 $ 36.1 $ 2.2 2023 26.9 2.2 2024 14.5 2.2 2025 7.6 2.0 2026 5.1 2.0 Thereafter 9.2 14.6 Total lease payments $ 99.4 $ 25.2 Less imputed interest (3.5) (8.1) Total $ 95.9 $ 17.1

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Fair Value Assumptions	The fair value of stock options that the Company assumed in connection with the acquisition of Ingersoll Rand Industrial was estimated using the Black-Scholes model with the following assumptions. Converted Stock Option Awards Assumptions: Expected life of options (in years) 2.0 - 3.6 Risk-free interest rate 0.9 % Assumed volatility 34.2 % Expected dividend rate 0.0 % The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Expected life of options (in years) 6.3 6.3 6.3 Risk-free interest rate 0.9% - 1.3% 0.4% - 1.5% 1.7% - 2.6% Assumed volatility 38.6% - 39.4% 24.6% - 41.1% 24.8% - 31.8% Expected dividend rate 0.0% - 0.1% 0.0 % 0.0 % The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2021 and 2020 using the Monte Carlo simulation pricing model. 2021 2020 Expected term (in years) 2.9 2.8 Risk-free interest rate 0.2 % 0.5 % Assumed volatility 36.9 % 35.2 % Expected dividend rate 0.0 % 0.0 %
Schedule of Stock-based Compensation Expense	Stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019 are included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and are as follows. 2021 2020 2019 Stock-based compensation expense recognized in: Continuing operations $ 87.2 $ 47.5 $ 18.7 Discontinued operations 10.9 3.8 0.5 Total stock-based compensation expense $ 98.1 $ 51.3 $ 19.2
Schedule of Stock Option Activity	A summary of the Company’s stock option (including SARs) activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Exercise Price Wtd. Avg. Remaining Contractual Term (years) Aggregate Intrinsic Value of In-The-Money Options Outstanding at December 31, 2020 7,742 $ 18.47 Granted 795 45.78 Exercised or Settled (1,530) 16.11 Forfeited (255) 30.77 Expired (6) 13.01 Outstanding at December 31, 2021 6,746 21.76 5.7 $ 268.7 Vested at December 31, 2021 4,351 15.89 4.4 $ 198.2
Schedule of Restricted Stock Unit Activity	A summary of the Company’s restricted stock unit activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2020 5,546 $ 33.09 Granted 340 45.76 Vested (2,542) 33.44 Forfeited (667) 34.27 Non-vested as of December 31, 2021 2,677 34.08
Schedule of Performance Stock Unit Activity	A summary of the Company’s performance stock unit activity for the year ended December 31, 2021 is presented in the following table (underlying shares in thousands). Shares Weighted-Average Grant-Date Fair Value Non-vested as of December 31, 2020 255 $ 29.72 Granted 158 55.84 Vested — — Forfeited (20) 36.36 Non-vested as of December 31, 2021 393 39.89

Hedging Activities, Derivativ_2

Hedging Activities, Derivative Instruments and Credit Risk (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020. December 31, 2021 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair Value $ 22.1 $ — $ — $ — $ — Foreign currency forwards Fair Value $ 19.3 $ — $ — $ 0.2 $ — December 31, 2020 Derivative Classification Notional Amount (1) Fair Value (1) Other Current Assets Fair Value (1) Other Assets Fair Value (1) Accrued Liabilities Fair Value (1) Other Liabilities Derivatives Not Designated as Hedging Instruments Foreign currency forwards Fair Value $ 230.5 $ 2.9 $ — $ — $ — Foreign currency forwards Fair Value $ 51.2 $ — $ — $ 0.7 $ — (1) Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Schedule of Cash Flow Hedges Included in Comprehensive (Loss) Income	Gains and losses on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2021, 2020 and 2019 are presented in the table below. 2021 2020 2019 Interest Rate Swap Contracts Gain (loss) recognized in AOCI on derivatives $ — $ (4.4) $ (7.4) Loss reclassified from AOCI into income (effective portion) (1) — (18.5) (15.6) (1) Losses on derivatives reclassified from accumulated other comprehensive income (“AOCI”) into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Gains (Losses) on Derivative Instruments Not Designated as Accounting Hedges and Total Net Foreign Currency (Losses) Gains	The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2021, 2020 and 2019 were as follows. 2021 2020 2019 Foreign currency forward contracts gains (losses) (3.2) 15.0 (4.9) Total foreign currency transaction gains (losses), net 12.0 (18.6) (7.3)
Schedule of Changes in Value of Debt and Designated Interest Rate Swaps	The Company’s gains, net of income tax, associated with changes in the value of debt for the years ended December 31, 2021 and 2020, and the net balance of such gains included in accumulated other comprehensive income (loss) as of December 31, 2021 and 2020 were as follows. 2021 2020 Gain (loss), net of income tax, recorded through other comprehensive income $ 35.0 $ (45.1) Balance included in accumulated other comprehensive income (loss) as of December 31, 2021 and 2020, respectively 65.7 30.7

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value	The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis. December 31, 2021 Level 1 Level 2 Level 3 Total Financial Assets Foreign currency forwards (1) $ — $ — $ — $ — Trading securities held in deferred compensation plan (2) 12.0 — — 12.0 Total $ 12.0 $ — $ — $ 12.0 Financial Liabilities Foreign currency forwards (1) $ — $ 0.2 $ — $ 0.2 Deferred compensation plan (2) 22.4 — — 22.4 Total $ 22.4 $ 0.2 $ — $ 22.6 December 31, 2020 Level 1 Level 2 Level 3 Total Financial Assets Foreign currency forwards (1) $ — $ 2.9 $ — $ 2.9 Trading securities held in deferred compensation plan (2) 9.1 — — 9.1 Total $ 9.1 $ 2.9 $ — $ 12.0 Financial Liabilities Foreign currency forwards (1) $ — $ 0.7 $ — $ 0.7 Deferred compensation plan (2) 25.7 — — 25.7 Total $ 25.7 $ 0.7 $ — $ 26.4 (1) Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates. (2) Based on the quoted price of publicly traded mutual funds which are classified as trading securities and accounted for using the mark-to-market method.

Other Operating Expense, Net (T

Other Operating Expense, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Schedule of Other Operating Expense, Net	The components of “Other operating expense, net” for the years ended December 31, 2021, 2020 and 2019 were as follows. 2021 2020 2019 Other Operating Expense, Net Foreign currency transaction losses (gains), net $ (12.0) $ 18.6 $ 7.3 Restructuring charges (1) 13.4 83.0 11.1 Shareholder litigation settlement recoveries (2) — — (6.0) Acquisition related expenses (3) 55.3 93.3 53.8 Other, net 5.2 6.1 3.1 Total other operating expense, net $ 61.9 $ 201.0 $ 69.3 (1) See Note 5 “Restructuring.” (2) Represents insurance recoveries of the Company’s shareholder litigation settlement in 2014.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The number of weighted-average shares outstanding used in the computations of basic and diluted earnings (loss) per share are as follows. Year Ended December 31, 2021 2020 2019 Average shares outstanding: Basic 414.8 382.8 203.5 Diluted 421.2 382.8 208.9

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash and Cash Equivalents [Abstract]
Restricted cash and cash equivalents	$ 2.5	$ 3.1
Goodwill and Indefinite-Lived Intangible Assets [Abstract]
Fair value percentage of reporting units using income approach	75.00%
Fair value percentage of reporting units using market approach	25.00%
Guarantees and Product Warranties [Abstract]
Warranty period after time of sale	12 months
Income Taxes [Abstract]
Income tax expense under the Tax Act	$ 11.7
Research and Development [Abstract]
Research and development expense	$ 74	$ 58	$ 22
Buildings | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	10 years
Buildings | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	30 years
Machinery and equipment | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	7 years
Machinery and equipment | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	10 years
Office furniture and equipment | Minimum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	3 years
Office furniture and equipment | Maximum
Cash and Cash Equivalents [Abstract]
Estimated useful lives of property, plant and equipment	10 years

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) $ in Millions	Feb. 14, 2021USD ($)	Dec. 31, 2021USD ($)business	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 01, 2021USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of businesses that comprise discontinued operations | business		2
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss (gain) on sale		$ (90.6)	$ 0	$ 0
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration for sale of business					$ 1,680
Loss (gain) on sale		(298.3)	0	0
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration for sale of business	$ 278.3
Loss (gain) on sale		$ 207.7	$ 0	$ 0
Majority interest sold (as a percent)	55.00%
Common equity interest retained after disposal (as a percent)	45.00%

Discontinued Operations - Resul

Discontinued Operations - Results of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (Loss) from Discontinued Operations, Net of Tax	$ 41.6	$ 24.4	$ 61.8
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	502.8	937	434.4
Cost of sales	381.5	728.5	301
Gross Profit	121.3	208.5	133.4
Selling and administrative expenses	41	105.5	26.8
Amortization of intangible assets	12.8	60.7	19
Loss on sale	(90.6)	0	0
Other operating expense, net	37.1	16.2	6.4
Operating Income (Loss)	121	26.1	81.2
Interest expense	0	0	0.5
Other expense, net	0	0.1	0
Income (Loss) from Discontinued Operations Before Income Taxes	121	26	80.7
Provision (benefit) for income taxes	79.4	1.6	18.9
Income (Loss) from Discontinued Operations, Net of Tax	41.6	24.4	61.8
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	430.9	741.4	0
Cost of sales	321.3	564.6	0
Gross Profit	109.6	176.8	0
Selling and administrative expenses	35.7	63	0
Amortization of intangible assets	10.4	37.1	0
Loss on sale	(298.3)	0	0
Other operating expense, net	18.1	1.7	0
Operating Income (Loss)	343.7	75	0
Interest expense	0	0	0
Other expense, net	0	0	0
Income (Loss) from Discontinued Operations Before Income Taxes	343.7	75	0
Provision (benefit) for income taxes	87.1	12.9	0
Income (Loss) from Discontinued Operations, Net of Tax	256.6	62.1	0
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	71.9	195.6	434.4
Cost of sales	60.2	163.9	301
Gross Profit	11.7	31.7	133.4
Selling and administrative expenses	5.3	42.5	26.8
Amortization of intangible assets	2.4	23.6	19
Loss on sale	207.7	0	0
Other operating expense, net	19	14.5	6.4
Operating Income (Loss)	(222.7)	(48.9)	81.2
Interest expense	0	0	0.5
Other expense, net	0	0.1	0
Income (Loss) from Discontinued Operations Before Income Taxes	(222.7)	(49)	80.7
Provision (benefit) for income taxes	(7.7)	(11.3)	18.9
Income (Loss) from Discontinued Operations, Net of Tax	$ (215)	$ (37.7)	$ 61.8

Discontinued Operations - Balan

Discontinued Operations - Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Total current assets	$ 15.6	$ 337.4
Total non-current assets	0	1,862.8
Current liabilities:
Total current liabilities	17.1	212.9
Total non-current liabilities	0	192.8
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Current assets:
Cash and cash equivalents	6.2	0
Accounts receivable, net	2.5	104.8
Inventories	5.6	226.9
Other current assets	0.1	5.7
Total current assets	14.4	337.4
Property, plant and equipment, net	1.2	188.3
Goodwill	0	721
Other intangible assets, net	0	935.4
Deferred tax assets	0	0.5
Other assets	0	17.6
Total non-current assets	1.2	1,862.8
Total assets	15.6	2,200.2
Current liabilities:
Accounts payable	2.2	134.7
Accrued liabilities	14.9	78.2
Total current liabilities	17.1	212.9
Pensions and other postretirement benefits	0	2.5
Deferred income taxes	0	173.3
Other liabilities	0	17
Total non-current liabilities	0	192.8
Total liabilities	$ 17.1	405.7
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Current assets:
Total assets		1,512.7
Current liabilities:
Total liabilities		$ 354.1

Discontinued Operations - Cash

Discontinued Operations - Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Stock-based compensation expense recognized	$ 98.1	$ 51.3	$ 19.2
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss (gain) on sale	(90.6)	0	0
Depreciation and amortization	18.8	88.4	31.6
Stock-based compensation expense recognized	10.9	3.8	0.5
Capital expenditures	1.9	6.7	5.3
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss (gain) on sale	(298.3)	0	0
Depreciation and amortization	14.8	51.5	0
Stock-based compensation expense recognized	8.2	3	0
Capital expenditures	1.6	3.1	0
Discontinued Operations, Disposed of by Sale | High Pressure Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss (gain) on sale	207.7	0	0
Depreciation and amortization	4	36.9	31.6
Stock-based compensation expense recognized	2.7	0.8	0.5
Capital expenditures	$ 0.3	$ 3.6	$ 5.3

Segment Reporting - Narrative (

Segment Reporting - Narrative (Details)	12 Months Ended
	Dec. 31, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Reporting - Segment Res

Segment Reporting - Segment Results (Details) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting [Abstract]
Revenues			$ 5,152,400,000	$ 3,973,200,000	$ 2,017,500,000
Adjusted EBITDA			1,325,100,000	980,000,000	487,200,000
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Interest expense			87,700,000	111,100,000	88,400,000
Depreciation and amortization expense			422,100,000	412,500,000	146,500,000
Impairment of other intangible assets		$ 19,900,000	0	19,900,000	0
Restructuring and related business transformation costs			18,800,000	88,000,000	19,600,000
Acquisition related expenses and non-cash charges			55,300,000	93,300,000	53,800,000
Stock-based compensation			87,200,000	47,500,000	18,700,000
Loss on extinguishment of debt	$ 9,000,000		9,000,000	2,000,000	200,000
Foreign currency transaction losses (gains), net			(12,000,000)	18,600,000	7,300,000
Non-cash adjustments to carrying value of LIFO inventories			33,200,000	39,800,000	200,000
Shareholder litigation settlement recoveries			0	0	(6,000,000)
Income (Loss) Before Income Taxes			513,000,000	(45,400,000)	110,200,000
Depreciation of rental equipment			4,100,000	2,100,000
Restructuring Costs [Abstract]
Restructuring charges			13,400,000	83,000,000	11,100,000
Facility reorganization, relocation and other costs			3,100,000	2,100,000	2,400,000
Other, net			2,300,000	2,900,000	6,100,000
Total restructuring and related business transformation costs			18,800,000	88,000,000	19,600,000
Stock-based compensation expense recognized in continuing operations			87,200,000	47,500,000	18,700,000
Increase (decrease) in stock-based compensation expense due to costs associated with employer taxes			8,700,000	(500,000)	1,500,000
LIFO reserve changes			33,200,000	4,200,000
Total capital expenditures			64,100,000	42,000,000	37,900,000
Total identifiable assets			15,154,500,000	16,058,600,000
Ingersoll Rand Industrial
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Non-cash adjustments to carrying value of LIFO inventories				35,600,000
Restructuring Costs [Abstract]
Reduction in carrying value of inventories				35,600,000
Industrial Technologies and Services
Segment Reporting [Abstract]
Revenues			4,161,000,000	3,248,200,000
Precision and Science Technologies
Segment Reporting [Abstract]
Revenues			991,400,000	725,000,000
Operating segments | Industrial Technologies and Services
Segment Reporting [Abstract]
Revenues			4,161,000,000	3,248,200,000	1,700,900,000
Adjusted EBITDA			1,033,700,000	759,800,000	391,400,000
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Depreciation and amortization expense			296,600,000	306,000,000	120,000,000
Restructuring Costs [Abstract]
Total capital expenditures			53,100,000	32,200,000	31,500,000
Total identifiable assets			9,101,700,000	9,113,400,000
Operating segments | Precision and Science Technologies
Segment Reporting [Abstract]
Revenues			991,400,000	725,000,000	316,600,000
Adjusted EBITDA			291,400,000	220,200,000	95,800,000
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Depreciation and amortization expense			108,300,000	102,400,000	23,600,000
Restructuring Costs [Abstract]
Total capital expenditures			10,700,000	9,800,000	5,500,000
Total identifiable assets			3,572,200,000	2,852,800,000
Corporate expenses not allocated to segments
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Corporate expenses not allocated to segments			133,200,000	101,900,000	45,600,000
Depreciation and amortization expense			17,200,000	4,100,000	2,900,000
Restructuring Costs [Abstract]
Total capital expenditures			300,000	0	900,000
Total identifiable assets			2,465,000,000	1,892,200,000
Segment reconciling items
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]
Interest expense			87,700,000	111,100,000	88,400,000
Depreciation and amortization expense			418,000,000	410,400,000	146,500,000
Impairment of other intangible assets			0	19,900,000	0
Restructuring and related business transformation costs			18,800,000	88,000,000	19,600,000
Acquisition related expenses and non-cash charges			65,200,000	181,500,000	54,600,000
Gain on settlement of post-acquisition contingencies			(30,100,000)	0	0
Stock-based compensation			95,900,000	47,000,000	20,200,000
Loss on extinguishment of debt			9,000,000	2,000,000	200,000
Foreign currency transaction losses (gains), net			(12,000,000)	18,600,000	7,300,000
Non-cash adjustments to carrying value of LIFO inventories			33,200,000	39,800,000	200,000
Shareholder litigation settlement recoveries			0	0	(6,000,000)
Other adjustments			(6,800,000)	5,200,000	400,000
Restructuring Costs [Abstract]
Total restructuring and related business transformation costs			18,800,000	88,000,000	$ 19,600,000
Total identifiable assets			$ 15,600,000	$ 2,200,200,000

Segment Reporting - Property, P

Segment Reporting - Property, Plant and Equipment by Geographic Region (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 648.6	$ 609
Americas | Reportable geographical components
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	242.3	218.3
United States | Reportable geographical components
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	225.8	203.7
Other Americas | Reportable geographical components
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	16.5	14.6
EMEIA | Reportable geographical components
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	221.3	216
Asia Pacific | Reportable geographical components
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 185	$ 174.7

Business Combinations - Narrati

Business Combinations - Narrative (Details) $ in Millions

Dec. 01, 2021USD ($)

Oct. 29, 2021USD ($)

Aug. 31, 2021USD ($)

Jul. 30, 2021USD ($)

Jan. 31, 2021USD ($)

Sep. 01, 2020USD ($)

Feb. 29, 2020USD ($)

Sep. 30, 2021USD ($)

Jun. 30, 2021USD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)business

Dec. 31, 2019USD ($)

Dec. 31, 2020USD ($)

Feb. 28, 2020

Business Acquisition [Line Items]

Cash consideration

$ 64.1

$ 42

$ 37.9

Net cash paid to acquire business

974.8

12

Revenues

23.5

8.9

Operating income

2.1

0.9

Industrial Technologies and Services

Business Acquisition [Line Items]

Cash consideration

15

Deferred payment

$ 5.1

United States and Europe

Business Acquisition [Line Items]

Number of businesses acquired | business

2

U.S. Plans

Business Acquisition [Line Items]

Number of businesses acquired | business

1

Europe

Business Acquisition [Line Items]

Number of businesses acquired | business

1

Pump Group of Tuthill Corporation

Business Acquisition [Line Items]

Cash consideration

$ 85.5

M-D Pneumatics and Kinney Vacuum Pumps

Business Acquisition [Line Items]

Cash consideration

$ 184

Revenue from acquisition date

145.9

Operating income (loss) from acquisition date

(4.5)

Maximus Solutions

Business Acquisition [Line Items]

Cash consideration

$ 111

Amount of goodwill deductible

$ 0

Seepex

Business Acquisition [Line Items]

Cash consideration

$ 482.1

Amount of goodwill deductible

$ 0

Air Dimensions Inc

Business Acquisition [Line Items]

Cash consideration

$ 70.6

Ingersoll Rand Industrial

Business Acquisition [Line Items]

Aggregate consideration

$ 6,937

Revenue from acquisition date

$ 2,930.3

Acquisition costs

42.3

45

$ 87.3

Net loss from acquisition date

10.8

Adjustment consideration transferred

$ 49.5

Realized a gain

$ 30.1

Revenues

$ 5,398

$ 6,146.5

Ingersoll Rand Industrial | IR India Limited

Business Acquisition [Line Items]

Ownership interest acquired (as a percent)

74.00%

Albin Pump SAS

Business Acquisition [Line Items]

Net cash paid to acquire business

$ 15.5

Deferred payment

$ 0.9

Other acquisitions

Business Acquisition [Line Items]

Aggregate consideration

$ 44.6

Business Combinations - Assets

Business Combinations - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Dec. 31, 2021	Aug. 31, 2021	Jul. 30, 2021	Jan. 31, 2021	Dec. 31, 2020	Feb. 29, 2020	Dec. 31, 2019
Estimated Fair Value [Abstract]
Property, plant and equipment						$ 516.5
Goodwill	$ 5,981.6				$ 5,582.6		$ 1,092.9
Seepex
Estimated Fair Value [Abstract]
Accounts receivable		$ 24.9
Inventories		40.5
Other current assets		1.9
Property, plant and equipment		40.7
Goodwill		245.3
Intangible assets		243.6
Other noncurrent assets		1.1
Total current liabilities		(34.4)
Deferred tax liabilities		(75.4)
Other noncurrent liabilities		(6.1)
Total consideration		$ 482.1
M-D Pneumatics and Kinney Vacuum Pumps
Estimated Fair Value [Abstract]
Accounts receivable				$ 4.8
Inventories				3.8
Other current assets				0.2
Property, plant and equipment				16.2
Goodwill				80
Intangible assets				82.5
Other noncurrent assets				0
Total current liabilities				(3.5)
Deferred tax liabilities				0
Other noncurrent liabilities				0
Total consideration				$ 184
Maximus Solutions
Estimated Fair Value [Abstract]
Accounts receivable			$ 4.3
Inventories			2.9
Other current assets			0.2
Property, plant and equipment			2.1
Goodwill			75.7
Intangible assets			39.5
Other noncurrent assets			0
Total current liabilities			(2.4)
Deferred tax liabilities			(11.3)
Other noncurrent liabilities			0
Total consideration			$ 111
Ingersoll Rand Industrial
Estimated Fair Value [Abstract]
Cash						38.8
Accounts receivable						585.8
Inventories						625.4
Other current assets						87.2
Property, plant and equipment						516.5
Goodwill						4,899.2
Intangible assets	3,766.6					3,766.6
Other noncurrent assets						270.9
Total current liabilities						(753)
Deferred tax liabilities						(842.4)
Long-term debt, net of debt issuance costs and an original issue discount						(1,851.7)
Other noncurrent liabilities						(333)
Noncontrolling interest						(73.3)
Total consideration						6,937
Current maturities of long-term debt acquired						$ 19
All Others
Estimated Fair Value [Abstract]
Accounts receivable	9.3
Inventories	10.5
Other current assets	0.6
Property, plant and equipment	15.2
Goodwill	78.3
Intangible assets	95.9
Other noncurrent assets	0
Total current liabilities	(4)
Deferred tax liabilities	(4.1)
Other noncurrent liabilities	(1)
Total consideration	$ 200.7

Business Combinations - Prelimi

Business Combinations - Preliminary Purchase Price Allocation (Details) - Ingersoll Rand Industrial - USD ($) $ in Millions	Dec. 31, 2020	Feb. 29, 2020
Purchase Price [Abstract]
Fair value of common stock		$ 6,919.5
Fair value replacement equity awards		8.6
Fair value deferred compensation plan	$ 8.9
Aggregate consideration		$ 6,937

Business Combinations - Propert

Business Combinations - Property, Plant and Equipment (Details) $ in Millions	Feb. 29, 2020USD ($)
Business Acquisition [Line Items]
Total property, plant and equipment	$ 516.5
Ingersoll Rand Industrial
Business Acquisition [Line Items]
Total property, plant and equipment	516.5
Ingersoll Rand Industrial | Land and buildings
Business Acquisition [Line Items]
Total property, plant and equipment	215.1
Ingersoll Rand Industrial | Machinery and equipment
Business Acquisition [Line Items]
Total property, plant and equipment	256.9
Ingersoll Rand Industrial | Office furniture and equipment
Business Acquisition [Line Items]
Total property, plant and equipment	13.4
Ingersoll Rand Industrial | Other
Business Acquisition [Line Items]
Total property, plant and equipment	1
Ingersoll Rand Industrial | Construction in progress
Business Acquisition [Line Items]
Total property, plant and equipment	$ 30.1

Business Combinations - Identif

Business Combinations - Identifiable Intangible Assets (Details) - Ingersoll Rand Industrial - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Feb. 29, 2020
Business Acquisition [Line Items]
Fair Value	$ 3,766.6	$ 3,766.6
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 236
Weighted Average Useful Life (Years)	7 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 2,101
Weighted Average Useful Life (Years)	13 years
Backlog
Business Acquisition [Line Items]
Fair Value	$ 81.2
Other
Business Acquisition [Line Items]
Fair Value	$ 36.4
Weighted Average Useful Life (Years)	2 years
Tradenames
Business Acquisition [Line Items]
Fair Value	$ 1,312

Business Combinations - Unaudit

Business Combinations - Unaudited Pro Forma Information (Details) - USD ($) $ in Millions	12 Months Ended			24 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Unaudited Pro Forma Information [Abstract]
Revenues	$ 23.5	$ 8.9
Increase (decrease) to revenue as a result of deferred revenue fair value adjustment, net of tax	5,152.4	3,973.2	$ 2,017.5
Increase (decrease) to expense as a result of inventory fair value adjustment, net of tax	$ 3,163.9	2,568.3	1,239.2
Ingersoll Rand Industrial
Unaudited Pro Forma Information [Abstract]
Revenues		5,398	6,146.5
Net Income (Loss)		164.8	101.1
Increase (decrease) to expense as a result of transaction costs, net of tax		42.3	45	$ 87.3
Ingersoll Rand Industrial | Deferred Revenue
Unaudited Pro Forma Information [Abstract]
Increase (decrease) to revenue as a result of deferred revenue fair value adjustment, net of tax		13.8	(13.8)
Ingersoll Rand Industrial | Inventory
Unaudited Pro Forma Information [Abstract]
Increase (decrease) to expense as a result of inventory fair value adjustment, net of tax		(89.6)	89.6
Ingersoll Rand Industrial | Transaction Costs
Unaudited Pro Forma Information [Abstract]
Increase (decrease) to expense as a result of transaction costs, net of tax		$ (34.8)	$ 34.8

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	12 Months Ended			24 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2021
Restructuring Costs [Abstract]
Restructuring charges	$ 13.4	$ 83	$ 11.1
Restructuring Programs 2020 to 2022
Restructuring Costs [Abstract]
Restructuring charges	13.4	83		$ 96.4
Restructuring Programs 2020 to 2022 | Minimum
Restructuring Costs [Abstract]
Expected cost of restructuring program	100			100
Restructuring Programs 2020 to 2022 | Maximum
Restructuring Costs [Abstract]
Expected cost of restructuring program	115			115
Restructuring Programs 2020 to 2022 | Corporate expenses not allocated to segments
Restructuring Costs [Abstract]
Restructuring charges	5	5.8		10.8
Restructuring Programs 2020 to 2022 | Industrial Technologies and Services
Restructuring Costs [Abstract]
Restructuring charges	8.4	70.3		78.7
Restructuring Programs 2020 to 2022 | Precision and Science Technologies
Restructuring Costs [Abstract]
Restructuring charges	$ 0	$ 6.9		$ 6.9

Restructuring - Restructuring C

Restructuring - Restructuring Charges Net And Activity in Restructuring Programs (Details) - USD ($) $ in Millions	12 Months Ended			24 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 13.4	$ 83	$ 11.1
Restructuring Reserve [Roll Forward]
Balance at beginning of period	17.5	4.8		$ 4.8
Charged to expense - termination benefits	9.6	73.5
Charged to expense - other	2.7	3.3
Acquired restructuring	0	5.1
Payments	(15.9)	(70.1)
Foreign currency translation and other	(1.6)	0.9
Balance at end of period	12.3	17.5	$ 4.8	12.3
Restructuring Programs 2020 to 2022
Restructuring Cost and Reserve [Line Items]
Restructuring charges	13.4	83		96.4
Restructuring Programs 2020 to 2022 | Corporate expenses not allocated to segments
Restructuring Cost and Reserve [Line Items]
Restructuring charges	5	5.8		10.8
Restructuring Programs 2020 to 2022 | Industrial Technologies and Services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	8.4	70.3		78.7
Restructuring Programs 2020 to 2022 | Precision and Science Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	6.9		$ 6.9
Restructuring Programs 2020 to 2022 | Energy | Other operating income (expense)
Restructuring Cost and Reserve [Line Items]
Amount of non-cash write offs	$ 1.1	$ 6.2

Allowance for Credit Losses - S

Allowance for Credit Losses - Summary (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of the period		$ 50.9	$ 16.6	$ 16
Acquisition - Ingersoll Rand Industrial		0	25.1	0
Provision (benefit) charged to expense	$ 6.6	(4.3)	10.3	2.4
Write-offs, net of recoveries		(3.8)	(3.5)	(1.6)
Foreign currency translation and other		(0.5)	2.4	(0.2)
Balance at end of the period	42.3	$ 42.3	$ 50.9	$ 16.6
Allowance of selling And administrative expense	$ 6.6

Inventories - Summary (Details)

Inventories - Summary (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Inventories [Abstract]
Raw materials, including parts and subassemblies	$ 506.6	$ 451
Work-in-process	88.6	62.2
Finished goods	283.4	194.7
Inventories, gross	878.6	707.9
LIFO excess (reserve)	(24.4)	8.8
Inventories	$ 854.2	$ 716.7

Inventory - Narrative (Details)

Inventory - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventory [Line Items]
Percentage of LIFO inventory	41.00%	39.00%
Non-cash adjustments to carrying value of LIFO inventories	$ 33.2	$ 39.8	$ 0.2
Ingersoll Rand Industrial
Inventory [Line Items]
Non-cash adjustments to carrying value of LIFO inventories		$ 35.6

Property, Plant, and Equipmen_2

Property, Plant, and Equipment - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Land and land improvements	$ 60.1	$ 54.3
Buildings	300.3	278.3
Machinery and equipment	548.1	485
Office furniture and equipment	58.3	53.4
Construction in progress	39.5	29.1
Property, plant and equipment, gross	1,006.3	900.1
Accumulated depreciation	(357.7)	(291.1)
Property, plant and equipment, net	$ 648.6	$ 609

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Goodwill by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Balance at beginning of period	$ 5,582.6	$ 1,092.9
Acquisitions	479.3	4,379
Foreign currency translation and other	(80.3)	110.7
Balance at end of period	5,981.6	5,582.6
Industrial Technologies and Services
Goodwill [Roll Forward]
Balance at beginning of period	4,151.2	865.4
Acquisitions	87.9	3,213.5
Foreign currency translation and other	(61.8)	72.3
Balance at end of period	4,177.3	4,151.2
Precision and Science Technologies
Goodwill [Roll Forward]
Balance at beginning of period	1,431.4	227.5
Acquisitions	391.4	1,165.5
Foreign currency translation and other	(18.5)	38.4
Balance at end of period	$ 1,804.3	$ 1,431.4

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Goodwill by Acquisition (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Business Combination, Goodwill [Abstract]
Goodwill acquired	$ 479.3	$ 4,379
Seepex
Business Combination, Goodwill [Abstract]
Goodwill acquired	245.3
M-D Pneumatics and Kinney Vacuum Pumps
Business Combination, Goodwill [Abstract]
Goodwill acquired		80
Maximus Solutions
Business Combination, Goodwill [Abstract]
Goodwill acquired	75.7
Ingersoll Rand Industrial
Business Combination, Goodwill [Abstract]
Goodwill acquired		4,360.3
Albin Pump SAS
Business Combination, Goodwill [Abstract]
Goodwill acquired		3.2
Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	78.3	15.5
Industrial Technologies and Services
Business Combination, Goodwill [Abstract]
Goodwill acquired	87.9	3,213.5
Industrial Technologies and Services | Seepex
Business Combination, Goodwill [Abstract]
Goodwill acquired	0
Industrial Technologies and Services | M-D Pneumatics and Kinney Vacuum Pumps
Business Combination, Goodwill [Abstract]
Goodwill acquired		80
Industrial Technologies and Services | Maximus Solutions
Business Combination, Goodwill [Abstract]
Goodwill acquired	0
Industrial Technologies and Services | Ingersoll Rand Industrial
Business Combination, Goodwill [Abstract]
Goodwill acquired		3,198
Industrial Technologies and Services | Albin Pump SAS
Business Combination, Goodwill [Abstract]
Goodwill acquired		0
Industrial Technologies and Services | Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	7.9	15.5
Precision and Science Technologies
Business Combination, Goodwill [Abstract]
Goodwill acquired	391.4	1,165.5
Precision and Science Technologies | Seepex
Business Combination, Goodwill [Abstract]
Goodwill acquired	245.3
Precision and Science Technologies | M-D Pneumatics and Kinney Vacuum Pumps
Business Combination, Goodwill [Abstract]
Goodwill acquired		0
Precision and Science Technologies | Maximus Solutions
Business Combination, Goodwill [Abstract]
Goodwill acquired	75.7
Precision and Science Technologies | Ingersoll Rand Industrial
Business Combination, Goodwill [Abstract]
Goodwill acquired		1,162.3
Precision and Science Technologies | Albin Pump SAS
Business Combination, Goodwill [Abstract]
Goodwill acquired		3.2
Precision and Science Technologies | Other acquisitions
Business Combination, Goodwill [Abstract]
Goodwill acquired	$ 70.4	$ 0

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Amortized intangible assets:
Accumulated Amortization	$ (1,227.1)	$ (953.6)
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	5,139.8	4,750.8
Accumulated Amortization	(1,227.1)	(953.6)
Net Carrying Amount	3,912.7	3,797.2
Tradenames
Unamortized intangible assets:
Carrying amount	1,565.4	1,491.3
Customer lists and relationships
Amortized intangible assets:
Gross Carrying Amount	3,055	2,835
Accumulated Amortization	(1,048.3)	(841.3)
Net Carrying Amount	2,006.7	1,993.7
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(1,048.3)	(841.3)
Technology
Amortized intangible assets:
Gross Carrying Amount	356.4	279.9
Accumulated Amortization	(77.8)	(38.1)
Net Carrying Amount	278.6	241.8
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(77.8)	(38.1)
Tradenames
Amortized intangible assets:
Gross Carrying Amount	47.8	41.8
Accumulated Amortization	(19)	(15.6)
Net Carrying Amount	28.8	26.2
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(19)	(15.6)
Backlog
Amortized intangible assets:
Gross Carrying Amount	8.1	0
Accumulated Amortization	(5.1)	0
Net Carrying Amount	3	0
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(5.1)	0
Other
Amortized intangible assets:
Gross Carrying Amount	107.1	102.8
Accumulated Amortization	(76.9)	(58.6)
Net Carrying Amount	30.2	44.2
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (76.9)	$ (58.6)

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Narrative (Details)	3 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)tradename	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Goodwill [Line Items]
Goodwill impairment		$ 0	$ 0	$ 0
Amortization of intangible assets		332,900,000	335,100,000	105,300,000
Anticipated amortization of intangible assets in 2022		300,000,000
Anticipated amortization of intangible assets in 2023		300,000,000
Anticipated amortization of intangible assets in 2024		300,000,000
Anticipated amortization of intangible assets in 2025		200,000,000
Anticipated amortization of intangible assets in 2026		160,000,000
Impairment of other intangible assets	$ 19,900,000	0	19,900,000	0
Number of trade names | tradename	2
Tradenames
Goodwill [Line Items]
Impairment of indefinite-lived intangible assets		0	0	$ 0
Industrial Technologies and Services
Goodwill [Line Items]
Accumulated impairment loss of goodwill		$ 220,600,000	$ 220,600,000

Accrued Liabilities - Summary (

Accrued Liabilities - Summary (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Accrued Liabilities [Abstract]
Salaries, wages, and related fringe benefits	$ 232.1	$ 197
Contract liabilities	242.1	164.6
Product warranty	42.5	41.1
Operating lease liabilities	34.9	47.1
Restructuring	12.3	17.5
Taxes	41.6	116.1
Other	135.8	125.5
Total accrued liabilities	$ 741.3	$ 708.9

Accrued Liabilities - Accrued P

Accrued Liabilities - Accrued Product Warranty Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of period	$ 41.1	$ 19.1
Product warranty accruals	16.1	17.2
Acquired warranty	2.1	19.8
Settlements	(15.7)	(16.7)
Foreign currency translation and other	(1.1)	1.7
Balance at the end of period	$ 42.5	$ 41.1

Debt - Summary (Details)

Debt - Summary (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jun. 29, 2020	Feb. 29, 2020
Debt [Abstract]
Short-term borrowings	$ 0	$ 0
Long-term Debt and Lease Obligation, Net, Alternative [Abstract]
Finance leases and other long-term debt	23,900,000	17,200,000
Unamortized debt issuance costs	(29,500,000)	(41,400,000)
Total long-term debt, net, including current maturities	3,440,600,000	3,899,500,000
Current maturities of long-term debt	38,800,000	40,400,000
Total long-term debt, net	3,401,800,000	3,859,100,000
Dollar Term Loan B, due 2027
Long-term Debt and Lease Obligation, Net, Alternative [Abstract]
Long-term debt	$ 1,865,000,000	1,883,700,000		$ 1,900,000,000
Stated interest rate of debt instrument (as a percent)	1.84%
Weighted-average interest rate of debt instrument (as a percent)	1.86%
Unamortized discounts	$ 1,700,000			$ 2,400,000
Dollar Term Loan, due 2027
Long-term Debt and Lease Obligation, Net, Alternative [Abstract]
Long-term debt	$ 910,500,000	919,600,000
Stated interest rate of debt instrument (as a percent)	1.84%
Weighted-average interest rate of debt instrument (as a percent)	1.86%
Unamortized discounts	$ 900,000
Euro Term Loan, due 2027
Long-term Debt and Lease Obligation, Net, Alternative [Abstract]
Long-term debt	$ 670,700,000	728,000,000
Stated interest rate of debt instrument (as a percent)	2.00%
Weighted-average interest rate of debt instrument (as a percent)	2.00%
Unamortized discounts	$ 600,000
Dollar Term Loan Series A, due 2027
Long-term Debt and Lease Obligation, Net, Alternative [Abstract]
Long-term debt	$ 0	$ 392,400,000	$ 400,000,000
Weighted-average interest rate of debt instrument (as a percent)	2.86%
Unamortized discounts			$ 6,000,000

Debt - Narrative (Details)

Debt - Narrative (Details) € in Millions

Sep. 30, 2021USD ($)

Feb. 28, 2020USD ($)

Aug. 17, 2017USD ($)

Jun. 30, 2017

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)

Dec. 31, 2019USD ($)

Dec. 31, 2021EUR (€)

Jun. 29, 2020USD ($)

Feb. 29, 2020USD ($)

Feb. 28, 2020EUR (€)

Jun. 28, 2019USD ($)

Dec. 13, 2018

Dec. 12, 2018

Jul. 30, 2018USD ($)

Aug. 17, 2017EUR (€)

Mar. 04, 2016USD ($)

Mar. 03, 2016USD ($)

Jul. 30, 2013USD ($)

Jul. 30, 2013EUR (€)

Debt Instrument, Senior Secured Credit Facilities [Abstract]

"Change of Control" threshold (as a percent)

50.00%

35.00%

Write-off of unamortized debt issuance costs

$ 200,000

Loss on extinguishment of debt

$ 9,000,000

$ 9,000,000

2,000,000

$ 200,000

Outstanding borrowing

2,778,100,000

€ 590.6

Long-term Debt, Fiscal Year Maturity [Abstract]

Debt maturities, next twelve months

38,800,000

Debt maturities, year two

37,800,000

Debt maturities, year three

37,300,000

Debt maturities, year four

37,100,000

Debt maturities, year five

37,200,000

Debt maturities, after year five

$ 3,285,100,000

LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

1.00%

Interest Rate and Fees [Abstract]

Term of variable rate

1 month

Federal Funds Effective Rate

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.50%

Base Rate

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

1.00%

Senior Secured Credit Facility

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Aggregate borrowing

$ 2,825,000,000

Interest Rate and Fees [Abstract]

Commitment fee (as a percent)

0.375%

Commitment fee upon achievement of Level 1 status (as a percent)

0.25%

Commitment fee upon achievement of Level 2 status (as a percent)

0.125%

Prepayments [Abstract]

Reduction in proportion of the net cash proceeds of all non-ordinary course asset sales for prepayment of outstanding term loan (as a percent)

50.00%

Proportion of annual excess cash flow for prepayment of outstanding loan under restrictive covenants (as a percent)

25.00%

Proportion of the net cash proceeds of all non-ordinary course asset sales for prepayment of outstanding term loan (as a percent)

100.00%

Proportion of net cash proceeds of any incurrence of debt for prepayment of outstanding term loan (as a percent)

100.00%

Senior Secured Credit Facility | Incremental Term Loans / Revolving Commitments

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Maximum borrowing capacity

$ 1,600,000,000

Proportion of Consolidated EBITDA to determine maximum borrowing capacity (as a percent)

100.00%

100.00%

Receivables Financing Agreement [Abstract]

Aggregate borrowing capacity

$ 1,600,000,000

Senior Secured Credit Facility | Maximum

Interest Rate and Fees [Abstract]

Consolidated senior secured debt to consolidated EBITDA ratio at Level 1 status

1.75

Consolidated senior secured debt to consolidated EBITDA ratio at Level 2 status

1.50

Prepayments [Abstract]

Consolidated secured debt to consolidated EBITDA ratio considered for prepayment of outstanding term loan

2.25

Senior Secured Credit Facility | Minimum

Prepayments [Abstract]

Consolidated secured debt to consolidated EBITDA ratio considered for prepayment of outstanding term loan

2

Certain Covenants and Events of Default [Abstract]

Proportion of non-cash collateralized letters of credit (as a percent)

40.00%

Senior Secured Credit Facility | Condition One | Maximum

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Consolidated senior secured debt to consolidated EBITDA ratio

4.50

Senior Secured Credit Facility | Condition Two | Maximum

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Consolidated senior secured debt to consolidated EBITDA ratio

5

Original Dollar Term Loan Facility

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Aggregate borrowing

1,900,000,000

Maximum borrowing capacity

$ 1,285,500,000

Long-term debt

$ 927,600,000

Original issue discounts

1,200,000

Receivables Financing Agreement [Abstract]

Aggregate borrowing capacity

$ 1,285,500,000

Original Dollar Term Loan Facility | LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.00%

1.00%

Euro Term Loan due in 2020

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Aggregate borrowing | €

€ 400

Maximum borrowing capacity | €

€ 615

Long-term debt | €

€ 601.2

Write-off of unamortized debt issuance costs

$ 2,000,000

Original issue discounts | €

€ 0.8

Receivables Financing Agreement [Abstract]

Aggregate borrowing capacity | €

€ 615

Euro Term Loan due in 2020 | LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.00%

1.00%

2.00%

Revolving Credit Facility due 2020

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Maximum borrowing capacity

$ 269,900,000

$ 360,000,000

400,000,000

Decrease in borrowing capacity

40,000,000

Increase (decrease) in debt instrument

$ 100,000,000

Minimum aggregate principal amount for extension amendments

35,000,000

$ 50,000,000

Long-term debt

1,100,000,000

Receivables Financing Agreement [Abstract]

Aggregate borrowing capacity

$ 269,900,000

$ 360,000,000

$ 400,000,000

Revolving Credit Facility due 2020 | Ingersoll Rand

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Aggregate borrowing

1,100,000,000

Letters of credit outstanding

$ 400,000,000

Revolving Credit Facility due 2020 | LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

2.00%

Revolving Credit Facility due 2020 | Base Rate

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

1.00%

Revolving Credit Facility due 2020 | EURIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

2.00%

Revolving Credit Facility due 2020 | SONIA

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

2.00%

Revolving Credit Facility due 2020 | Maximum

Certain Covenants and Events of Default [Abstract]

Consolidated senior secured debt to consolidated EBITDA ratio

6.25

New Revolving Credit Facility

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Aggregate borrowing

$ 450,000,000

Basis spread on variable rate (as a percent)

0.00%

Letters of credit outstanding

$ 6,600,000

Outstanding borrowing

0

Unused borrowing capacity

$ 1,093,400,000

New Revolving Credit Facility | Ingersoll Rand

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Long-term debt

$ 1,000,000,000

Letters of credit outstanding

400,000,000

New Revolving Credit Facility | EURIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.00%

New Revolving Credit Facility | SONIA

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.00%

New Revolving Credit Facility | Letter of Credit

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Maximum borrowing capacity

200,000,000

Receivables Financing Agreement [Abstract]

Aggregate borrowing capacity

$ 200,000,000

Dollar Term Loan B, due 2027

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Long-term debt

$ 1,865,000,000

1,883,700,000

1,900,000,000

Original issue discounts

$ 1,700,000

$ 2,400,000

Dollar Term Loan B, due 2027 | LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

1.75%

Dollar Term Loan B, due 2027 | Base Rate

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.75%

Dollar Term Loan Series A, due 2027

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Long-term debt

$ 0

392,400,000

$ 400,000,000

Original issue discounts

$ 6,000,000

Prepayments [Abstract]

Proportion of prepayment premium of principal amount (as a percent)

1.00%

Dollar Term Loan, due 2024

Prepayments [Abstract]

Proportion of prepayment premium of principal amount (as a percent)

1.00%

Amortization and Final Maturity [Abstract]

Proportion of original principal amount for quarterly installment payment of debt amortization (as a percent)

1.00%

Dollar Term Loan, due 2024 | LIBOR

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

1.75%

Dollar Term Loan, due 2024 | Base Rate

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Basis spread on variable rate (as a percent)

0.75%

Dollar Term Loan, due 2027

Debt Instrument, Senior Secured Credit Facilities [Abstract]

Long-term debt

$ 910,500,000

$ 919,600,000

Original issue discounts

$ 900,000

Repayments of debt

$ 396,000,000

Benefit Plans - Reconciliation

Benefit Plans - Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Fair Value of Plan Assets:
Beginning balance	$ 679.8
Fair value of plan assets ending balance	682.4	$ 679.8
Pension Benefits | U.S. Plans
Reconciliation of Benefit Obligations:
Beginning balance	484.3	59.8
Service cost	5.3	5.8	$ 0
Interest cost	10.8	9.5	2.2
Plan amendments	0	0
Actuarial losses (gains)	(20)	18.1
Benefit payments	(25.7)	(29)
Acquisitions	0	421
Plan settlements	(12.9)	(0.9)
Effect of foreign currency exchange rate changes	0	0
Benefit obligations ending balance	441.8	484.3	59.8
Reconciliation of Fair Value of Plan Assets:
Beginning balance	395	61.1
Actual return on plan assets	4.8	36.5
Employer contributions	11.5	0.1
Acquisitions	12	327.2
Plan settlements	(12.9)	(0.9)
Benefit payments	(25.7)	(29)
Effect of foreign currency exchange rate changes	0	0
Fair value of plan assets ending balance	384.7	395	61.1
Funded Status as of Period End	(57.1)	(89.3)
Pension Benefits | Non-U.S. Plans
Reconciliation of Benefit Obligations:
Beginning balance	445.7	346.5
Service cost	4.3	3.8	1.5
Interest cost	4.6	6.1	7.7
Plan amendments	0	0
Actuarial losses (gains)	(30)	24.4
Benefit payments	(13.7)	(12.8)
Acquisitions	0	56.7
Plan settlements	0	0
Effect of foreign currency exchange rate changes	(14.7)	21
Benefit obligations ending balance	396.2	445.7	346.5
Reconciliation of Fair Value of Plan Assets:
Beginning balance	284.8	249.1
Actual return on plan assets	25.4	19
Employer contributions	7.6	7.6
Acquisitions	0	12
Plan settlements	0	0
Benefit payments	(13.7)	(12.8)
Effect of foreign currency exchange rate changes	(6.4)	9.9
Fair value of plan assets ending balance	297.7	284.8	249.1
Funded Status as of Period End	(98.5)	(160.9)
Other Postretirement Benefits
Reconciliation of Benefit Obligations:
Beginning balance	31.3	3.4
Service cost	0	0
Interest cost	0.6	0.5	0.1
Plan amendments	1.8	(1.6)
Actuarial losses (gains)	(1.6)	2
Benefit payments	(3.3)	(2.7)
Acquisitions	0	29.3
Plan settlements	0	0.3
Effect of foreign currency exchange rate changes	(0.1)	0.1
Benefit obligations ending balance	28.7	31.3	$ 3.4
Reconciliation of Fair Value of Plan Assets:
Funded Status as of Period End	$ (28.7)	$ (31.3)

Benefit Plans - Recognized as C

Benefit Plans - Recognized as Component of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Pension Benefits | U.S. Plans
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	$ (12.7)	$ (0.8)
Prior service cost	0	0
Amounts included in accumulated other comprehensive income (loss)	(12.7)	(0.8)
Pension Benefits | Non-U.S. Plans
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	26	75.7
Prior service cost	3.1	3.2
Amounts included in accumulated other comprehensive income (loss)	29.1	78.9
Other Postretirement Benefits
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]
Net actuarial losses (gains)	0.5	2.4
Prior service cost	0.2	(1.6)
Amounts included in accumulated other comprehensive income (loss)	$ 0.7	$ 0.8

Benefit Plans - Pension and Oth

Benefit Plans - Pension and Other Postretirement Benefit Liabilities in Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Total Pension and Other Postretirement Benefit Liabilities Included in Balance Sheets [Abstract]
Other assets	$ 10.4	$ 2.3
Accrued liabilities	(10.9)	(17.9)
Pension and other postretirement benefits	$ (183.8)	$ (265.9)

Benefit Plans - Accumulated Ben

Benefit Plans - Accumulated Benefit Obligation in Excess of Plan Assets (Details) - Pension Benefits - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
U.S. Plans
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	$ 385	$ 425.2
Accumulated benefit obligation	382.8	415.9
Fair value of plan assets	326.7	331
Accumulated benefit obligation	439.6	478
Non-U.S. Plans
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Projected benefit obligations	154.7	441.4
Accumulated benefit obligation	126.4	406.3
Fair value of plan assets	26.9	260.5
Accumulated benefit obligation	$ 386.4	$ 426.7

Benefit Plans - Net Periodic Be

Benefit Plans - Net Periodic Benefit Cost and Other Comprehensive (Loss) Income, Before Income Tax Effects (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pension Benefits | U.S. Plans
Net Periodic Benefit Cost (Income):
Service cost	$ 5.3	$ 5.8	$ 0
Interest cost	10.8	9.5	2.2
Expected return on plan assets	(12.2)	(12)	(2.2)
Amortization of net actuarial loss	0	0	0.1
Net periodic benefit cost	3.9	3.3	0.1
Gain due to settlement	(0.6)	0	0
Total net periodic benefit cost recognized	3.3	3.3	0.1
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial gain	(12.5)	(6.4)	(0.9)
Amortization of net actuarial gain (loss)	0.6	0	(0.1)
Total recognized in other comprehensive income (loss)	(11.9)	(6.4)	(1)
Total recognized in net periodic benefit (income) cost and other comprehensive income (loss)	(8.6)	(3.1)	(0.9)
Pension Benefits | Non-U.S. Plans
Net Periodic Benefit Cost (Income):
Service cost	4.3	3.8	1.5
Interest cost	4.6	6.1	7.7
Expected return on plan assets	(12.2)	(11)	(10.3)
Amortization of prior-service cost	0.2	0.1	0.1
Amortization of net actuarial loss	4.9	2.9	2
Total net periodic benefit cost recognized	1.8	1.9	1
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial gain	(43.3)	16.3	10.9
Amortization of net actuarial gain (loss)	(4.9)	(2.9)	(2)
Amortization of prior service cost	(0.2)	(0.1)	(0.1)
Effect of foreign currency exchange rate changes	(1.4)	4.2	1.1
Total recognized in other comprehensive income (loss)	(49.8)	17.5	9.9
Total recognized in net periodic benefit (income) cost and other comprehensive income (loss)	(48)	19.4	10.9
Other Postretirement Benefits
Net Periodic Benefit Cost (Income):
Service cost	0	0
Interest cost	0.6	0.5	0.1
Amortization of prior-service cost	0.1	0	0
Amortization of net actuarial loss	0.1	0	0
Net periodic benefit cost	0.8	0.5	0.1
Gain due to settlement	0	0.3	0
Total net periodic benefit cost recognized	0.8	0.8	0.1
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial gain	(1.6)	2	0.4
Amortization of net actuarial gain (loss)	(0.1)	0	0
Prior service cost	1.9	(1.6)	0
Amortization of prior service cost	(0.1)	0	0
Effect of foreign currency exchange rate changes	0	0	0
Total recognized in other comprehensive income (loss)	0.1	0.4	0.4
Total recognized in net periodic benefit (income) cost and other comprehensive income (loss)	$ 0.9	$ 1.2	$ 0.5

Benefit Plans - Weighted Averag

Benefit Plans - Weighted Average Actuarial Assumptions (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pension Benefits | U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate (as a percent)	2.40%	2.70%	4.00%
Expected long-term rate of return on plan assets (as a percent)	3.20%	2.60%	4.00%
Rate of compensation increases (as a percent)	3.00%	4.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate (as a percent)	2.70%	2.40%	3.00%
Rate of compensation increases (as a percent)	3.00%	3.00%
Pension Benefits | Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate (as a percent)	1.10%	1.60%	2.60%
Expected long-term rate of return on plan assets (as a percent)	4.30%	4.40%	4.90%
Rate of compensation increases (as a percent)	3.10%	2.70%	2.80%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate (as a percent)	1.60%	1.10%	1.70%
Rate of compensation increases (as a percent)	4.30%	3.10%	2.70%
Other Postretirement Benefits
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate (as a percent)			4.70%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate (as a percent)			3.80%
Other Postretirement Benefits | Minimum
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate (as a percent)	1.80%	2.30%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate (as a percent)	2.40%	1.90%
Other Postretirement Benefits | Maximum
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate (as a percent)	2.40%	3.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate (as a percent)	3.00%	2.30%

Benefit Plans - Assumed Health

Benefit Plans - Assumed Health Care Cost Trend Rate (Details) - Other Postretirement Benefits	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]
Healthcare cost trend rate assumed for next year (as a percent)	6.80%	6.30%	7.10%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) (as a percent)	4.50%	4.70%	7.10%

Benefit Plans - Estimated Benef

Benefit Plans - Estimated Benefit Payments for the Next Five Years (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Pension Benefits | U.S. Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2022		$ 38.1
2023		31
2024		28.6
2025		28.5
2026		26.8
Aggregate 2027-2031		127
Pension Benefits | U.S. Plans | Subsequent Event
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Expected future employer contributions in the next year	$ 4.2
Pension Benefits | Non-U.S. Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2022		13.7
2023		13.5
2024		14.3
2025		16.2
2026		16.4
Aggregate 2027-2031		85.8
Pension Benefits | Non-U.S. Plans | Subsequent Event
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Expected future employer contributions in the next year	6.8
Other Postretirement Benefits
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2022		3.3
2023		3.1
2024		2.8
2025		2.6
2026		2.3
Aggregate 2027-2031		$ 8.8
Other Postretirement Benefits | Subsequent Event
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Expected future employer contributions in the next year	$ 3.3

Benefit Plans - Long-Term Targe

Benefit Plans - Long-Term Target Allocations (Details)	12 Months Ended
	Dec. 31, 2021
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Proportion of U.S. and U.K pension plans in total benefit obligation (as a percent)	81.00%
Proportion of U.S. and U.K pension plans in total plan assets (as a percent)	93.00%
U.S. Plans
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	100.00%
U.S. Plans | Equity
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	13.00%
U.S. Plans | Fixed income
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	84.00%
U.S. Plans | Real estate and other
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	3.00%
UK Plan
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	100.00%
UK Plan | Equity
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	32.00%
UK Plan | Fixed income
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	30.00%
UK Plan | Real estate and other
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Long-term target allocations (as a percent)	38.00%

Benefit Plans - Fair Values of

Benefit Plans - Fair Values of Pension Plan Assets by Asset Category (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	$ 682.4	$ 679.8
Total contribution to defined contribution plans	40.6	35.9	$ 19.5
Amount of actuarially calculated contribution	4.9	4.4
Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	12.7	8.5
Equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	181.8	201.1
Equity | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	6.3
Equity | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	37	55.4
Equity | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	138.5	145.7
Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	403.4	391.7
Fixed income | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	34.9	25.2
Fixed income | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	35.9	41.5
Fixed income | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	38	103.6
Fixed income | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	5.2	19.7
Fixed income | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	41.1	71.5
Fixed income | U.S. fixed income - long corporate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	234.8	130.2
Fixed income | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	13.5
Other types of investments | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	49.5	42.3
Other types of investments | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	35	36.2
Investments Measured at NAV
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	446.8	194.7
Investments Measured at NAV | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | Equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	103.6	130.7
Investments Measured at NAV | Equity | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	6.3
Investments Measured at NAV | Equity | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	29	49
Investments Measured at NAV | Equity | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	68.3	81.7
Investments Measured at NAV | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	342.2	64
Investments Measured at NAV | Fixed income | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	9.6	0
Investments Measured at NAV | Fixed income | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | Fixed income | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	38	4.7
Investments Measured at NAV | Fixed income | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	5.2	4.5
Investments Measured at NAV | Fixed income | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	41.1	45.2
Investments Measured at NAV | Fixed income | U.S. fixed income - long corporate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	234.8	9.6
Investments Measured at NAV | Fixed income | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	13.5
Investments Measured at NAV | Other types of investments | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Investments Measured at NAV | Other types of investments | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	1	0
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	37	32.7
Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	12.7	8.5
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	24.3	24.2
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	24.3	24.2
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | U.S. fixed income - long corporate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other types of investments | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other types of investments | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets		0
Significant Observable Inputs (Level 2)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	164.6	416.2
Significant Observable Inputs (Level 2) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Observable Inputs (Level 2) | Equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	53.9	46.2
Significant Observable Inputs (Level 2) | Equity | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Observable Inputs (Level 2) | Equity | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	8	6.4
Significant Observable Inputs (Level 2) | Equity | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	45.9	39.8
Significant Observable Inputs (Level 2) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	61.2	327.7
Significant Observable Inputs (Level 2) | Fixed income | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	25.3	25.2
Significant Observable Inputs (Level 2) | Fixed income | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	35.9	41.5
Significant Observable Inputs (Level 2) | Fixed income | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	98.9
Significant Observable Inputs (Level 2) | Fixed income | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	15.2
Significant Observable Inputs (Level 2) | Fixed income | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	26.3
Significant Observable Inputs (Level 2) | Fixed income | U.S. fixed income - long corporate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	120.6
Significant Observable Inputs (Level 2) | Fixed income | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Observable Inputs (Level 2) | Other types of investments | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	49.5	42.3
Significant Observable Inputs (Level 2) | Other types of investments | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	34	36.2
Significant Unobservable Inputs (Level 3) | Cash and cash equivalents
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Equity | U.S. small-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Unobservable Inputs (Level 3) | Equity | U.S. large-cap
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Equity | International equity
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | Corporate bonds - international
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | UK index-linked gilts
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | U.S. fixed income - government securities
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | U.S. fixed income - short duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | U.S. fixed income - intermediate duration
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | U.S. fixed income - long corporate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Fixed income | Global fixed income
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0
Significant Unobservable Inputs (Level 3) | Other types of investments | International real estate
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) | Other types of investments | Other
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]
Fair value of plan assets	$ 34	$ 36.2

Stockholders' Equity and Nonc_2

Stockholders' Equity and Noncontrolling Interests - Narrative (Details) - USD ($)	Aug. 06, 2021	Jul. 17, 2020	Dec. 31, 2020	Nov. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Aug. 24, 2021
Noncontrolling Interest [Line Items]
Voting common stock authorized (shares)			1,000,000,000				1,000,000,000	1,000,000,000
Voting common stock outstanding (shares)			418,627,809				407,785,207	418,627,809
Voting common stock, par value (USD per share)			$ 0.01				$ 0.01	$ 0.01
Payments for repurchase of common stock							$ 736,800,000	$ 2,100,000	$ 18,600,000
Common Stock | Ingersoll Rand
Noncontrolling Interest [Line Items]
Number of shares owned by non-controlling owners (in shares)	14,894,317
Stock repurchased (usd per share)	$ 49.05
2018 Repurchase Program
Noncontrolling Interest [Line Items]
Stock repurchased (shares)								0
2021 Repurchase Program
Noncontrolling Interest [Line Items]
Amount authorized for repurchase							$ 250,000,000			$ 750,000,000
Stock repurchased (shares)							0
IR India Limited
Noncontrolling Interest [Line Items]
Ownership interest by parent (as a percent)		80.00%			74.00%		75.00%
Ownership interest by non-controlling owners (as a percent)		6.00%
Payments for repurchase of common stock		$ 14,900,000
Proportion of total shares authorized for sale in IPO (as a percent)				5.00%
Proportion of total shares sold in IPO (as a percent)				5.00%
Aggregate purchase price of stock sold during IPO				$ 11,900,000
Ownership interest in subsidiary (as a percent)			75.00%			80.00%
IR India Limited | Maximum
Noncontrolling Interest [Line Items]
Proportion of outstanding shares offered to be purchased in tender offer (as a percent)					26.00%
Ingersoll Rand | Common Stock | KKR
Noncontrolling Interest [Line Items]
Number of shares owned by non-controlling owners (in shares)	29,788,635						0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity	$ 9,071.2	$ 9,189.5	$ 1,869.9	$ 1,676
Other comprehensive loss, net of tax:	(2.3)	(1.4)	0
Unrealized Gains (Losses) on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity	$ 0	$ 0	(10.9)	(11.4)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity			(1)	0
Cumulative Effect, Period of Adoption, Adjustment | Unrealized Gains (Losses) on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity				$ (6.7)
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2018-02
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity			$ (8.2)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	$ 9,189.5	$ 1,869.9	$ 1,676
Other comprehensive income (loss), net of tax	(56.6)	268.8	(0.8)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	9,071.2	9,189.5	1,869.9
Cumulative Effect, Period of Adoption, Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period		(1)	0
Balance at end of period			(1)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	14.2	(256)	(247)
Before tax income (loss)	(58.3)	255.8	3
Income tax effect	4	14.4	(3.8)
Other comprehensive income (loss), net of tax	(54.3)	270.2	(0.8)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	(41.6)	14.2	(256)
Accumulated Other Comprehensive Income (Loss) | Cumulative Effect, Period of Adoption, Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			(8.2)
Foreign Currency Translation Adjustments, Net
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	74.6	(193.6)	(190.6)
Before tax income (loss)	(119.9)	253.1	4.1
Income tax effect	16.9	15.1	(5.6)
Other comprehensive income (loss), net of tax	(103)	268.2	(1.5)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	(29.9)	74.6	(193.6)
Foreign Currency Translation Adjustments, Net | Cumulative Effect, Period of Adoption, Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			(1.5)
Unrealized Gains (Losses) on Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	0	(10.9)	(11.4)
Before tax income (loss)	0	14.2	8.2
Income tax effect	0	(3.3)	(1)
Other comprehensive income (loss), net of tax	0	10.9	7.2
Divestiture of foreign subsidiaries	0
Balance at end of period	0	0	(10.9)
Unrealized Gains (Losses) on Cash Flow Hedges | Cumulative Effect, Period of Adoption, Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			(6.7)
Pension and Postretirement Benefit Plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	(60.4)	(51.5)	(45)
Before tax income (loss)	61.6	(11.5)	(9.3)
Income tax effect	(12.9)	2.6	2.8
Other comprehensive income (loss), net of tax	48.7	(8.9)	(6.5)
Divestiture of foreign subsidiaries	0
Balance at end of period	$ (11.7)	$ (60.4)	(51.5)
Pension and Postretirement Benefit Plans | Cumulative Effect, Period of Adoption, Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			$ 0

Accumulated Other Comprehensi_5

Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	$ 9,189.5	$ 1,869.9	$ 1,676
Other comprehensive income (loss), net of tax	(56.6)	268.8	(0.8)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	9,071.2	9,189.5	1,869.9
Cumulative Effect, Period of Adoption, Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period		(1)	0
Balance at end of period			(1)
Accumulated Other Comprehensive Income (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	14.2	(256)	(247)
Other comprehensive income (loss) before reclassifications	(57.8)	254	(14.4)
Amounts reclassified from accumulated other comprehensive income (loss)	3.5	16.2	13.6
Other comprehensive income (loss), net of tax	(54.3)	270.2	(0.8)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	(41.6)	14.2	(256)
Accumulated Other Comprehensive Income (Loss) | Cumulative Effect, Period of Adoption, Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period			(8.2)
Foreign Currency Translation Adjustments, Net
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	74.6	(193.6)	(190.6)
Other comprehensive income (loss) before reclassifications	(103)	268.2	(1.5)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Other comprehensive income (loss), net of tax	(103)	268.2	(1.5)
Divestiture of foreign subsidiaries	(1.5)
Balance at end of period	(29.9)	74.6	(193.6)
Foreign Currency Translation Adjustments, Net | Cumulative Effect, Period of Adoption, Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period			(1.5)
Unrealized Gains (Losses) on Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	0	(10.9)	(11.4)
Other comprehensive income (loss) before reclassifications	0	(3)	(4.7)
Amounts reclassified from accumulated other comprehensive income (loss)	0	13.9	11.9
Other comprehensive income (loss), net of tax	0	10.9	7.2
Divestiture of foreign subsidiaries	0
Balance at end of period	0	0	(10.9)
Unrealized Gains (Losses) on Cash Flow Hedges | Cumulative Effect, Period of Adoption, Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period			(6.7)
Pension and Postretirement Benefit Plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	(60.4)	(51.5)	(45)
Other comprehensive income (loss) before reclassifications	45.2	(11.2)	(8.2)
Amounts reclassified from accumulated other comprehensive income (loss)	3.5	2.3	1.7
Other comprehensive income (loss), net of tax	48.7	(8.9)	(6.5)
Divestiture of foreign subsidiaries	0
Balance at end of period	$ (11.7)	$ (60.4)	(51.5)
Pension and Postretirement Benefit Plans | Cumulative Effect, Period of Adoption, Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period			$ 0

Accumulated Other Comprehensi_6

Accumulated Other Comprehensive Income (Loss) - Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Interest expense	$ 87.7	$ 111.1	$ 88.4
Benefit for income taxes	21.8	(11.4)	(12.9)
Net income (loss) attributable to parent	562.5	(33.3)	159.1
Reclassification out of Accumulated Other Comprehensive (Loss) Income
Income Statement [Abstract]
Net income (loss) attributable to parent	3.5	16.2	13.6
Unrealized Gains (Losses) on Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive (Loss) Income
Income Statement [Abstract]
Interest expense	0	18.5	15.6
Benefit for income taxes	0	(4.6)	(3.7)
Net income (loss) attributable to parent	0	13.9	11.9
Pension and Postretirement Benefit Plans | Reclassification out of Accumulated Other Comprehensive (Loss) Income
Income Statement [Abstract]
Net periodic benefit cost	4.7	3	2.2
Benefit for income taxes	(1.2)	(0.7)	(0.5)
Net income (loss) attributable to parent	$ 3.5	$ 2.3	$ 1.7

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Abstract]
Revenues	$ 5,152.4	$ 3,973.2	$ 2,017.5
Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	4,799.6	3,662.1
Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	352.8	311.1
Original Equipment
Disaggregation of Revenue [Abstract]
Revenues	3,289.4	2,561.6
Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	1,863	1,411.6
Americas
Disaggregation of Revenue [Abstract]
Revenues	2,272.2	1,759.3
U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	1,986.8	1,439.9
Other Americas
Disaggregation of Revenue [Abstract]
Revenues	285.4	319.4
EMEIA
Disaggregation of Revenue [Abstract]
Revenues	1,731.5	1,310.9
Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	1,148.7	903
Industrial Technologies and Services
Disaggregation of Revenue [Abstract]
Revenues	4,161	3,248.2
Industrial Technologies and Services | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	3,811.3	2,937.1
Industrial Technologies and Services | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	349.7	311.1
Industrial Technologies and Services | Original Equipment
Disaggregation of Revenue [Abstract]
Revenues	2,467.1	1,942.8
Industrial Technologies and Services | Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	1,693.9	1,305.4
Industrial Technologies and Services | Americas
Disaggregation of Revenue [Abstract]
Revenues	1,819.5	1,423.5
Industrial Technologies and Services | U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	1,554.6	1,142.8
Industrial Technologies and Services | Other Americas
Disaggregation of Revenue [Abstract]
Revenues	264.9	280.7
Industrial Technologies and Services | EMEIA
Disaggregation of Revenue [Abstract]
Revenues	1,363.4	1,054.4
Industrial Technologies and Services | Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	978.1	770.3
Precision and Science Technologies
Disaggregation of Revenue [Abstract]
Revenues	991.4	725
Precision and Science Technologies | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	988.3	725
Precision and Science Technologies | Revenue recognized at point in time
Disaggregation of Revenue [Abstract]
Revenues	3.1	0
Precision and Science Technologies | Original Equipment
Disaggregation of Revenue [Abstract]
Revenues	822.3	618.8
Precision and Science Technologies | Aftermarket
Disaggregation of Revenue [Abstract]
Revenues	169.1	106.2
Precision and Science Technologies | Americas
Disaggregation of Revenue [Abstract]
Revenues	452.7	335.8
Precision and Science Technologies | U.S. Plans
Disaggregation of Revenue [Abstract]
Revenues	432.2	297.1
Precision and Science Technologies | Other Americas
Disaggregation of Revenue [Abstract]
Revenues	20.5	38.7
Precision and Science Technologies | EMEIA
Disaggregation of Revenue [Abstract]
Revenues	368.1	256.5
Precision and Science Technologies | Asia Pacific
Disaggregation of Revenue [Abstract]
Revenues	$ 170.6	$ 132.7

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Performance Obligations (Details) $ in Millions	Dec. 31, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Performance Obligation [Abstract]
Remaining performance obligation	$ 472.3
Remaining performance obligation, expected timing of satisfaction	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Performance Obligation [Abstract]
Remaining performance obligation	$ 396.7
Remaining performance obligation, expected timing of satisfaction

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Contract Balances (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Contract with Customer, Asset and Liability [Abstract]
Accounts receivable, net	$ 948.6	$ 861.8
Contract assets	60.8	60.4
Contract liabilities	$ 243.5	$ 166.2

Revenue from Contracts with C_6

Revenue from Contracts with Customers - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Revenue, Performance Obligation [Abstract]
Contract liabilities	$ 243.5	$ 166.2

Income Taxes - Income (Loss) Be

Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Income (loss) before income taxes, U.S.	$ 121.3	$ (158.4)	$ (100.5)
Income (loss) before income taxes, Non-U.S.	391.7	113	210.7
Income (Loss) Before Income Taxes	$ 513	$ (45.4)	$ 110.2

Income Taxes - Provision (Benef

Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
U.S. federal	$ (33.1)	$ 6.6	$ (14.6)
U.S. state and local	5.8	6.7	2.9
Non-U.S.	109.1	79.6	45.2
Deferred:
U.S. federal	(19.5)	(33.4)	(13.2)
U.S. state and local	(0.9)	(2.9)	0.5
Non-U.S.	(83.2)	(45.2)	(7.9)
Provision (benefit) for income taxes	$ (21.8)	$ 11.4	$ 12.9

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. federal corporate statutory rate (as a percent)	21.00%	21.00%	21.00%
State and local taxes, less federal tax benefit (as a percent)	1.10%	(8.00%)	4.10%
Net effects of foreign tax rate differential (as a percent)	1.00%	(14.60%)	2.30%
Sale of subsidiary (as a percent)	3.00%	(12.90%)	0.00%
Repatriation cost (as a percent)	1.40%	17.70%	0.00%
Global Intangible Low-Tax Income ("GILTI") (as a percent)	2.30%	(11.70%)	(4.30%)
ASC 740-30 (formerly APB 23) (as a percent)	2.90%	(18.60%)	2.00%
Valuation allowance changes (as a percent)	(5.40%)	4.80%	(4.30%)
Uncertain tax positions (as a percent)	(1.30%)	(4.70%)	0.70%
Equity compensation (as a percent)	(2.50%)	6.10%	(13.90%)
Capital gain (as a percent)	0.00%	0.00%	5.10%
Nondeductible acquisition costs (as a percent)	0.40%	(7.70%)	6.10%
Foreign Derived Intangible Income (“FDII”) deduction (as a percent)	(3.20%)	10.10%	0.00%
Tax credits (as a percent)	(0.80%)	4.70%	0.00%
Income not subject to tax (as a percent)	(3.30%)	0.00%	0.00%
Utilization of capital loss (as a percent)	(9.10%)	0.00%	0.00%
Non-U.S. deferred change related to asset sales (as a percent)	(8.00%)	0.00%	0.00%
Return to provision adjustment (as a percent)	(1.30%)	0.50%	0.00%
Other, net (as a percent)	(2.40%)	(11.80%)	(7.10%)
Effective income tax rate (as a percent)	(4.20%)	(25.10%)	11.70%

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deferred Tax Assets:
Reserves and accruals	$ 69.3	$ 72.9
Allowance for credit losses	10	11
Inventory reserve	12	10.4
Pension and postretirement benefit plans	41.7	62.6
Tax loss carryforwards	95.9	101.7
Deferred taxes recorded in other comprehensive income	10.2	18
Foreign tax credit carryforwards	43.8	74.6
Other	30.9	10.7
Total deferred tax assets	313.8	361.9
Valuation allowance	(106.4)	(140.6)
Deferred Tax Liabilities:
LIFO inventory	(16.2)	(16.2)
Investment in partnership	(37.4)	0
Property, plant and equipment	(40.9)	(49.4)
Intangible assets	(742.1)	(809.9)
Unremitted foreign earnings	(49.6)	(32.5)
Deferred taxes recorded in other comprehensive income	0	0
Other	(1.6)	0
Total deferred tax liabilities	(887.8)	(908)
Net deferred income tax liability	$ (680.4)	$ (686.7)

Income Taxes - Net Operating Lo

Income Taxes - Net Operating Loss and Tax Credit Carryforwards (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Tax Credit Carryforward [Line Items]
Excess interest	$ 11.3
Other deferred tax assets	3.7
Total tax carryforwards	144.4
Valuation Allowance [Abstract]
Excess interest	(3.7)
Other deferred tax assets	(4.9)
Total tax carryforwards	(106.4)
Domestic Tax Authority
Tax Credit Carryforward [Line Items]
Net operating loss not subject to expiration	0.3
Net operating loss subject to expiration	6.3
Tax credit carryforward	43.8
Alternative minimum tax credit	0.8
Valuation Allowance [Abstract]
Net operating loss not subject to expiration	(0.3)
Net operating loss subject to expiration	(0.1)
Tax credit carryforward	(43.8)
Alternative minimum tax credit		$ (0.1)
Domestic Tax Authority | Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Capital loss	0
Tax credit carryforward	0
Valuation Allowance [Abstract]
Capital loss	0
Tax credit carryforward	0
State and Local Jurisdiction
Tax Credit Carryforward [Line Items]
Net operating loss subject to expiration	6.5
Tax credit carryforward	0.2
Valuation Allowance [Abstract]
Net operating loss subject to expiration	(3.1)
Tax credit carryforward	0
Non U.S. Tax Authority
Tax Credit Carryforward [Line Items]
Net operating loss not subject to expiration	70.7
Valuation Allowance [Abstract]
Net operating loss not subject to expiration	(49.7)
Non U.S. Tax Authority | Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	0.8
Valuation Allowance [Abstract]
Tax credit carryforward	$ (0.7)

Income Taxes - Valuation Allowa

Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) - Valuation allowance for deferred tax assets - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ 140.6	$ 67.9	$ 72.5
Revaluation or additions due to acquisitions or mergers	0	63.3	0
Charged to tax expense	(27.6)	8.3	(5.4)
Charged to other accounts	(6.6)	1.1	0.1
Deductions	0	0	0.7
Ending balance	$ 106.4	$ 140.6	$ 67.9

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)Jurisdiction	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Income Tax Contingency [Line Items]
Unrecognized tax benefits	$ 21.1	$ 27.8	$ 12.5	$ 11.5
Gross increases for tax positions of current year	5.3	16.8	0
Changes due to currency fluctuations		2	$ 0.4
Unrecognized tax benefits, that would effect effective tax rate if recognized	21.1
Unrecognized tax benefits offset by reduction of corresponding deferred tax asset	0.1
Interest and penalties accrued	$ 1.2	$ 2.3
Number of jurisdictions outside U.S. | Jurisdiction	47
Income tax reconciliation withholding tax	$ 49.6

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits and Other Disclosures (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$ 27.8	$ 12.5	$ 11.5
Gross increases for tax positions of prior years	0.8	0	0.6
Gross increases for tax positions of current year	5.3	16.8	0
Lapse of statute of limitations	(11.8)	(3.5)	0
Changes due to currency fluctuations	(1)
Changes due to currency fluctuations		2	0.4
Ending balance	$ 21.1	$ 27.8	$ 12.5

Leases - Components of Lease Ex

Leases - Components of Lease Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Lease, Cost [Abstract]
Operating lease cost	$ 50.6	$ 46.1
Finance lease cost
Amortization of right-of-use assets	1.5	1.2
Interest on lease liabilities	1.1	1.1
Total finance lease cost	2.6	2.3
Short-term lease cost	$ 2	$ 2

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flows Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases	$ 52	$ 56.6
Operating cash flows from finance leases	1.1	1.1
Financing cash flows from finance leases	1.1	0.7
Leased Assets Obtained in Exchange for New Operating Lease Liabilities(1)	$ 15.8	$ 161.3

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Operating leases
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets	Other assets
Other assets	$ 101.8	$ 142.9
Operating Lease Liabilities, Gross Difference, Amount [Abstract]
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued liabilities	Accrued liabilities
Accrued liabilities	$ 34.9	$ 47.1
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities	Other liabilities
Other liabilities	$ 61	$ 90.5
Total operating lease liabilities	$ 95.9	$ 137.6
Finance Leases
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, net of accumulated depreciation of $357.7 and $291.1, respectively	Property, plant and equipment, net of accumulated depreciation of $357.7 and $291.1, respectively
Property, plant and equipment	$ 15.1	$ 15.7
Finance Lease Liabilities, Gross Difference, Amount [Abstract]
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Short-term borrowings and current maturities of long-term debt	Short-term borrowings and current maturities of long-term debt
Short-term borrowings and current maturities of long-term debt	$ 1.1	$ 0.7
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-term debt, less current maturities	Long-term debt, less current maturities
Long-term debt, less current maturities	$ 16	$ 16.5
Total finance lease liabilities	$ 17.1	$ 17.2
Weighted Average Remaining Lease Term (in years)
Operating leases, weighted average remaining lease term	4 years	3 years 6 months
Finance leases, weighted average remaining lease term	11 years 10 months 24 days	13 years 2 months 12 days
Weighted Average Discount Rate
Operating leases (as a percent)	1.80%	1.80%
Finance leases (as a percent)	6.30%	6.40%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Operating Leases
2022	$ 36.1
2023	26.9
2024	14.5
2025	7.6
2026	5.1
Thereafter	9.2
Total lease payments	99.4
Less imputed interest	(3.5)
Total operating lease liabilities	95.9	$ 137.6
Finance Leases
2022	2.2
2023	2.2
2024	2.2
2025	2
2026	2
Thereafter	14.6
Total lease payments	25.2
Less imputed interest	(8.1)
Total finance lease liabilities	$ 17.1	$ 17.2

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ / shares in Units, employee in Thousands, shares in Millions	3 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020USD ($)employee	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / shares	Dec. 31, 2019USD ($)$ / shares	May 31, 2017shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			$ 98,100,000	$ 51,300,000	$ 19,200,000
Accrued liabilities			$ 741,300,000	$ 708,900,000
Weighted average grant date fair value of stock options granted (USD per share) | $ / shares			$ 18.06	$ 9.29	$ 10.16
Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			$ 87,200,000	$ 47,500,000	$ 18,700,000
Share-based Payment Arrangement, Total Equity Grant to Employees		$ 150,000,000
Share-based Payment Arrangement, Total Equity Grant to Employees, Number of Employees | employee		16
Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			$ 10,900,000	$ 3,800,000	500,000
Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			3 years
Expected life of options (in years)			2 years 10 months 24 days	2 years 9 months 18 days
Risk-free interest rate (as a percent)			0.20%	0.50%
Volatility rate (as a percent)			36.90%	35.20%
Expected dividend rate (as a percent)			0.00%	0.00%
Stock Appreciation Rights (SARs) | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized					8,000,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of stock options exercised			$ 53,500,000	$ 66,000,000	109,800,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Former Employee | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized				2,900,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Former Employee | Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			3,800,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Equity Awards | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			85,800,000	43,300,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Equity Awards | Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			7,100,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Equity Awards - Founders Grant | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized		$ 23,400,000	57,400,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Equity Awards - Founders Grant | Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized			5,400,000
2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan | Stock Appreciation Rights (SARs) | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase (decrease) in liabilities			$ 1,400,000	1,300,000
Omnibus Incentive Plan 2017 | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized					9,700,000
Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award expiration period			10 years
2013 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital stock reserved for future issuance (shares) | shares			20.9
2013 Stock Incentive Plan | Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized					$ 1,000,000
2013 Stock Incentive Plan | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accrued liabilities			$ 4,500,000	$ 3,500,000
2013 Stock Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense			85,500,000
2013 Stock Incentive Plan | Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense			$ 85,500,000
2013 Stock Incentive Plan | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
2013 Stock Incentive Plan | Tranche One | Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
2013 Stock Incentive Plan | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
2013 Stock Incentive Plan | Tranche Two | Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
2013 Stock Incentive Plan | Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
2013 Stock Incentive Plan | Tranche Three | Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate (as a percent)			50.00%
Minimum | Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			4 years
Maximum | Omnibus Incentive Plan 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital stock reserved for future issuance (shares) | shares						19.6
Maximum | Omnibus Incentive Plan 2017 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			5 years

Stock-Based Compensation -Stock

Stock-Based Compensation -Stock-based Compensation Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized	$ 98.1	$ 51.3	$ 19.2
Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized	10.9	3.8	0.5
Continuing Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense recognized	$ 87.2	$ 47.5	$ 18.7

Stock-Based Compensation - Assu

Stock-Based Compensation - Assumptions Used to Estimate Fair Value (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stock Options and SARs
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	6 years 3 months 18 days	6 years 3 months 18 days	6 years 3 months 18 days
Expected dividend rate (as a percent)		0.00%	0.00%
Stock Options and SARs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate (as a percent)	0.90%	0.40%	1.70%
Volatility rate (as a percent)	38.60%	24.60%	24.80%
Expected dividend rate (as a percent)	0.00%
Stock Options and SARs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate (as a percent)	1.30%	1.50%	2.60%
Volatility rate (as a percent)	39.40%	41.10%	31.80%
Expected dividend rate (as a percent)	0.10%
Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	2 years 10 months 24 days	2 years 9 months 18 days
Risk-free interest rate (as a percent)	0.20%	0.50%
Volatility rate (as a percent)	36.90%	35.20%
Expected dividend rate (as a percent)	0.00%	0.00%
Ingersoll Rand
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate (as a percent)	0.90%
Volatility rate (as a percent)	34.20%
Expected dividend rate (as a percent)	0.00%
Ingersoll Rand | Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	2 years
Ingersoll Rand | Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life of options (in years)	3 years 7 months 6 days

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Awards (Details) - Stock Options and SARs $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Shares
Balance at beginning of period (shares) | shares	7,742
Granted (shares) | shares	795
Exercised or settled (shares) | shares	(1,530)
Forfeited (shares) | shares	(255)
Expired (shares) | shares	(6)
Balance at end of period (shares) | shares	6,746
Vested (shares) | shares	4,351
Weighted-Average Exercise Price (per share)
Balance at beginning of period (USD per share) | $ / shares	$ 18.47
Granted (USD per share) | $ / shares	45.78
Exercised or settled (USD per share) | $ / shares	16.11
Forfeited (USD per share) | $ / shares	30.77
Expired (USD per share) | $ / shares	13.01
Balance at end of period (USD per share) | $ / shares	21.76
Vested (USD per share) | $ / shares	$ 15.89
Weighted average remaining contractual term of options outstanding	5 years 8 months 12 days
Weighted average remaining contractual term of options vested	4 years 4 months 24 days
Aggregate intrinsic value of in-the-money options outstanding | $	$ 268.7
Aggregate intrinsic value of in-the-money options vested | $	$ 198.2

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Unit Awards (Details) - Restricted Stock Units shares in Thousands	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shares [Roll Forward]
Balance at beginning of period (shares) | shares	5,546
Granted (shares) | shares	340
Vested (shares) | shares	(2,542)
Forfeited (shares) | shares	(667)
Balance at end of period (shares) | shares	2,677
Weighted-Average Grant-Date Fair Value [Abstract]
Balance at beginning of period (USD per share) | $ / shares	$ 33.09
Granted (USD per share) | $ / shares	45.76
Vested (USD per share) | $ / shares	33.44
Forfeited (USD per share) | $ / shares	34.27
Balance at end of period (USD per share) | $ / shares	$ 34.08

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance Share Unit Awards (Details) - Performance Share Units shares in Thousands	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shares [Roll Forward]
Balance at beginning of period (shares) | shares	255
Granted (shares) | shares	158
Vested (shares) | shares	0
Forfeited (shares) | shares	(20)
Balance at end of period (shares) | shares	393
Weighted-Average Grant-Date Fair Value [Abstract]
Balance at beginning of period (USD per share) | $ / shares	$ 29.72
Granted (USD per share) | $ / shares	55.84
Vested (USD per share) | $ / shares	0
Forfeited (USD per share) | $ / shares	36.36
Balance at end of period (USD per share) | $ / shares	$ 39.89

Hedging Activities, Derivativ_3

Hedging Activities, Derivative Instruments and Credit Risk - Narrative (Details) € in Millions	12 Months Ended
	Dec. 31, 2021USD ($)contract	Dec. 31, 2021EUR (€)contract	Dec. 31, 2020USD ($)
Derivatives, Fair Value [Line Items]
Outstanding borrowing	$ 2,778,100,000	€ 590.6
Off-balance sheet derivative instruments	$ 0		$ 0
Interest rate swap contracts
Derivatives, Fair Value [Line Items]
Number of instruments held | contract	0	0
Foreign currency forwards
Derivatives, Fair Value [Line Items]
Number of instruments held | contract	5	5
Foreign currency forwards | Minimum
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 2,300,000
Foreign currency forwards | Maximum
Derivatives, Fair Value [Line Items]
Term of derivative contract	1 year
Notional amount of derivative	$ 14,900,000

Hedging Activities, Derivativ_4

Hedging Activities, Derivative Instruments and Credit Risk - Balance Sheets (Details) - Foreign currency forwards - Derivatives Not Designated as Hedging Instruments - Fair Value - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 22.1	$ 230.5
Other Current Assets
Derivatives, Fair Value [Line Items]
Assets fair value	0	2.9
Other Assets
Derivatives, Fair Value [Line Items]
Assets fair value	0	0
Accrued Liabilities
Derivatives, Fair Value [Line Items]
Liabilities fair value	0	0
Other Liabilities
Derivatives, Fair Value [Line Items]
Liabilities fair value	0	0
Notional amount of derivative	19.3	51.2
Other Current Assets
Derivatives, Fair Value [Line Items]
Assets fair value	0	0
Other Assets
Derivatives, Fair Value [Line Items]
Assets fair value	0	0
Accrued Liabilities
Derivatives, Fair Value [Line Items]
Liabilities fair value	0.2	0.7
Other Liabilities
Derivatives, Fair Value [Line Items]
Liabilities fair value	$ 0	$ 0

Hedging Activities, Derivativ_5

Hedging Activities, Derivative Instruments and Credit Risk - Comprehensive Income (Loss) (Details) - Interest rate swap contracts - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Gains and Losses on Derivatives Designated as Cash Flow Hedges [Abstract]
Gain (loss) recognized in AOCI on derivatives	$ 0	$ (4.4)	$ (7.4)
Loss reclassified from AOCI into income (effective portion)	$ 0	$ (18.5)	$ (15.6)

Hedging Activities, Derivativ_6

Hedging Activities, Derivative Instruments and Credit Risk - Derivative Instruments not Designated as Accounting Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]
Total foreign currency transaction gains (losses), net	$ 12	$ (18.6)	$ (7.3)
Foreign currency forward contracts gains (losses)
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]
Total foreign currency transaction gains (losses), net	$ (3.2)	$ 15	$ (4.9)

Hedging Activities, Derivativ_7

Hedging Activities, Derivative Instruments and Credit Risk - Investment in Consolidated Subsidiaries with Functional Currencies Other than USD (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2021EUR (€)	Dec. 31, 2021USD ($)	Aug. 17, 2017EUR (€)
Euro Term Loan due in 2020
Derivatives, Fair Value [Line Items]
Amount of hedged item | €			€ 590.6		€ 615
Interest rate swap contracts
Derivatives, Fair Value [Line Items]
Gain (loss), net of income tax, recorded through other comprehensive income	$ 35	$ (45.1)
Balance included in accumulated other comprehensive income (loss) as of December 31, 2021 and 2020, respectively		$ 30.7		$ 65.7

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements (Details)	3 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)trademark	Dec. 31, 2019USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Impairment of other intangible assets	$ 19,900,000	$ 0	$ 19,900,000	$ 0
Number of trademarks with carrying value above estimated fair value | trademark			2
Recurring
Financial Assets
Foreign currency forwards		0	$ 2,900,000
Trading securities held in deferred compensation plan		12,000,000	9,100,000
Total		12,000,000	12,000,000
Financial Liabilities
Foreign currency forwards		200,000	700,000
Deferred compensation plan		22,400,000	25,700,000
Total		22,600,000	26,400,000
Level 1 | Recurring
Financial Assets
Foreign currency forwards		0	0
Trading securities held in deferred compensation plan		12,000,000	9,100,000
Total		12,000,000	9,100,000
Financial Liabilities
Foreign currency forwards		0	0
Deferred compensation plan		22,400,000	25,700,000
Total		22,400,000	25,700,000
Level 2 | Recurring
Financial Assets
Foreign currency forwards		0	2,900,000
Trading securities held in deferred compensation plan		0	0
Total		0	2,900,000
Financial Liabilities
Foreign currency forwards		200,000	700,000
Deferred compensation plan		0	0
Total		200,000	700,000
Level 3 | Recurring
Financial Assets
Foreign currency forwards		0	0
Trading securities held in deferred compensation plan		0	0
Total		0	0
Financial Liabilities
Foreign currency forwards		0	0
Deferred compensation plan		0	0
Total		$ 0	$ 0

Contingencies (Details)

Contingencies (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)defendant	Dec. 31, 2020USD ($)
Loss Contingencies [Line Items]
Undiscounted accrual liabilities for environmental loss contingencies	$ 12.9	$ 13.7
Asbestos and Silica Related Litigation
Loss Contingencies [Line Items]
Estimated litigation liability	136.9	131.4
Insurance recovery receivable	145.1	132.1
Asbestos related insurance recoveries	$ 0	$ 0
Asbestos and Silica Related Litigation | Minimum
Loss Contingencies [Line Items]
Number of defendants | defendant	25

Other Operating Expense, Net -

Other Operating Expense, Net - Summary (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Operating Expense, Net [Abstract]
Foreign currency transaction losses (gains), net	$ (12)	$ 18.6	$ 7.3
Restructuring charges	13.4	83	11.1
Shareholder litigation settlement recoveries	0	0	(6)
Acquisition related expenses and non-cash charges	55.3	93.3	53.8
Other, net	5.2	6.1	3.1
Total other operating expense, net	$ 61.9	$ 201	$ 69.3

Former Related Party - Narrativ

Former Related Party - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2021	Aug. 06, 2021
Affiliated Entity
Related Party Transaction [Line Items]
Expenses from transactions with related party	$ 0.4	$ 7.5
Common Stock | Ingersoll Rand
Related Party Transaction [Line Items]
Number of shares owned by non-controlling owners (in shares)				14,894,317
Ingersoll Rand | Common Stock | KKR
Related Party Transaction [Line Items]
Number of shares owned by non-controlling owners (in shares)			0	29,788,635

Earnings Per Share - Summary (D

Earnings Per Share - Summary (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Average shares outstanding:
Basic (in shares)	414.8	382.8	203.5
Diluted (in shares)	421.2	382.8	208.9

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings (loss) per share (shares)	0.7	4.4	1.8

SCHEDULE I - STATEMENTS OF OPER

SCHEDULE I - STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statements of Operations and Comprehensive Income [Abstract]
Revenues	$ 5,152.4	$ 3,973.2	$ 2,017.5
Cost of sales	3,163.9	2,568.3	1,239.2
Gross Profit	1,988.5	1,404.9	778.3
Other operating expense, net	61.9	201	69.3
Operating Income	565.7	59.6	194.1
Income (Loss) Before Income Taxes	513	(45.4)	110.2
Income tax provision (benefit)	(21.8)	11.4	12.9
Income (loss) from continuing operations	523.4	(56.8)	97.3
Income from discontinued operations, net of tax	41.6	24.4	61.8
Net Income (Loss) Attributable to Ingersoll Rand Inc.	562.5	(33.3)	159.1
Other comprehensive income (loss)	(54.3)	270.2	(0.8)
Comprehensive income attributable to Ingersoll Rand Inc.	508.2	236.9	158.3
Parent Company
Statements of Operations and Comprehensive Income [Abstract]
Revenues	0	0	0
Cost of sales	1	14.6	0.6
Gross Profit	(1)	(14.6)	(0.6)
Operating costs	67.9	30.9	10.4
Other operating expense, net	(8.4)	(4.9)	(47)
Operating Income	(60.5)	(40.6)	36
Interest income	(28.8)	42.5	42.3
Income (Loss) Before Income Taxes	(89.3)	1.9	78.3
Income tax provision (benefit)	(18.1)	(3.9)	(5.1)
Income (Loss) of Parent Company	(71.2)	5.8	83.4
Equity in undistributed income of subsidiaries	592.1	(63.5)	13.9
Income (loss) from continuing operations	520.9	(57.7)	97.3
Income from discontinued operations, net of tax	41.6	24.4	61.8
Net Income (Loss) Attributable to Ingersoll Rand Inc.	562.5	(33.3)	159.1
Other comprehensive income (loss)	(54.3)	270.2	(0.8)
Comprehensive income attributable to Ingersoll Rand Inc.	$ 508.2	$ 236.9	$ 158.3

SCHEDULE I - BALANCE SHEETS (De

SCHEDULE I - BALANCE SHEETS (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets [Abstract]
Cash and cash equivalents	$ 2,109.6	$ 1,750.9
Other current assets	186.9	195.3
Total current assets	4,114.9	3,862.1
Deferred tax assets	28	15.6
Total identifiable assets	15,154.5	16,058.6
Liabilities and Equity
Total liabilities	6,083.3	6,869.1
Stockholders’ equity:
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 423,785,571 and 420,123,978 shares issued as of December 31, 2021 and 2020, respectively	4.3	4.2
Capital in excess of par value	9,408.6	9,310.3
Accumulated deficit	378.6	(175.7)
Accumulated other comprehensive loss	(41.6)	14.2
Treasury stock at cost; 16,000,364 and 1,496,169 shares as of December 31, 2021 and 2020, respectively	(748.4)	(33.3)
Total Ingersoll Rand Inc. stockholders’ equity	9,001.5	9,119.7
Total liabilities and equity	$ 15,154.5	$ 16,058.6
Balance Sheet Related Disclosures [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock authorized (shares)	1,000,000,000	1,000,000,000
Common stock issued (shares)	423,785,571	420,123,978
Treasury stock (shares)	16,000,364	1,496,169
Parent Company
Current assets [Abstract]
Cash and cash equivalents	$ 0	$ 0
Other current assets	0	0.4
Total current assets	0	0.4
Equity in net assets of subsidiaries	8,513.3	8,006
Intercompany receivables	484.1	1,107.3
Deferred tax assets	10.8	10.9
Total identifiable assets	9,008.2	9,124.6
Liabilities and Equity
Other liabilities	6.7	4.9
Total liabilities	6.7	4.9
Stockholders’ equity:
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 423,785,571 and 420,123,978 shares issued as of December 31, 2021 and 2020, respectively	4.3	4.2
Capital in excess of par value	9,408.6	9,310.3
Accumulated deficit	378.6	(175.7)
Accumulated other comprehensive loss	(41.6)	14.2
Treasury stock at cost; 16,000,364 and 1,496,169 shares as of December 31, 2021 and 2020, respectively	(748.4)	(33.3)
Total Ingersoll Rand Inc. stockholders’ equity	9,001.5	9,119.7
Total liabilities and equity	$ 9,008.2	$ 9,124.6

SCHEDULE I - CONDENSED STATEMEN

SCHEDULE I - CONDENSED STATEMENTS OF CASH FLOWS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash Flows From Financing Activities [Abstract]
Proceeds from stock option exercises	$ 23.7	$ 22.7	$ 42.7
Cash dividends on common stock	(8.2)	0	0
Purchases of treasury stock	(736.8)	(2.1)	(18.6)
Purchase of shares from noncontrolling interests	0	(14.9)	0
Proceeds from sale of noncontrolling interests	0	11.9	0
Net increase in cash and cash equivalents	358.7	1,245.4	284.3
Cash and cash equivalents, beginning of year	1,750.9	505.5	221.2
Cash and cash equivalents, end of year	2,109.6	1,750.9	505.5
Parent Company
Cash Flows From Operating Activities [Abstract]
Net cash provided by (used in) operating activities	(9.7)	(15.1)	(15.1)
Cash Flows From Investing Activities [Abstract]
Advances to subsidiaries	731	(2.5)	(10.1)
Net cash used in investing activities from continuing operations	731	(2.5)	(10.1)
Cash Flows From Financing Activities [Abstract]
Proceeds from stock option exercises	23.7	22.7	42.8
Cash dividends on common stock	(8.2)	0	0
Purchases of treasury stock	(736.8)	(2.1)	(18.6)
Purchase of shares from noncontrolling interests	0	(14.9)	0
Proceeds from sale of noncontrolling interests	0	11.9	0
Net cash (used in) provided by financing activities from continuing operations	(721.3)	17.6	24.2
Net increase in cash and cash equivalents	0	0	(1)
Cash and cash equivalents, beginning of year	0	0	1
Cash and cash equivalents, end of year	$ 0	$ 0	$ 0

SCHEDULE I - FINANCIAL STATEM_2

SCHEDULE I - FINANCIAL STATEMENTS, Disclosure (Details) € in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2021EUR (€)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Debt [Abstract]
Long-term debt obligations	$ 2,778,100,000	€ 590.6
Parent Company
Subsidiary Transactions [Abstract]
Dividends receivable	$ 0		$ 0	$ 0
Debt [Abstract]
Debt instrument, term	5 years
Long-term debt obligations	$ 0		$ 0

Uncategorized Items - gdi-20211

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2018-02 [Member]